LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3re4-assembly1.cif.gz_A	3re4-assembly1.cif.gz_A Crystal Structure of Archaeoglobus Fulgidus Rio1 Kinase bound to Toyocamycin.	2.598E-21	1.000	729	15	260	263	10	251	252	257	0.935	0.960
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3re4-assembly2.cif.gz_B	3re4-assembly2.cif.gz_B Crystal Structure of Archaeoglobus Fulgidus Rio1 Kinase bound to Toyocamycin.	4.335E-21	1.000	720	15	258	263	10	246	249	255	0.928	0.952
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6zxf-assembly1.cif.gz_z	6zxf-assembly1.cif.gz_z Cryo-EM structure of a late human pre-40S ribosomal subunit - State G	3.175E-20	1.000	692	21	258	263	6	258	373	256	0.905	0.678
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1zth-assembly4.cif.gz_D	1zth-assembly4.cif.gz_D Crystal Structure of A.fulgidus Rio1 serine protein kinase bound to ADP and Manganese ion	1.049E-19	1.000	686	15	259	263	12	243	244	252	0.932	0.951
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1zth-assembly2.cif.gz_B	1zth-assembly2.cif.gz_B Crystal Structure of A.fulgidus Rio1 serine protein kinase bound to ADP and Manganese ion	9.359E-20	1.000	684	15	260	263	10	240	241	257	0.935	0.959
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1zth-assembly3.cif.gz_C	1zth-assembly3.cif.gz_C Crystal Structure of A.fulgidus Rio1 serine protein kinase bound to ADP and Manganese ion	1.750E-19	1.000	683	15	260	263	12	240	241	252	0.935	0.950
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1zth-assembly1.cif.gz_A	1zth-assembly1.cif.gz_A Crystal Structure of A.fulgidus Rio1 serine protein kinase bound to ADP and Manganese ion	1.852E-19	1.000	672	15	260	263	10	244	245	257	0.935	0.959
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1ztf-assembly1.cif.gz_A	1ztf-assembly1.cif.gz_A Crystal Structure of A.fulgidus Rio1 serine protein kinase	3.371E-18	1.000	636	28	259	263	20	252	253	243	0.882	0.921
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6zxh-assembly1.cif.gz_z	6zxh-assembly1.cif.gz_z Cryo-EM structure of a late human pre-40S ribosomal subunit - State H2	3.000E-20	1.000	616	3	260	263	1	277	349	295	0.981	0.794
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4otp-assembly1.cif.gz_A	4otp-assembly1.cif.gz_A Crystal structure of the catalytic domain of the human RioK1 atypical protein kinase in complex with ADP/Mg2+	7.705E-17	1.000	582	36	258	263	1	190	235	224	0.848	0.809
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6zxd-assembly1.cif.gz_z	6zxd-assembly1.cif.gz_z Cryo-EM structure of a late human pre-40S ribosomal subunit - State F1	6.496E-17	1.000	579	34	258	263	25	224	292	227	0.856	0.685
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6zxe-assembly1.cif.gz_z	6zxe-assembly1.cif.gz_z Cryo-EM structure of a late human pre-40S ribosomal subunit - State F2	1.286E-16	1.000	485	36	260	263	1	214	265	241	0.856	0.808
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6zv6-assembly1.cif.gz_h	6zv6-assembly1.cif.gz_h Human RIO1(kd)-StHA late pre-40S particle, structural state B (post 18S rRNA cleavage)	1.761E-15	1.000	471	36	260	263	1	209	221	241	0.856	0.946
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1zar-assembly1.cif.gz_A	1zar-assembly1.cif.gz_A Crystal Structure of A.fulgidus Rio2 Kinase Complexed With ADP and Manganese Ions	4.259E-14	1.000	471	42	259	263	80	266	267	218	0.829	0.700
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1zao-assembly1.cif.gz_A	1zao-assembly1.cif.gz_A Crystal Structure of A.fulgidus Rio2 Kinase Complexed With ATP and Manganese Ions	2.218E-13	1.000	446	42	260	263	81	270	271	219	0.833	0.701
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6fdm-assembly2.cif.gz_C	6fdm-assembly2.cif.gz_C Human Rio2 kinase structure	8.430E-14	1.000	429	38	262	263	73	278	285	231	0.856	0.723
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7vbt-assembly1.cif.gz_B	7vbt-assembly1.cif.gz_B Crystal structure of RIOK2 in complex with CQ211	4.024E-14	1.000	429	38	262	263	73	278	286	236	0.856	0.720
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6fdm-assembly1.cif.gz_B	6fdm-assembly1.cif.gz_B Human Rio2 kinase structure	1.329E-13	1.000	428	38	262	263	67	269	280	228	0.856	0.725
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6fdm-assembly2.cif.gz_D	6fdm-assembly2.cif.gz_D Human Rio2 kinase structure	7.964E-14	1.000	427	38	262	263	69	276	283	233	0.856	0.735
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6fdn-assembly1.cif.gz_A	6fdn-assembly1.cif.gz_A Rio2 structure	3.302E-13	1.000	419	38	253	263	43	231	232	219	0.821	0.815
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6hk6-assembly3.cif.gz_E	6hk6-assembly3.cif.gz_E Human RIOK2 bound to inhibitor	3.917E-13	1.000	416	43	253	263	84	277	289	215	0.802	0.671
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6fdo-assembly2.cif.gz_B	6fdo-assembly2.cif.gz_B Rio2 structure	8.430E-14	1.000	413	38	261	263	68	280	284	238	0.852	0.750
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6hk6-assembly4.cif.gz_G	6hk6-assembly4.cif.gz_G Human RIOK2 bound to inhibitor	9.734E-13	1.000	411	43	253	263	75	259	271	215	0.802	0.683
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6fdm-assembly1.cif.gz_A	6fdm-assembly1.cif.gz_A Human Rio2 kinase structure	2.784E-13	1.000	409	38	262	263	73	280	286	236	0.856	0.727
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6fdo-assembly1.cif.gz_A	6fdo-assembly1.cif.gz_A Rio2 structure	2.485E-13	1.000	409	38	262	263	69	278	286	238	0.856	0.734
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7vbt-assembly1.cif.gz_A	7vbt-assembly1.cif.gz_A Crystal structure of RIOK2 in complex with CQ211	2.630E-13	1.000	403	38	262	263	77	287	300	236	0.856	0.703
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6hk6-assembly5.cif.gz_H	6hk6-assembly5.cif.gz_H Human RIOK2 bound to inhibitor	1.091E-12	1.000	402	38	255	263	78	271	282	222	0.829	0.688
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6fdn-assembly1.cif.gz_B	6fdn-assembly1.cif.gz_B Rio2 structure	1.294E-12	1.000	400	38	253	263	64	251	252	219	0.821	0.746
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6hk6-assembly2.cif.gz_F	6hk6-assembly2.cif.gz_F Human RIOK2 bound to inhibitor	5.511E-13	1.000	400	43	253	263	83	277	289	220	0.802	0.675
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6hk6-assembly4.cif.gz_J	6hk6-assembly4.cif.gz_J Human RIOK2 bound to inhibitor	5.833E-13	1.000	400	43	253	263	84	278	290	220	0.802	0.672
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7wu0-assembly1.cif.gz_v	7wu0-assembly1.cif.gz_v Cryo-EM structure of a human pre-40S ribosomal subunit - State RRP12-B3	1.062E-11	1.000	371	38	245	263	72	255	324	209	0.791	0.568
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6g51-assembly1.cif.gz_v	6g51-assembly1.cif.gz_v Cryo-EM structure of a late human pre-40S ribosomal subunit - State D	4.787E-12	1.000	349	38	262	263	72	294	325	249	0.856	0.686
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6fai-assembly1.cif.gz_l	6fai-assembly1.cif.gz_l Structure of a eukaryotic cytoplasmic pre-40S ribosomal subunit	7.570E-10	1.000	312	42	256	263	83	284	286	227	0.817	0.706
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4gyi-assembly1.cif.gz_A	4gyi-assembly1.cif.gz_A Crystal structure of the Rio2 kinase-ADP/Mg2+-phosphoaspartate complex from Chaetomium thermophilum	3.712E-11	1.000	302	24	256	263	51	300	338	279	0.886	0.740
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4gyg-assembly1.cif.gz_A	4gyg-assembly1.cif.gz_A Crystal structure of the Rio2 kinase from Chaetomium thermophilum	2.878E-10	1.000	287	24	256	263	43	293	331	280	0.886	0.758
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6eml-assembly1.cif.gz_r	6eml-assembly1.cif.gz_r Cryo-EM structure of a late pre-40S ribosomal subunit from Saccharomyces cerevisiae	4.675E-09	1.000	281	42	241	263	80	258	264	200	0.760	0.678
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6rbd-assembly1.cif.gz_l	6rbd-assembly1.cif.gz_l State 1 of yeast Tsr1-TAP Rps20-Deltaloop pre-40S particles	1.991E-09	1.000	272	35	256	263	65	268	271	231	0.844	0.753
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7szc-assembly2.cif.gz_C	7szc-assembly2.cif.gz_C Crystal Structure Analysis of human PRPK complex with a compound	2.576E-08	1.000	241	40	262	263	7	202	223	231	0.848	0.879
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7szc-assembly1.cif.gz_A	7szc-assembly1.cif.gz_A Crystal Structure Analysis of human PRPK complex with a compound	2.727E-08	1.000	228	43	262	263	7	208	229	234	0.837	0.882
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6y7c-assembly1.cif.gz_l	6y7c-assembly1.cif.gz_l Early cytoplasmic yeast pre-40S particle (purified with Tsr1 as bait)	2.508E-07	1.000	211	31	250	263	76	273	286	227	0.837	0.692
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8sam-assembly2.cif.gz_B	8sam-assembly2.cif.gz_B Crystal structure of class III lanthipeptide synthetase LP-GS-ThurKC in complex with ATP	4.689E-07	1.000	175	35	262	263	202	466	858	292	0.867	0.309
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8sam-assembly1.cif.gz_A	8sam-assembly1.cif.gz_A Crystal structure of class III lanthipeptide synthetase LP-GS-ThurKC in complex with ATP	3.735E-07	1.000	167	36	262	263	204	467	859	291	0.863	0.307
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7up4-assembly1.cif.gz_A	7up4-assembly1.cif.gz_A Crystal structure of C-terminal Domain of MSK1 in complex with covalently bound pyrrolopyrimidine compound 20 (co-crystal)	1.012E-05	1.000	162	53	240	263	7	171	273	205	0.715	0.604
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4oav-assembly1.cif.gz_B	4oav-assembly1.cif.gz_B Complete human RNase L in complex with 2-5A (5'-ppp heptamer), AMPPCP and RNA substrate.	9.564E-06	1.000	160	50	260	263	328	513	673	224	0.802	0.276
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8sap-assembly2.cif.gz_B	8sap-assembly2.cif.gz_B Crystal structure of class III lanthipeptide synthetase ThurKC	2.736E-06	1.000	160	36	262	263	188	449	842	288	0.863	0.311
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7up8-assembly1.cif.gz_A	7up8-assembly1.cif.gz_A Crystal structure of C-terminal Domain of MSK1 in complex with covalently bound pyrrolopyrimidine compound 27 (co-crystal)	1.639E-06	1.000	158	54	259	263	10	218	273	246	0.783	0.766
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7up7-assembly1.cif.gz_A	7up7-assembly1.cif.gz_A Crystal structure of C-terminal Domain of MSK1 in complex with covalently bound with literature RSK2 inhibitor indazole cyanoacrylamide compound 26 (soak)	1.735E-06	1.000	156	58	263	263	17	228	277	252	0.783	0.765
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5yk2-assembly1.cif.gz_A	5yk2-assembly1.cif.gz_A The complex structure of Rv3197-erythromycin from Mycobacterium tuberculosis	1.549E-06	1.000	155	4	220	263	3	267	391	272	0.825	0.678
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6m13-assembly1.cif.gz_a	6m13-assembly1.cif.gz_a Crystal structure of Rnase L in complex with Toceranib	8.063E-06	1.000	155	50	261	263	332	525	681	233	0.806	0.285
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6m12-assembly1.cif.gz_a	6m12-assembly1.cif.gz_a Crystal Structure of Rnase L in complex with SU11652	6.422E-06	1.000	154	50	260	263	330	538	681	247	0.802	0.307
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7cz2-assembly1.cif.gz_A	7cz2-assembly1.cif.gz_A The complex structure of MSMEG_1954-ADP from Mycobacterium smegmatis	1.101E-06	1.000	152	32	262	263	5	252	313	267	0.878	0.792
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7cyr-assembly1.cif.gz_A	7cyr-assembly1.cif.gz_A The closed conformation of MSMEG_1954 from Mycobacterium smegmatis	1.639E-06	1.000	151	40	262	263	65	316	395	263	0.848	0.638
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3kn6-assembly2.cif.gz_B	3kn6-assembly2.cif.gz_B Crystal structure of the C-terminal kinase domain of MSK1	6.252E-05	1.000	149	53	243	263	7	179	288	208	0.726	0.601
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3kn5-assembly2.cif.gz_B	3kn5-assembly2.cif.gz_B Crystal structure of the C-terminal kinase domain of msk1 in complex with AMP-PNP	7.005E-05	1.000	147	53	243	263	7	179	289	208	0.726	0.599
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4oav-assembly1.cif.gz_D	4oav-assembly1.cif.gz_D Complete human RNase L in complex with 2-5A (5'-ppp heptamer), AMPPCP and RNA substrate.	1.689E-05	1.000	147	41	261	263	312	513	674	240	0.840	0.300
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4krd-assembly1.cif.gz_A	4krd-assembly1.cif.gz_A Crystal Structure of Pho85-Pcl10 Complex	5.271E-05	1.000	146	54	218	263	7	150	294	177	0.627	0.490
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5yk1-assembly1.cif.gz_A	5yk1-assembly1.cif.gz_A The complex structure of Rv3197-AMPPNP from Mycobacterium tuberculosis	1.101E-06	1.000	146	4	241	263	3	298	401	303	0.905	0.738
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7elw-assembly1.cif.gz_a	7elw-assembly1.cif.gz_a Crystal structure of RNase L in complex with Myricetin	9.035E-06	1.000	146	58	258	263	339	534	675	234	0.764	0.290
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6m11-assembly1.cif.gz_b	6m11-assembly1.cif.gz_b Crystal structure of Rnase L in complex with Sunitinib	1.508E-05	1.000	146	50	262	263	332	539	684	247	0.810	0.304
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7up4-assembly2.cif.gz_B	7up4-assembly2.cif.gz_B Crystal structure of C-terminal Domain of MSK1 in complex with covalently bound pyrrolopyrimidine compound 20 (co-crystal)	6.798E-06	1.000	143	58	263	263	17	234	286	254	0.783	0.762
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4oau-assembly1.cif.gz_C-2	4oau-assembly1.cif.gz_C-2 Complete human RNase L in complex with biological activators.	1.201E-05	1.000	141	35	263	263	315	531	692	256	0.871	0.314
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6pk6-assembly1.cif.gz_A	6pk6-assembly1.cif.gz_A Human PRPF4B bound to benzothiophene inhibitor 329	6.798E-06	1.000	139	53	258	263	18	233	338	251	0.783	0.639
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4o1p-assembly2.cif.gz_D	4o1p-assembly2.cif.gz_D Crystal Structure of RNase L in complex with 2-5A and AMP-PNP	1.689E-05	1.000	139	52	262	263	325	532	668	246	0.802	0.311
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7cy2-assembly1.cif.gz_A	7cy2-assembly1.cif.gz_A The open conformation of MSMEG_1954 from Mycobacterium smegmatis	2.584E-06	1.000	138	40	262	263	10	258	320	260	0.848	0.778
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4fk3-assembly3.cif.gz_B	4fk3-assembly3.cif.gz_B B-Raf Kinase V600E Oncogenic Mutant in Complex with PLX3203	5.906E-05	1.000	136	50	263	263	8	210	257	237	0.814	0.790
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5uhn-assembly2.cif.gz_B	5uhn-assembly2.cif.gz_B Crystal Structure of the Tyrosine Kinase Domain of FGF Receptor 2 harboring a N549H/E565A Double Gain-of-Function Mutation	7.415E-05	1.000	135	54	260	263	14	223	269	241	0.787	0.781
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6pjj-assembly1.cif.gz_B	6pjj-assembly1.cif.gz_B Human PRPF4B bound to benzothiophene inhibitor 224	1.788E-05	1.000	135	53	238	263	12	207	326	226	0.707	0.601
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3kn6-assembly1.cif.gz_A	3kn6-assembly1.cif.gz_A Crystal structure of the C-terminal kinase domain of MSK1	2.984E-05	1.000	134	53	259	263	7	221	282	252	0.787	0.762
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2jd5-assembly1.cif.gz_A	2jd5-assembly1.cif.gz_A Sky1p bound to Npl3p-derived substrate peptide	3.747E-05	1.000	134	55	244	263	17	224	353	232	0.722	0.589
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3og7-assembly2.cif.gz_B	3og7-assembly2.cif.gz_B B-Raf Kinase V600E oncogenic mutant in complex with PLX4032	8.795E-05	1.000	133	50	263	263	7	208	254	236	0.814	0.795
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8gmd-assembly1.cif.gz_A	8gmd-assembly1.cif.gz_A CRYSTAL STRUCTURE OF AP2 ASSOCIATED KINASE 1 COMPLEXED WITH (5P)-3-({(8R)-5-[(4-aminopiperidin-1-yl)methyl]pyrrolo[2,1-f][1,2,4]triazin-4-yl}amino)-5-[2-(propan-2-yl)-2H-tetrazol-5-yl]phenol	2.245E-05	1.000	133	58	244	263	18	187	294	208	0.711	0.578
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8pqb-assembly1.cif.gz_A	8pqb-assembly1.cif.gz_A c-KIT kinase domain in complex with avapritinib derivative 8	2.377E-05	1.000	132	55	258	263	25	255	280	265	0.776	0.825
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4ian-assembly1.cif.gz_B	4ian-assembly1.cif.gz_B Crystal Structure of apo Human PRPF4B kinase domain	5.271E-05	1.000	132	53	238	263	10	207	320	232	0.707	0.619
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5i35-assembly1.cif.gz_A	5i35-assembly1.cif.gz_A Structure of the Human mitochondrial kinase COQ8A R611K with AMPPNP (Cerebellar Ataxia and Ubiquinone Deficiency Through Loss of Unorthodox Kinase Activity)	2.663E-05	1.000	132	31	262	263	49	307	384	275	0.882	0.674
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7ozy-assembly2.cif.gz_BBB	7ozy-assembly2.cif.gz_BBB FGFR2 kinase domain (residues 461-763) in complex with 38.	3.344E-05	1.000	131	54	263	263	16	278	278	295	0.798	0.946
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6agx-assembly1.cif.gz_A	6agx-assembly1.cif.gz_A The cocrystal structure of FGFR2 bound with compound 14 harboring 5H-pyrrolo[2,3-b]pyrazine scaffold	3.539E-05	1.000	131	54	260	263	16	239	285	259	0.787	0.786
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5ui0-assembly1.cif.gz_A	5ui0-assembly1.cif.gz_A Crystal Structure of the Tyrosine Kinase Domain of FGF Receptor 2 harboring an E565A/K659M Double Gain-of-Function Mutation	4.198E-05	1.000	131	54	263	263	22	276	301	287	0.798	0.847
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7up5-assembly2.cif.gz_B	7up5-assembly2.cif.gz_B Crystal structure of C-terminal Domain of MSK1 in complex with covalently bound pyrrolopyrimidine compound 23 (co-crystal)	2.663E-05	1.000	130	53	259	263	7	226	286	256	0.787	0.769
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7kia-assembly2.cif.gz_B	7kia-assembly2.cif.gz_B Crystal structure of FGFR2 kinase domain gatekeeper mutant V564F in complex with covalent compound 19	4.444E-05	1.000	130	54	263	263	16	262	288	280	0.798	0.858
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1mqb-assembly2.cif.gz_B	1mqb-assembly2.cif.gz_B Crystal Structure of Ephrin A2 (ephA2) Receptor Protein Kinase	3.747E-05	1.000	129	58	260	263	17	214	265	234	0.772	0.747
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5uhn-assembly1.cif.gz_A	5uhn-assembly1.cif.gz_A Crystal Structure of the Tyrosine Kinase Domain of FGF Receptor 2 harboring a N549H/E565A Double Gain-of-Function Mutation	4.979E-05	1.000	129	54	260	263	14	236	282	258	0.787	0.791
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4ped-assembly1.cif.gz_A	4ped-assembly1.cif.gz_A Mitochondrial ADCK3 employs an atypical protein kinase-like fold to enable coenzyme Q biosynthes	3.159E-05	1.000	129	31	262	263	46	310	387	277	0.882	0.685
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5l4q-assembly2.cif.gz_B	5l4q-assembly2.cif.gz_B Crystal Structure of Adaptor Protein 2 Associated Kinase 1 (AAK1) in Complex with LKB1 (AAK1 Dual Inhibitor)	2.984E-05	1.000	128	52	252	263	16	198	287	224	0.764	0.638
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5flf-assembly1.cif.gz_A	5flf-assembly1.cif.gz_A DISEASE LINKED MUTATION IN FGFR	4.198E-05	1.000	128	54	260	263	20	249	296	265	0.787	0.777
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5xp7-assembly1.cif.gz_A	5xp7-assembly1.cif.gz_A C-Src in complex with ATP-CHCl	1.310E-04	1.000	127	58	260	263	16	209	265	229	0.772	0.732
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1gjo-assembly1.cif.gz_A	1gjo-assembly1.cif.gz_A The FGFr2 tyrosine kinase domain	3.966E-05	1.000	127	54	260	263	16	234	280	254	0.787	0.782
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2psq-assembly1.cif.gz_B	2psq-assembly1.cif.gz_B Crystal Structure of Unphosphorylated Unactivated Wild Type FGF Receptor 2 (FGFR2) Kinase Domain	5.271E-05	1.000	127	54	260	263	16	238	286	258	0.787	0.780
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2zv9-assembly1.cif.gz_A	2zv9-assembly1.cif.gz_A Lyn Tyrosine Kinase Domain-PP2 complex	4.979E-05	1.000	125	55	260	263	12	213	256	239	0.783	0.789
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5ugl-assembly2.cif.gz_B	5ugl-assembly2.cif.gz_B Crystal Structure of FGF Receptor 2 Tyrosine Kinase Domain Harboring the D650V Activating Mutation	1.169E-04	1.000	125	55	260	263	17	225	271	244	0.783	0.771
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7lgs-assembly1.cif.gz_A	7lgs-assembly1.cif.gz_A Structure of EGFR_D770_N771insNPG/V948R in complex with covalent inhibitor Osimertinib.	6.252E-05	1.000	125	53	262	263	9	271	283	297	0.798	0.929
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4j98-assembly1.cif.gz_A	4j98-assembly1.cif.gz_A Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Gain-of-Function K659Q Mutation.	6.618E-05	1.000	125	54	260	263	22	258	304	272	0.787	0.780
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7elw-assembly1.cif.gz_b	7elw-assembly1.cif.gz_b Crystal structure of RNase L in complex with Myricetin	1.072E-05	1.000	125	43	262	263	312	531	676	258	0.837	0.325
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4mxo-assembly2.cif.gz_B	4mxo-assembly2.cif.gz_B human Src kinase bound to kinase inhibitor bosutinib	1.237E-04	1.000	124	58	260	263	15	208	264	229	0.772	0.735
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4j96-assembly3.cif.gz_A	4j96-assembly3.cif.gz_A Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic Gain-of-Function K659M Mutation Identified in Cervical Cancer.	4.198E-05	1.000	124	54	260	263	22	254	302	271	0.787	0.772
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1zyl-assembly1.cif.gz_A	1zyl-assembly1.cif.gz_A Crystal Structure of Hypothetical Protein YihE from Escherichia coli	1.346E-05	1.000	124	42	262	263	12	273	325	299	0.840	0.806
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4yht-assembly2.cif.gz_B	4yht-assembly2.cif.gz_B bRaf complexed with an inhibitor	4.444E-05	1.000	123	50	263	263	7	212	258	245	0.814	0.798
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4mxz-assembly2.cif.gz_B	4mxz-assembly2.cif.gz_B Src M314L T338M double mutant bound to kinase inhibitor bosutinib	6.618E-05	1.000	123	54	263	263	11	231	264	260	0.798	0.837
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4j99-assembly5.cif.gz_A	4j99-assembly5.cif.gz_A Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Gain-of-Function K659T Mutation.	8.795E-05	1.000	123	54	260	263	17	275	280	292	0.787	0.925
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4w9x-assembly1.cif.gz_A	4w9x-assembly1.cif.gz_A Crystal Structure of BMP-2-inducible kinase in complex with baricitinib	2.065E-04	1.000	123	58	244	263	18	184	300	204	0.711	0.557
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5uxa-assembly1.cif.gz_A	5uxa-assembly1.cif.gz_A Crystal structure of macrolide 2'-phosphotransferase MphB from Escherichia coli	9.564E-06	1.000	123	43	262	263	7	269	301	297	0.837	0.874
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2dq7-assembly1.cif.gz_X	2dq7-assembly1.cif.gz_X Crystal Structure of Fyn kinase domain complexed with staurosporine	2.065E-04	1.000	122	54	260	263	12	221	263	248	0.787	0.798
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3zc6-assembly3.cif.gz_C	3zc6-assembly3.cif.gz_C Crystal structure of JAK3 kinase domain in complex with an indazole substituted pyrrolopyrazine inhibitor	3.344E-05	1.000	122	54	263	263	10	235	277	264	0.798	0.816
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5flf-assembly2.cif.gz_B	5flf-assembly2.cif.gz_B DISEASE LINKED MUTATION IN FGFR	9.310E-05	1.000	122	54	260	263	20	243	292	259	0.787	0.767
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4mnf-assembly1.cif.gz_B	4mnf-assembly1.cif.gz_B Crystal structure of BRAF-V600E bound to GDC0879	2.377E-05	1.000	121	54	263	263	10	235	257	259	0.798	0.879
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2zv8-assembly1.cif.gz_A	2zv8-assembly1.cif.gz_A Lyn Tyrosine Kinase Domain-AMP-PNP complex	1.468E-04	1.000	121	55	263	263	12	244	257	267	0.795	0.907
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3psd-assembly1.cif.gz_A	3psd-assembly1.cif.gz_A Non-oxime pyrazole based inhibitors of B-Raf kinase	7.005E-05	1.000	121	58	263	263	15	213	262	236	0.783	0.760
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4mxo-assembly1.cif.gz_A	4mxo-assembly1.cif.gz_A human Src kinase bound to kinase inhibitor bosutinib	1.554E-04	1.000	121	58	260	263	16	210	266	230	0.772	0.733
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6vnv-assembly1.cif.gz_A	6vnv-assembly1.cif.gz_A Crystal structure of TYK2 kinase with compound 14	6.618E-05	1.000	121	54	263	263	10	229	275	256	0.798	0.800
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8h75-assembly1.cif.gz_D	8h75-assembly1.cif.gz_D FGFR2 in complex with YJ001	1.043E-04	1.000	121	55	263	263	17	233	277	252	0.795	0.783
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4j95-assembly5.cif.gz_A	4j95-assembly5.cif.gz_A Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K659N Mutation Responsible for an Unclassified Craniosynostosis Syndrome in Space Group C2.	1.386E-04	1.000	121	54	260	263	16	233	279	253	0.787	0.781
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3nz0-assembly1.cif.gz_A	3nz0-assembly1.cif.gz_A Non-phosphorylated TYK2 kinase with CMP6	9.855E-05	1.000	121	54	263	263	11	239	285	267	0.798	0.804
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3kxx-assembly4.cif.gz_D	3kxx-assembly4.cif.gz_D Structure of the mutant Fibroblast Growth Factor receptor 1	2.592E-04	1.000	121	54	260	263	24	241	288	249	0.787	0.757
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5flf-assembly4.cif.gz_D	5flf-assembly4.cif.gz_D DISEASE LINKED MUTATION IN FGFR	4.979E-05	1.000	121	54	260	263	15	242	290	257	0.787	0.786
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5ui0-assembly2.cif.gz_B	5ui0-assembly2.cif.gz_B Crystal Structure of the Tyrosine Kinase Domain of FGF Receptor 2 harboring an E565A/K659M Double Gain-of-Function Mutation	1.104E-04	1.000	121	54	260	263	21	257	304	274	0.787	0.780
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4j96-assembly3.cif.gz_B	4j96-assembly3.cif.gz_B Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic Gain-of-Function K659M Mutation Identified in Cervical Cancer.	8.795E-05	1.000	121	54	260	263	21	257	305	275	0.787	0.777
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4fv5-assembly1.cif.gz_A	4fv5-assembly1.cif.gz_A Crystal Structure of the ERK2 complexed with EK9	1.169E-04	1.000	121	54	259	263	16	215	331	234	0.783	0.604
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4yht-assembly1.cif.gz_A	4yht-assembly1.cif.gz_A bRaf complexed with an inhibitor	6.618E-05	1.000	120	50	263	263	7	211	256	243	0.814	0.801
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3ri1-assembly2.cif.gz_B	3ri1-assembly2.cif.gz_B Crystal structure of the catalytic domain of FGFR2 kinase in complex with ARQ 069	1.104E-04	1.000	120	55	263	263	16	258	283	276	0.795	0.859
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2pwl-assembly1.cif.gz_B	2pwl-assembly1.cif.gz_B Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic N549H Mutation Responsible for Crouzon Syndrome.	1.169E-04	1.000	120	55	260	263	16	239	286	259	0.783	0.783
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7b7s-assembly1.cif.gz_A	7b7s-assembly1.cif.gz_A CDK2/cyclin A2 in complex with 3H-pyrazolo[4,3-f]quinoline-based derivative HSD1368	6.086E-04	1.000	120	52	218	263	1	145	287	181	0.635	0.505
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5kbq-assembly1.cif.gz_A	5kbq-assembly1.cif.gz_A Pak1 in complex with bis-anilino pyrimidine inhibitor	1.468E-04	1.000	120	44	260	263	2	225	289	259	0.825	0.775
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6u6a-assembly1.cif.gz_A	6u6a-assembly1.cif.gz_A Crystal structure of Yck2 from Candida albicans in complex with kinase inhibitor GW461484A	3.075E-04	1.000	120	53	262	263	6	233	306	264	0.798	0.745
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4hvd-assembly1.cif.gz_A	4hvd-assembly1.cif.gz_A JAK3 kinase domain in complex with 2-Cyclopropyl-5H-pyrrolo[2,3-b]pyrazine-7-carboxylic acid ((S)-1,2,2-trimethyl-propyl)-amide	1.310E-04	1.000	119	54	263	263	9	234	276	262	0.798	0.819
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1v0o-assembly1.cif.gz_A	1v0o-assembly1.cif.gz_A Structure of P. falciparum PfPK5-Indirubin-5-sulphonate ligand complex	7.005E-05	1.000	119	55	255	263	2	200	276	241	0.764	0.721
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4gvj-assembly1.cif.gz_A	4gvj-assembly1.cif.gz_A Tyk2 (JH1) in complex with adenosine di-phosphate	1.554E-04	1.000	119	54	263	263	10	265	290	290	0.798	0.883
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8gmc-assembly1.cif.gz_A	8gmc-assembly1.cif.gz_A CRYSTAL STRUCTURE OF AP2 ASSOCIATED KINASE 1 COMPLEXED WITH 5-[(4-aminopiperidin-1-yl)methyl]-N-{3-[5-(propan-2-yl)-1,3,4-thiadiazol-2-yl]phenyl}pyrrolo[2,1-f][1,2,4]triazin-4-amine	2.984E-05	1.000	119	58	240	263	18	198	293	220	0.696	0.618
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4fv8-assembly1.cif.gz_A	4fv8-assembly1.cif.gz_A Crystal Structure of the ERK2 complexed with E63	3.445E-04	1.000	119	54	259	263	17	218	334	233	0.783	0.605
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6yu1-assembly2.cif.gz_c	6yu1-assembly2.cif.gz_c CLK3 bound with beta-carboline KH-CARB13 (Cpd 3)	5.131E-04	1.000	119	53	242	263	30	236	350	240	0.722	0.591
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7p6n-assembly1.cif.gz_H-2	7p6n-assembly1.cif.gz_H-2 ROCK2 IN COMPLEX WITH COMPOUND 12	1.237E-04	1.000	119	26	260	263	25	261	366	271	0.894	0.648
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7udp-assembly1.cif.gz_A	7udp-assembly1.cif.gz_A Crystal structure of COQ8A-CA157 inhibitor complex in space group C2	8.309E-05	1.000	119	42	262	263	49	302	378	269	0.840	0.672
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6c2y-assembly1.cif.gz_A	6c2y-assembly1.cif.gz_A Human GRK2 in complex with Gbetagamma subunits and CCG257142	9.855E-05	1.000	119	54	263	263	163	382	617	248	0.798	0.357
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2psq-assembly1.cif.gz_A	2psq-assembly1.cif.gz_A Crystal Structure of Unphosphorylated Unactivated Wild Type FGF Receptor 2 (FGFR2) Kinase Domain	1.386E-04	1.000	118	55	260	263	16	240	287	260	0.783	0.784
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4k33-assembly1.cif.gz_A	4k33-assembly1.cif.gz_A Crystal Structure of FGF Receptor 3 (FGFR3) Kinase Domain Harboring the K650E Mutation, a Gain-of-Function Mutation Responsible for Thanatophoric Dysplasia Type II and Spermatocytic Seminoma	1.310E-04	1.000	118	55	262	263	16	290	293	306	0.791	0.939
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3nr9-assembly1.cif.gz_A-2	3nr9-assembly1.cif.gz_A-2 Structure of human CDC2-like kinase 2 (CLK2)	4.847E-04	1.000	118	53	242	263	25	231	341	239	0.722	0.607
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7udq-assembly1.cif.gz_A	7udq-assembly1.cif.gz_A Crystal structure of COQ8A-CA157 inhibitor complex in space group P1	7.415E-05	1.000	118	42	262	263	45	296	369	262	0.840	0.683
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5wne-assembly1.cif.gz_A	5wne-assembly1.cif.gz_A X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR	4.979E-05	1.000	118	19	259	263	34	304	384	306	0.916	0.706
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5wne-assembly2.cif.gz_C	5wne-assembly2.cif.gz_C X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR	3.539E-05	1.000	118	19	259	263	44	305	384	297	0.916	0.682
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4cva-assembly1.cif.gz_A	4cva-assembly1.cif.gz_A MPS1 kinase with 3-aminopyridin-2-one inhibitors	2.744E-04	1.000	117	55	263	263	13	210	255	229	0.795	0.776
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1nd4-assembly1.cif.gz_B	1nd4-assembly1.cif.gz_B Crystal structure of aminoglycoside-3'-phosphotransferase-IIa	1.741E-04	1.000	117	44	263	263	5	236	255	285	0.837	0.910
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7lgs-assembly2.cif.gz_B	7lgs-assembly2.cif.gz_B Structure of EGFR_D770_N771insNPG/V948R in complex with covalent inhibitor Osimertinib.	7.849E-05	1.000	117	53	262	263	9	274	286	301	0.798	0.930
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7lvi-assembly2.cif.gz_B	7lvi-assembly2.cif.gz_B CRYSTAL STRUCTURE OF AP2 ASSOCIATED KINASE 1 ISOFORM 1 COMPLEXED WITH LIGAND (2R)-2-AMINO-N-[3-METHOXY-4- (1,3-OXAZOL-5-YL)PHENYL]-4-METHYLPENTANAMIDE	9.855E-05	1.000	117	58	255	263	17	205	288	229	0.753	0.656
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3fy0-assembly1.cif.gz_A	3fy0-assembly1.cif.gz_A Crystal structure of PAK1 kinase domain with ruthenium complex DW1	1.310E-04	1.000	117	40	260	263	3	230	293	262	0.840	0.778
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4d2t-assembly4.cif.gz_D	4d2t-assembly4.cif.gz_D Structure of MELK in complex with inhibitors	4.979E-05	1.000	117	53	260	263	7	213	319	238	0.791	0.649
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7jov-assembly1.cif.gz_B	7jov-assembly1.cif.gz_B CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 2 (ROCK2) IN COMPLEX WITH A PHENYLPYRAZOLE AMIDE INHIBITOR	1.645E-04	1.000	117	36	260	263	43	275	378	263	0.856	0.616
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7p6n-assembly1.cif.gz_A	7p6n-assembly1.cif.gz_A ROCK2 IN COMPLEX WITH COMPOUND 12	1.310E-04	1.000	117	26	260	263	26	279	384	282	0.894	0.661
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1v0p-assembly1.cif.gz_A	1v0p-assembly1.cif.gz_A Structure of P. falciparum PfPK5-Purvalanol B ligand complex	3.255E-04	1.000	116	52	212	263	1	143	277	175	0.612	0.516
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7rj8-assembly1.cif.gz_A	7rj8-assembly1.cif.gz_A CRYSTAL STRUCTURE OF AP2 ASSOCIATED KINASE 1 ISOFORM 1 COMPLEXED WITH LIGAND (2R)-2-AMINO-N-[3-(DIFLUOROM ETHOXY)-4-(1,3-OXAZOL-5-YL)PHENYL]-4-METHYLPENTANAMIDE	7.005E-05	1.000	116	58	240	263	19	203	297	222	0.696	0.623
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5ugx-assembly2.cif.gz_A	5ugx-assembly2.cif.gz_A Crystal Structure of the Tyrosine Kinase Domain of FGF Receptor 2 Harboring a E565A/D650V double Gain-of-Function Mutation	2.186E-04	1.000	116	54	260	263	15	251	297	271	0.787	0.798
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5wne-assembly1.cif.gz_B	5wne-assembly1.cif.gz_B X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR	8.535E-06	1.000	116	19	262	263	43	294	352	291	0.928	0.716
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7udq-assembly2.cif.gz_B	7udq-assembly2.cif.gz_B Crystal structure of COQ8A-CA157 inhibitor complex in space group P1	1.951E-04	1.000	116	42	263	263	51	306	378	264	0.844	0.677
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7p6n-assembly4.cif.gz_G-5	7p6n-assembly4.cif.gz_G-5 ROCK2 IN COMPLEX WITH COMPOUND 12	2.314E-04	1.000	116	26	260	263	25	280	385	284	0.894	0.665
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4l7s-assembly1.cif.gz_A	4l7s-assembly1.cif.gz_A Kinase domain mutant of human Itk in complex with an aminobenzothiazole inhibitor	1.310E-04	1.000	115	54	260	263	10	203	250	232	0.787	0.776
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2z2w-assembly1.cif.gz_A	2z2w-assembly1.cif.gz_A Human Wee1 kinase complexed with inhibitor PF0335770	1.104E-04	1.000	115	53	263	263	7	248	261	272	0.802	0.927
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5ntt-assembly1.cif.gz_A	5ntt-assembly1.cif.gz_A Crystal structure of human Mps1 (TTK) C604Y mutant in complex with NMS-P715	7.005E-05	1.000	115	55	263	263	17	229	277	244	0.795	0.769
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3fy2-assembly1.cif.gz_A	3fy2-assembly1.cif.gz_A Human EphA3 Kinase and Juxtamembrane Region Bound to Substrate KQWDNYEFIW	9.310E-05	1.000	115	47	256	263	12	219	285	249	0.798	0.730
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3fxx-assembly1.cif.gz_A	3fxx-assembly1.cif.gz_A Human EphA3 Kinase and Juxtamembrane Region Bound to Substrate KQWDNYE[pTyr]IW	8.309E-05	1.000	115	47	256	263	13	221	288	252	0.798	0.726
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7w19-assembly2.cif.gz_B	7w19-assembly2.cif.gz_B Crystal Structure of Acinetobacter baumannii MPH-E	2.121E-05	1.000	115	39	262	263	3	263	291	299	0.852	0.897
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4ax8-assembly1.cif.gz_A	4ax8-assembly1.cif.gz_A Medium resolution structure of the bifunctional kinase- methyltransferase WbdD	2.314E-04	1.000	115	67	261	263	238	426	450	218	0.741	0.420
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7kx8-assembly1.cif.gz_A	7kx8-assembly1.cif.gz_A Crystal structure of DCLK1-Cter in complex with FMF-03-055-1	4.087E-04	1.000	114	54	260	263	10	205	263	232	0.787	0.745
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3en4-assembly2.cif.gz_B	3en4-assembly2.cif.gz_B Targeted polypharmacology: crystal structure of the c-Src kinase domain in complex with PP121, a multitargeted kinase inhibitor	1.843E-04	1.000	114	58	260	263	16	210	266	236	0.772	0.733
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4mcv-assembly1.cif.gz_A	4mcv-assembly1.cif.gz_A Star 12 bound to analog-sensitive Src kinase	1.741E-04	1.000	114	58	260	263	17	211	267	234	0.772	0.730
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7dua-assembly1.cif.gz_B	7dua-assembly1.cif.gz_B Crystal structure of human Proto-oncogene tyrosine-protein kinase receptor Ret in complex with 4-amino-7-(1-methylcyclopropyl)-N-(5-methyl-1H-pyrazol-3-yl)pyrrolo[2,3-d]pyrimidine-5-carboxamide	7.005E-05	1.000	114	40	262	263	4	271	274	306	0.848	0.978
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7lvh-assembly2.cif.gz_B	7lvh-assembly2.cif.gz_B CRYSTAL STRUCTURE OF AP2 ASSOCIATED KINASE 1 ISOFORM 1 COMPLEXED WITH LIGAND N-[3-METHOXY-4-(1,3-OXAZOL-5-YL)PHENYL]-3-(PROPAN-2-YL)PIPERIDINE-2-CARBOXAMIDE	1.951E-04	1.000	114	58	240	263	17	190	281	211	0.696	0.619
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7w1a-assembly1.cif.gz_B	7w1a-assembly1.cif.gz_B Crystal Structure of MPH-E in complex with GMP and Azithromycin	2.663E-05	1.000	114	39	262	263	4	261	287	298	0.852	0.899
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8gmd-assembly2.cif.gz_B	8gmd-assembly2.cif.gz_B CRYSTAL STRUCTURE OF AP2 ASSOCIATED KINASE 1 COMPLEXED WITH (5P)-3-({(8R)-5-[(4-aminopiperidin-1-yl)methyl]pyrrolo[2,1-f][1,2,4]triazin-4-yl}amino)-5-[2-(propan-2-yl)-2H-tetrazol-5-yl]phenol	6.252E-05	1.000	114	49	255	263	4	218	299	253	0.787	0.719
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2hel-assembly1.cif.gz_A	2hel-assembly1.cif.gz_A Crystal structure of a mutant EphA4 kinase domain (Y742A)	1.645E-04	1.000	113	53	263	263	7	210	256	241	0.802	0.797
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3geq-assembly2.cif.gz_B	3geq-assembly2.cif.gz_B Structural basis for the chemical rescue of Src kinase activity	3.647E-04	1.000	113	58	260	263	25	217	273	234	0.772	0.707
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4gk4-assembly1.cif.gz_A	4gk4-assembly1.cif.gz_A Human EphA3 Kinase domain in complex with ligand 90	7.005E-05	1.000	113	47	260	263	10	218	275	252	0.814	0.760
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5flf-assembly3.cif.gz_C	5flf-assembly3.cif.gz_C DISEASE LINKED MUTATION IN FGFR	1.843E-04	1.000	113	55	260	263	17	235	283	254	0.783	0.774
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3q53-assembly1.cif.gz_A	3q53-assembly1.cif.gz_A Structure of phosphorylated PAK1 kinase domain in complex with ATP	6.442E-04	1.000	113	40	258	263	2	227	292	260	0.833	0.774
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4y12-assembly1.cif.gz_A	4y12-assembly1.cif.gz_A Crystal structure of the S/T protein kinase PknG from Mycobacterium tuberculosis in complex with AGS	2.065E-04	1.000	113	51	263	263	65	322	322	295	0.810	0.801
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5ita-assembly3.cif.gz_A	5ita-assembly3.cif.gz_A Crystal Structure of BRAF Kinase Domain Bound to AZ-VEM	2.592E-04	1.000	112	50	263	263	8	206	250	239	0.814	0.796
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3zfx-assembly2.cif.gz_B	3zfx-assembly2.cif.gz_B Crystal structure of EphB1	3.255E-04	1.000	112	54	260	263	10	201	254	230	0.787	0.756
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2fb8-assembly2.cif.gz_B	2fb8-assembly2.cif.gz_B Structure of the B-Raf kinase domain bound to SB-590885	1.951E-04	1.000	112	58	263	263	14	213	259	236	0.783	0.772
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6oql-assembly1.cif.gz_A	6oql-assembly1.cif.gz_A CDK6 in complex with Cpd13 (R)-5-fluoro-4-(4-methyl-5,6,7,8-tetrahydro-4H-pyrazolo[1,5-a]azepin-3-yl)-N-(5-(4-methylpiperazin-1-yl)pyridin-2-yl)pyrimidin-2-amine	3.075E-04	1.000	112	54	241	263	4	173	263	212	0.715	0.646
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3kul-assembly1.cif.gz_A	3kul-assembly1.cif.gz_A Kinase domain of human ephrin type-A receptor 8 (EPHA8)	8.795E-05	1.000	112	55	260	263	11	220	267	248	0.783	0.787
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8tuc-assembly1.cif.gz_A	8tuc-assembly1.cif.gz_A Unphosphorylated CaMKK2 in complex with CC-8977	7.415E-05	1.000	112	55	261	263	9	258	278	266	0.787	0.899
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7lvh-assembly1.cif.gz_A	7lvh-assembly1.cif.gz_A CRYSTAL STRUCTURE OF AP2 ASSOCIATED KINASE 1 ISOFORM 1 COMPLEXED WITH LIGAND N-[3-METHOXY-4-(1,3-OXAZOL-5-YL)PHENYL]-3-(PROPAN-2-YL)PIPERIDINE-2-CARBOXAMIDE	1.169E-04	1.000	112	50	261	263	7	211	284	244	0.806	0.722
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7b7s-assembly2.cif.gz_C	7b7s-assembly2.cif.gz_C CDK2/cyclin A2 in complex with 3H-pyrazolo[4,3-f]quinoline-based derivative HSD1368	1.695E-03	1.000	112	52	218	263	1	146	288	181	0.635	0.507
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7jov-assembly1.cif.gz_A	7jov-assembly1.cif.gz_A CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 2 (ROCK2) IN COMPLEX WITH A PHENYLPYRAZOLE AMIDE INHIBITOR	3.861E-04	1.000	112	36	260	263	41	272	377	260	0.856	0.615
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7p6n-assembly2.cif.gz_C-3	7p6n-assembly2.cif.gz_C-3 ROCK2 IN COMPLEX WITH COMPOUND 12	2.592E-04	1.000	112	26	260	263	27	274	378	276	0.894	0.656
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7p6n-assembly2.cif.gz_B	7p6n-assembly2.cif.gz_B ROCK2 IN COMPLEX WITH COMPOUND 12	1.237E-04	1.000	112	26	260	263	25	276	385	283	0.894	0.655
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7jou-assembly1.cif.gz_A-2	7jou-assembly1.cif.gz_A-2 CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 1 (ROCK1) IN COMPLEX WITH A PHENYLPYRAZOLE AMIDE INHIBITOR	8.562E-04	1.000	112	40	218	263	52	214	388	191	0.681	0.420
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3qgy-assembly2.cif.gz_B	3qgy-assembly2.cif.gz_B Crystal structure of ITK inhibitor complex	2.905E-04	1.000	111	55	260	263	10	202	245	234	0.783	0.788
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5l2t-assembly1.cif.gz_A	5l2t-assembly1.cif.gz_A The X-ray co-crystal structure of human CDK6 and Ribociclib.	4.087E-04	1.000	111	54	241	263	4	171	261	209	0.715	0.644
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6eas-assembly1.cif.gz_A	6eas-assembly1.cif.gz_A Co-crystal of pseudokinase DRIK1 (drought responsive inactive kinase 1) bound to ENMD-2076	1.169E-04	1.000	111	45	262	263	11	259	263	280	0.829	0.947
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3g6h-assembly1.cif.gz_A	3g6h-assembly1.cif.gz_A Src Thr338Ile inhibited in the DFG-Asp-Out conformation	1.645E-04	1.000	111	55	263	263	12	212	266	243	0.795	0.756
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2x2k-assembly1.cif.gz_A	2x2k-assembly1.cif.gz_A Crystal Structure of phosphorylated RET tyrosine kinase domain with inhibitor	2.186E-04	1.000	111	42	262	263	3	286	290	319	0.840	0.979
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1yhv-assembly1.cif.gz_A	1yhv-assembly1.cif.gz_A Crystal Structure of PAK1 kinase domain with two point mutations (K299R, T423E)	2.744E-04	1.000	111	40	260	263	3	230	293	266	0.840	0.778
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6pnx-assembly1.cif.gz_B	6pnx-assembly1.cif.gz_B Crystal Structure of an Asymmetric Dimer of FGF Receptor 3 Kinases Trapped in A-loop Tyrosine Transphosphorylation Reaction	1.310E-04	1.000	111	55	260	263	20	247	294	265	0.783	0.776
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6pjj-assembly1.cif.gz_A	6pjj-assembly1.cif.gz_A Human PRPF4B bound to benzothiophene inhibitor 224	1.169E-04	1.000	111	60	241	263	9	202	321	223	0.692	0.604
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5ax3-assembly1.cif.gz_A	5ax3-assembly1.cif.gz_A Crystal structure of ERK2 complexed with allosteric and ATP-competitive inhibitors.	5.749E-04	1.000	111	54	244	263	15	200	329	220	0.726	0.565
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6ytw-assembly2.cif.gz_B	6ytw-assembly2.cif.gz_B CLK3 bound with benzothiazole Tg003 (Cpd 2)	2.744E-04	1.000	111	53	242	263	21	225	339	235	0.722	0.605
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4fk3-assembly2.cif.gz_A	4fk3-assembly2.cif.gz_A B-Raf Kinase V600E Oncogenic Mutant in Complex with PLX3203	8.795E-05	1.000	110	55	263	263	12	207	251	238	0.795	0.781
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6cpy-assembly2.cif.gz_B	6cpy-assembly2.cif.gz_B Structure of apo GRMZM2G135359 pseudokinase	1.741E-04	1.000	110	47	262	263	12	258	262	285	0.821	0.943
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4mcv-assembly2.cif.gz_B	4mcv-assembly2.cif.gz_B Star 12 bound to analog-sensitive Src kinase	2.314E-04	1.000	110	58	260	263	16	209	265	232	0.772	0.732
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6lvl-assembly1.cif.gz_A	6lvl-assembly1.cif.gz_A Crystal structure of FGFR2 in complex with 1,3,5-triazine derivative	1.237E-04	1.000	110	54	260	263	15	281	288	303	0.787	0.927
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2qkw-assembly1.cif.gz_B	2qkw-assembly1.cif.gz_B Structural basis for activation of plant immunity by bacterial effector protein AvrPto	1.275E-03	1.000	110	59	218	263	18	159	292	175	0.608	0.486
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4fv1-assembly1.cif.gz_A	4fv1-assembly1.cif.gz_A Crystal Structure of the ERK2 complexed with EK4	8.562E-04	1.000	110	54	218	263	14	163	343	181	0.627	0.437
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6ytw-assembly1.cif.gz_A	6ytw-assembly1.cif.gz_A CLK3 bound with benzothiazole Tg003 (Cpd 2)	5.431E-04	1.000	110	53	242	263	30	235	349	235	0.722	0.590
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2ofv-assembly1.cif.gz_B	2ofv-assembly1.cif.gz_B crystal structure of aminoquinazoline 1 bound to Lck	2.744E-04	1.000	109	55	263	263	16	223	244	247	0.795	0.852
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2x9e-assembly1.cif.gz_A-2	2x9e-assembly1.cif.gz_A-2 HUMAN MPS1 IN COMPLEX WITH NMS-P715	1.043E-04	1.000	109	52	261	263	6	233	253	258	0.798	0.901
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2zva-assembly1.cif.gz_A	2zva-assembly1.cif.gz_A Lyn Tyrosine Kinase Domain-Dasatinib complex	1.951E-04	1.000	109	55	260	263	12	217	261	246	0.783	0.789
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2oiq-assembly2.cif.gz_B	2oiq-assembly2.cif.gz_B Crystal Structure of chicken c-Src kinase domain in complex with the cancer drug imatinib.	2.905E-04	1.000	109	58	263	263	15	211	265	235	0.783	0.743
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3dqx-assembly2.cif.gz_B	3dqx-assembly2.cif.gz_B chicken c-Src kinase domain in complex with ATPgS	2.314E-04	1.000	109	58	260	263	14	212	268	238	0.772	0.743
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3ad6-assembly1.cif.gz_A	3ad6-assembly1.cif.gz_A Crystal structure of Pyrazolo pyrimidine derivative bound to the kinase domain of human LCK, (auto-phosphorylated on TYR394)	2.065E-04	1.000	109	55	262	263	18	269	273	287	0.791	0.923
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6vny-assembly1.cif.gz_A	6vny-assembly1.cif.gz_A Crystal structure of TYK2 kinase with compound 10	1.169E-04	1.000	109	55	260	263	11	235	287	265	0.783	0.784
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6v6q-assembly1.cif.gz_B	6v6q-assembly1.cif.gz_B Crystal Structure of Monophosphorylated FGF Receptor 2 isoform IIIb with PTR657	1.310E-04	1.000	109	54	260	263	16	243	291	269	0.787	0.784
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8x5z-assembly1.cif.gz_A	8x5z-assembly1.cif.gz_A The Crystal Structure of PAK1 kinase domain from Biortus.	5.431E-04	1.000	109	40	258	263	3	225	292	259	0.833	0.764
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7q52-assembly1.cif.gz_AAA	7q52-assembly1.cif.gz_AAA Crystal structure of S/T protein kinase PknG from Mycobacterium tuberculosis in complex with inhibitor L2W	7.849E-05	1.000	109	51	263	263	55	312	312	294	0.810	0.827
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6xlo-assembly1.cif.gz_A	6xlo-assembly1.cif.gz_A Crystal structure of bRaf in complex with inhibitor	8.309E-05	1.000	108	58	263	263	14	212	258	238	0.783	0.771
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5vam-assembly2.cif.gz_B	5vam-assembly2.cif.gz_B BRAF in Complex with RAF709	3.861E-04	1.000	108	50	263	263	7	213	260	247	0.814	0.796
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6e6e-assembly8.cif.gz_H	6e6e-assembly8.cif.gz_H DGY-06-116, a novel and selective covalent inhibitor of SRC kinase	9.594E-04	1.000	108	58	263	263	15	210	264	228	0.783	0.742
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2ivv-assembly1.cif.gz_A-2	2ivv-assembly1.cif.gz_A-2 Crystal structure of phosphorylated RET tyrosine kinase domain complexed with the inhibitor PP1	4.087E-04	1.000	108	40	262	263	4	281	283	312	0.848	0.982
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2qoc-assembly1.cif.gz_A	2qoc-assembly1.cif.gz_A Human EphA3 kinase domain, phosphorylated, AMP-PNP bound structure	1.843E-04	1.000	108	53	256	263	7	212	283	242	0.776	0.728
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7qhl-assembly1.cif.gz_A	7qhl-assembly1.cif.gz_A Crystal structure of Cyclin-dependent kinase 2/cyclin A in complex with 3,5,7-Substituted pyrazolo[4,3-d]pyrimidine inhibitor 24	1.899E-03	1.000	108	52	218	263	1	142	285	178	0.635	0.498
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5ikw-assembly1.cif.gz_A	5ikw-assembly1.cif.gz_A Crystal Structure of BMP-2-inducible kinase in complex with an Indazole inhibitor	1.951E-04	1.000	108	58	238	263	15	196	297	214	0.688	0.613
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4fv9-assembly1.cif.gz_A	4fv9-assembly1.cif.gz_A Crystal Structure of the ERK2 complexed with E71	3.861E-04	1.000	108	57	259	263	22	215	332	230	0.772	0.584
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5hvu-assembly1.cif.gz_B	5hvu-assembly1.cif.gz_B Rho-associated protein kinase 1 (ROCK 1) in complex with a pyridine thiazole piperidine inhibitor	1.741E-04	1.000	108	19	259	263	43	309	394	302	0.916	0.678
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3qgw-assembly2.cif.gz_B	3qgw-assembly2.cif.gz_B Crystal Structure of ITK kinase bound to an inhibitor	3.445E-04	1.000	107	55	260	263	8	197	240	230	0.783	0.792
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4pp9-assembly3.cif.gz_B	4pp9-assembly3.cif.gz_B ITK kinase domain with compound 1 (N-[1-(3-CYANOBENZYL)-1H-PYRAZOL-4-YL]-2H-INDAZOLE-3-CARBOXAMIDE)	7.849E-05	1.000	107	55	262	263	10	244	247	275	0.791	0.951
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2og8-assembly2.cif.gz_B	2og8-assembly2.cif.gz_B crystal structure of aminoquinazoline 36 bound to Lck	3.647E-04	1.000	107	55	260	263	12	204	249	233	0.783	0.775
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4bi0-assembly1.cif.gz_A	4bi0-assembly1.cif.gz_A Scaffold Focused Virtual Screening: Prospective Application to the Discovery of TTK Inhibitor	2.592E-04	1.000	107	55	261	263	12	234	254	255	0.787	0.878
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3dbq-assembly1.cif.gz_A	3dbq-assembly1.cif.gz_A Crystal structure of TTK kinase domain	9.310E-05	1.000	107	55	263	263	13	243	259	262	0.795	0.892
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4g9r-assembly2.cif.gz_B	4g9r-assembly2.cif.gz_B B-Raf V600E Kinase Domain Bound to a Type II Dihydroquinazoline Inhibitor	2.744E-04	1.000	107	58	263	263	15	214	261	242	0.783	0.766
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6n0p-assembly1.cif.gz_A	6n0p-assembly1.cif.gz_A BRAF in complex with N-(3-(2-(2-hydroxyethoxy)-6-morpholinopyridin-4-yl)-4-methylphenyl)-2-(trifluoromethyl)isonicotinamide (LXH254)	3.445E-04	1.000	107	58	263	263	14	221	268	244	0.783	0.776
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8g6z-assembly1.cif.gz_A	8g6z-assembly1.cif.gz_A JAK2 crystal structure in complex with Compound 13	4.579E-04	1.000	107	54	260	263	8	233	281	257	0.787	0.804
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2py3-assembly1.cif.gz_A	2py3-assembly1.cif.gz_A Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic E565G Mutation Responsible for Pfeiffer Syndrome	2.905E-04	1.000	107	62	260	263	17	275	282	290	0.757	0.918
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5lpw-assembly1.cif.gz_A	5lpw-assembly1.cif.gz_A Crystal structure of the apo-BRI1 kinase domain (865-1160)	5.131E-04	1.000	107	41	218	263	9	165	284	194	0.677	0.553
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7w1a-assembly2.cif.gz_A	7w1a-assembly2.cif.gz_A Crystal Structure of MPH-E in complex with GMP and Azithromycin	2.984E-05	1.000	107	39	262	263	4	261	287	289	0.852	0.899
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2x2m-assembly1.cif.gz_A	2x2m-assembly1.cif.gz_A Crystal Structure of phosphorylated RET tyrosine kinase domain with inhibitor	2.314E-04	1.000	107	25	263	263	4	263	287	312	0.909	0.906
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3niz-assembly1.cif.gz_A	3niz-assembly1.cif.gz_A Cryptosporidium parvum cyclin-dependent kinase cgd5_2510 with ADP bound.	1.075E-03	1.000	107	58	261	263	14	208	288	235	0.776	0.677
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5te0-assembly1.cif.gz_A	5te0-assembly1.cif.gz_A Crystal Structure of Adaptor Protein 2 Associated Kinase (AAK1) in complex with BIBF 1120	1.951E-04	1.000	107	49	261	263	7	226	316	257	0.810	0.696
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5bue-assembly1.cif.gz_A	5bue-assembly1.cif.gz_A ERK2 complexed with N-benzylpyridone tetrahydroazaindazole	7.219E-04	1.000	107	54	259	263	14	212	329	233	0.783	0.605
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2fys-assembly2.cif.gz_A	2fys-assembly2.cif.gz_A Crystal structure of Erk2 complex with KIM peptide derived from MKP3	5.131E-04	1.000	107	54	259	263	15	231	348	250	0.783	0.624
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7p6n-assembly3.cif.gz_E-4	7p6n-assembly3.cif.gz_E-4 ROCK2 IN COMPLEX WITH COMPOUND 12	2.449E-04	1.000	107	26	260	263	27	280	385	285	0.894	0.660
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7jov-assembly4.cif.gz_G	7jov-assembly4.cif.gz_G CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 2 (ROCK2) IN COMPLEX WITH A PHENYLPYRAZOLE AMIDE INHIBITOR	4.087E-04	1.000	107	36	260	263	43	283	388	269	0.856	0.621
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4pp9-assembly1.cif.gz_A	4pp9-assembly1.cif.gz_A ITK kinase domain with compound 1 (N-[1-(3-CYANOBENZYL)-1H-PYRAZOL-4-YL]-2H-INDAZOLE-3-CARBOXAMIDE)	1.386E-04	1.000	106	55	260	263	10	200	246	233	0.783	0.776
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3my0-assembly10.cif.gz_J	3my0-assembly10.cif.gz_J Crystal structure of the ACVRL1 (ALK1) kinase domain bound to LDN-193189	5.749E-04	1.000	106	55	261	263	5	199	252	235	0.787	0.774
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2in6-assembly1.cif.gz_A	2in6-assembly1.cif.gz_A Wee1 kinase complex with inhibitor PD311839	5.579E-05	1.000	106	35	263	263	2	245	256	302	0.871	0.953
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6wiw-assembly1.cif.gz_B	6wiw-assembly1.cif.gz_B c-Src Bound to ATP-Competitive Inhibitor I14	6.819E-04	1.000	106	58	260	263	14	206	262	231	0.772	0.737
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5fm3-assembly1.cif.gz_A	5fm3-assembly1.cif.gz_A Crystal structure of hyper-phosphorylated RET kinase domain with (proximal) juxtamembrane segment	2.449E-04	1.000	106	54	262	263	19	278	280	295	0.795	0.929
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8g6z-assembly1.cif.gz_B	8g6z-assembly1.cif.gz_B JAK2 crystal structure in complex with Compound 13	4.087E-04	1.000	106	54	260	263	8	232	280	258	0.787	0.804
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4oth-assembly1.cif.gz_A	4oth-assembly1.cif.gz_A Crystal Structure of PRK1 Catalytic Domain in Complex with Ro-31-8220	1.601E-03	1.000	106	53	263	263	8	197	306	227	0.802	0.621
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7jnt-assembly2.cif.gz_D	7jnt-assembly2.cif.gz_D CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 2 (ROCK2) IN COMPLEX WITH A POTENT AND SELECTIVE DUAL ROCK INHIBITOR	3.861E-04	1.000	106	36	260	263	41	261	360	250	0.856	0.614
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7jov-assembly2.cif.gz_D	7jov-assembly2.cif.gz_D CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 2 (ROCK2) IN COMPLEX WITH A PHENYLPYRAZOLE AMIDE INHIBITOR	1.386E-04	1.000	106	26	263	263	25	284	361	291	0.905	0.720
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7p6n-assembly4.cif.gz_F	7p6n-assembly4.cif.gz_F ROCK2 IN COMPLEX WITH COMPOUND 12	2.744E-04	1.000	106	26	260	263	25	279	384	283	0.894	0.664
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7jnt-assembly2.cif.gz_C	7jnt-assembly2.cif.gz_C CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 2 (ROCK2) IN COMPLEX WITH A POTENT AND SELECTIVE DUAL ROCK INHIBITOR	3.255E-04	1.000	106	36	260	263	43	280	386	267	0.856	0.617
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5bml-assembly1.cif.gz_B	5bml-assembly1.cif.gz_B ROCK 1 bound to a pyridine thiazole inhibitor	2.314E-04	1.000	106	19	259	263	43	313	395	306	0.916	0.686
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3gfw-assembly1.cif.gz_A	3gfw-assembly1.cif.gz_A Crystal Structure of Human Dual Specificity Protein Kinase (TTK) in complex with a pyrolo-pyridin ligand	1.386E-04	1.000	105	54	261	263	12	233	253	254	0.791	0.877
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6l8l-assembly2.cif.gz_B	6l8l-assembly2.cif.gz_B C-Src in complex with ibrutinib	3.861E-04	1.000	105	58	260	263	10	200	256	229	0.772	0.746
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7shv-assembly1.cif.gz_A	7shv-assembly1.cif.gz_A Crystal structure of BRAF kinase domain bound to GDC0879	1.386E-04	1.000	105	58	263	263	14	214	261	241	0.783	0.770
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3zfx-assembly5.cif.gz_E	3zfx-assembly5.cif.gz_E Crystal structure of EphB1	6.442E-04	1.000	105	58	260	263	14	208	262	232	0.772	0.744
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6oqo-assembly1.cif.gz_A	6oqo-assembly1.cif.gz_A CDK6 in complex with Cpd24 N-(5-(6-ethyl-2,6-diazaspiro[3.3]heptan-2-yl)pyridin-2-yl)-5-fluoro-4-(4-methyl-5,6,7,8-tetrahydro-4H-pyrazolo[1,5-a]azepin-3-yl)pyrimidin-2-amine	5.431E-04	1.000	105	54	260	263	4	201	269	240	0.787	0.736
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5i9v-assembly1.cif.gz_A	5i9v-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with AGS	2.449E-04	1.000	105	58	260	263	14	215	279	235	0.772	0.724
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2pzp-assembly1.cif.gz_A	2pzp-assembly1.cif.gz_A Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K526E Mutation Responsible for Crouzon Syndrome	3.861E-04	1.000	105	53	263	263	12	255	280	278	0.802	0.871
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7uys-assembly1.cif.gz_A	7uys-assembly1.cif.gz_A Crystal structure of TYK2 kinase domain in complex with compound 16	4.087E-04	1.000	105	55	260	263	10	231	282	257	0.783	0.787
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6u2h-assembly1.cif.gz_D	6u2h-assembly1.cif.gz_D BRAF dimer bound to 14-3-3	4.326E-04	1.000	105	50	260	263	8	266	283	295	0.802	0.915
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5uxb-assembly1.cif.gz_A	5uxb-assembly1.cif.gz_A Crystal structure of macrolide 2'-phosphotransferase MphH from Brachybacterium faecium, apoenzyme	3.647E-04	1.000	105	43	259	263	4	257	290	289	0.825	0.876
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5dew-assembly1.cif.gz_A	5dew-assembly1.cif.gz_A Crystal structure of PAK1 in complex with an inhibitor compound 5	1.237E-04	1.000	105	40	263	263	2	276	295	310	0.852	0.932
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7uy3-assembly1.cif.gz_A	7uy3-assembly1.cif.gz_A Crystal structure of human Fgr tyrosine kinase in complex with TL02-59	9.594E-04	1.000	105	58	260	263	129	332	386	238	0.772	0.528
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4w7p-assembly3.cif.gz_D	4w7p-assembly3.cif.gz_D Crystal Structure of ROCK 1 bound to YB-15-QD37	2.744E-04	1.000	105	19	259	263	42	306	387	305	0.916	0.685
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5ap5-assembly1.cif.gz_A	5ap5-assembly1.cif.gz_A Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance.	2.186E-04	1.000	104	55	261	263	13	232	252	256	0.787	0.873
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3geq-assembly1.cif.gz_A	3geq-assembly1.cif.gz_A Structural basis for the chemical rescue of Src kinase activity	4.087E-04	1.000	104	58	263	263	25	239	272	252	0.783	0.790
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6xag-assembly1.cif.gz_D	6xag-assembly1.cif.gz_D Apo BRAF dimer bound to 14-3-3	9.594E-04	1.000	104	58	263	263	12	219	278	242	0.783	0.748
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7lvi-assembly1.cif.gz_A	7lvi-assembly1.cif.gz_A CRYSTAL STRUCTURE OF AP2 ASSOCIATED KINASE 1 ISOFORM 1 COMPLEXED WITH LIGAND (2R)-2-AMINO-N-[3-METHOXY-4- (1,3-OXAZOL-5-YL)PHENYL]-4-METHYLPENTANAMIDE	2.592E-04	1.000	104	58	255	263	18	211	294	233	0.753	0.660
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5ih0-assembly1.cif.gz_A	5ih0-assembly1.cif.gz_A Macrolide 2'-phosphotransferase type II Y92M mutant - complex with GDP and erythromycin	1.508E-05	1.000	104	43	261	263	8	271	299	293	0.833	0.883
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6yu1-assembly1.cif.gz_a	6yu1-assembly1.cif.gz_a CLK3 bound with beta-carboline KH-CARB13 (Cpd 3)	9.063E-04	1.000	104	53	242	263	20	226	340	242	0.722	0.609
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6ed6-assembly1.cif.gz_A	6ed6-assembly1.cif.gz_A Crystal structure of Rock2 with a pyridinylbenzamide based inhibitor	3.647E-04	1.000	104	36	260	263	39	278	378	267	0.856	0.635
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5uzj-assembly1.cif.gz_B	5uzj-assembly1.cif.gz_B Crystal Structure of ROCK1 bound to an aminopyridine inhibitor	2.186E-04	1.000	104	19	259	263	43	307	386	301	0.916	0.687
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5wnh-assembly2.cif.gz_C	5wnh-assembly2.cif.gz_C X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR	2.905E-04	1.000	104	33	259	263	37	305	388	297	0.863	0.693
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5kks-assembly1.cif.gz_B	5kks-assembly1.cif.gz_B ROCK 1 bound to azaindole thiazole inhibitor	1.843E-04	1.000	104	19	263	263	43	314	395	308	0.932	0.689
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5he2-assembly1.cif.gz_A	5he2-assembly1.cif.gz_A Bovine GRK2 in complex with Gbetagamma subunits and CCG224406	4.326E-04	1.000	104	36	261	263	140	402	628	293	0.859	0.419
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7mxb-assembly2.cif.gz_B	7mxb-assembly2.cif.gz_B Crystal structure of the S/T protein kinase PknG from Corynebacterium glutamicum in complex with AMP-PNP	4.087E-04	1.000	104	50	245	263	46	234	655	235	0.745	0.289
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5na0-assembly1.cif.gz_A	5na0-assembly1.cif.gz_A TTK kinase domain in complex with a PEG-linked pyrimido-indolizine	1.205E-03	1.000	103	54	256	263	11	203	254	226	0.772	0.760
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6l8l-assembly4.cif.gz_D	6l8l-assembly4.cif.gz_D C-Src in complex with ibrutinib	2.314E-04	1.000	103	58	260	263	11	200	256	233	0.772	0.742
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7shv-assembly1.cif.gz_B	7shv-assembly1.cif.gz_B Crystal structure of BRAF kinase domain bound to GDC0879	2.314E-04	1.000	103	50	263	263	7	215	262	248	0.814	0.798
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5ljj-assembly1.cif.gz_A	5ljj-assembly1.cif.gz_A Crystal structure of human Mps1 (TTK) in complex with Reversine	4.326E-04	1.000	103	54	261	263	12	243	264	263	0.791	0.879
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3f6x-assembly3.cif.gz_C	3f6x-assembly3.cif.gz_C c-Src kinase domain in complex with small molecule inhibitor	2.065E-04	1.000	103	58	263	263	18	192	265	229	0.783	0.660
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6yi8-assembly1.cif.gz_A	6yi8-assembly1.cif.gz_A HUMAN FGFR4 KINASE DOMAIN (447-753) IN COMPLEX WITH ROBLITINIB	1.554E-04	1.000	103	55	260	263	17	228	277	249	0.783	0.765
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2py3-assembly1.cif.gz_B	2py3-assembly1.cif.gz_B Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic E565G Mutation Responsible for Pfeiffer Syndrome	6.819E-04	1.000	103	55	260	263	16	236	284	258	0.783	0.778
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3lxp-assembly1.cif.gz_A	3lxp-assembly1.cif.gz_A Structural and Thermodynamic Characterization of the TYK2 and JAK3 Kinase Domains in Complex with CP-690550 and CMP-6	3.255E-04	1.000	103	54	263	263	11	261	286	286	0.798	0.878
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1xo2-assembly1.cif.gz_B	1xo2-assembly1.cif.gz_B Crystal structure of a human cyclin-dependent kinase 6 complex with a flavonol inhibitor, fisetin	1.205E-03	1.000	103	54	260	263	2	220	289	252	0.787	0.758
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5qin-assembly1.cif.gz_A	5qin-assembly1.cif.gz_A TGF-BETA RECEPTOR TYPE 2 KINASE DOMAIN IN COMPLEX WITH N- {4-[3-(6-METHOXYPYRIDIN-3-YL)-1H-PYRROLO[3,2-B]PYRIDIN-2- YL]PYRIDIN-2-YL}ACETAMIDE	8.088E-04	1.000	103	54	255	263	6	203	295	232	0.768	0.671
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6fd3-assembly1.cif.gz_A	6fd3-assembly1.cif.gz_A Thiophosphorylated PAK3 kinase domain	2.314E-04	1.000	103	35	263	263	2	278	296	314	0.871	0.936
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5kkt-assembly1.cif.gz_B	5kkt-assembly1.cif.gz_B ROCK 1 bound to azaindole thiazole piperazine inhibitor	2.592E-04	1.000	103	19	259	263	43	313	394	307	0.916	0.688
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4knb-assembly4.cif.gz_D	4knb-assembly4.cif.gz_D C-Met in complex with OSI ligand	1.554E-04	1.000	102	58	260	263	20	240	247	258	0.772	0.895
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2bdf-assembly2.cif.gz_B	2bdf-assembly2.cif.gz_B Src kinase in complex with inhibitor AP23451	1.512E-03	1.000	102	58	260	263	18	214	265	235	0.772	0.743
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6in0-assembly1.cif.gz_A	6in0-assembly1.cif.gz_A Crystal structure of EphA3 in complex with 18-Crown-6	2.744E-04	1.000	102	47	260	263	6	213	272	249	0.814	0.765
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4gk3-assembly1.cif.gz_A	4gk3-assembly1.cif.gz_A Human EphA3 Kinase domain in complex with ligand 87	1.468E-04	1.000	102	47	260	263	10	217	275	254	0.814	0.756
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3gql-assembly4.cif.gz_B	3gql-assembly4.cif.gz_B Crystal Structure of activated receptor tyrosine kinase in complex with substrates	5.749E-04	1.000	102	54	260	263	17	267	276	282	0.787	0.909
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3dls-assembly7.cif.gz_C	3dls-assembly7.cif.gz_C Crystal structure of human PAS kinase bound to ADP	5.749E-04	1.000	102	53	263	263	16	254	281	269	0.802	0.851
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5lpz-assembly1.cif.gz_A	5lpz-assembly1.cif.gz_A Crystal structure of the BRI1 kinase domain (865-1196) in complex with ADP from Arabidopsis thaliana	3.445E-04	1.000	102	41	263	263	9	265	286	296	0.848	0.899
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7rj7-assembly1.cif.gz_A	7rj7-assembly1.cif.gz_A CRYSTAL STRUCTURE OF AP2 ASSOCIATED KINASE 1 ISOFORM 1 COMPLEXED WITH LIGAND 2-(1-AMINO-3-METHYLBUTYL)-6- (PYRIDIN-4-YL)QUINOLINE-4-CARBONITRILE	2.592E-04	1.000	102	55	255	263	23	221	304	240	0.764	0.655
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6ed6-assembly2.cif.gz_B	6ed6-assembly2.cif.gz_B Crystal structure of Rock2 with a pyridinylbenzamide based inhibitor	4.326E-04	1.000	102	36	260	263	38	263	364	256	0.856	0.621
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7jov-assembly3.cif.gz_E	7jov-assembly3.cif.gz_E CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 2 (ROCK2) IN COMPLEX WITH A PHENYLPYRAZOLE AMIDE INHIBITOR	3.861E-04	1.000	102	26	260	263	27	283	385	288	0.894	0.668
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2og8-assembly1.cif.gz_A	2og8-assembly1.cif.gz_A crystal structure of aminoquinazoline 36 bound to Lck	6.086E-04	1.000	101	55	263	263	11	205	246	243	0.795	0.793
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5ehl-assembly1.cif.gz_A	5ehl-assembly1.cif.gz_A Rapid Discovery of Pyrido[3,4-d]pyrimidine Inhibitors of Monopolar Spindle kinase 1 (MPS1) Using a Structure-Based Hydridization Approach	3.445E-04	1.000	101	55	263	263	13	242	258	264	0.795	0.891
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3tv6-assembly1.cif.gz_A	3tv6-assembly1.cif.gz_A Human B-Raf Kinase Domain in Complex with a Methoxypyrazolopyridinyl Benzamide Inhibitor	1.951E-04	1.000	101	50	263	263	8	219	268	252	0.814	0.791
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1v0o-assembly2.cif.gz_B	1v0o-assembly2.cif.gz_B Structure of P. falciparum PfPK5-Indirubin-5-sulphonate ligand complex	4.847E-04	1.000	101	55	256	263	2	199	274	240	0.768	0.723
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7ozy-assembly1.cif.gz_AAA	7ozy-assembly1.cif.gz_AAA FGFR2 kinase domain (residues 461-763) in complex with 38.	4.579E-04	1.000	101	53	260	263	13	237	281	265	0.791	0.801
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8gmc-assembly2.cif.gz_B	8gmc-assembly2.cif.gz_B CRYSTAL STRUCTURE OF AP2 ASSOCIATED KINASE 1 COMPLEXED WITH 5-[(4-aminopiperidin-1-yl)methyl]-N-{3-[5-(propan-2-yl)-1,3,4-thiadiazol-2-yl]phenyl}pyrrolo[2,1-f][1,2,4]triazin-4-amine	1.741E-04	1.000	101	49	240	263	2	202	294	237	0.730	0.684
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5igw-assembly1.cif.gz_A	5igw-assembly1.cif.gz_A Macrolide 2'-phosphotransferase type II - complex with GDP and clarithromycin	4.444E-05	1.000	101	40	258	263	6	266	296	295	0.833	0.882
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6rq4-assembly1.cif.gz_A	6rq4-assembly1.cif.gz_A Inhibitor of ERK2	1.138E-03	1.000	101	54	259	263	6	223	332	254	0.783	0.657
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5bui-assembly1.cif.gz_A	5bui-assembly1.cif.gz_A ERK2 complexed with 2-pyridiyl tetrahydroazaindazole	1.695E-03	1.000	101	54	259	263	14	221	338	243	0.783	0.615
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5ke0-assembly1.cif.gz_A	5ke0-assembly1.cif.gz_A Discovery of 1-1H-Pyrazolo 4,3-c pyridine-6-yl urea Inhibitors of Extracellular Signal Regulated Kinase ERK for the Treatment of Cancers	1.601E-03	1.000	101	54	216	263	7	154	340	182	0.620	0.435
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5kkt-assembly1.cif.gz_A	5kkt-assembly1.cif.gz_A ROCK 1 bound to azaindole thiazole piperazine inhibitor	2.744E-04	1.000	101	36	259	263	44	308	389	297	0.852	0.681
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5bml-assembly1.cif.gz_A	5bml-assembly1.cif.gz_A ROCK 1 bound to a pyridine thiazole inhibitor	5.749E-04	1.000	101	19	259	263	42	310	393	306	0.916	0.684
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4d2s-assembly1.cif.gz_A	4d2s-assembly1.cif.gz_A Human TTK in complex with a Dyrk1B inhibitor	7.641E-04	1.000	100	55	261	263	15	230	249	252	0.787	0.867
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4r5y-assembly1.cif.gz_A	4r5y-assembly1.cif.gz_A The complex structure of Braf V600E kinase domain with a novel Braf inhibitor	6.442E-04	1.000	100	58	263	263	14	207	253	234	0.783	0.767
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4cv8-assembly1.cif.gz_A	4cv8-assembly1.cif.gz_A MPS1 kinase with 3-aminopyridin-2-one inhibitors	1.951E-04	1.000	100	54	261	263	11	235	255	257	0.791	0.882
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6l8l-assembly3.cif.gz_C	6l8l-assembly3.cif.gz_C C-Src in complex with ibrutinib	5.749E-04	1.000	100	58	263	263	12	204	258	232	0.783	0.748
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5yvc-assembly1.cif.gz_A	5yvc-assembly1.cif.gz_A Structure of CaMKK2 in complex with CKI-012	2.314E-04	1.000	100	55	261	263	8	240	259	271	0.787	0.900
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4o6l-assembly1.cif.gz_A	4o6l-assembly1.cif.gz_A Crystal Structure of TTK kinase domain with an inhibitor: 401498 (N-[(1R)-1-(2-chlorophenyl)propyl]-3-{4-[(1-methylpiperidin-4-yl)oxy]phenyl}-1H-indazole-5-carboxamide)	5.131E-04	1.000	100	54	263	263	12	247	260	265	0.798	0.908
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5ap7-assembly1.cif.gz_A	5ap7-assembly1.cif.gz_A Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance.	2.592E-04	1.000	100	55	261	263	19	243	263	257	0.787	0.856
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2fum-assembly1.cif.gz_A	2fum-assembly1.cif.gz_A Catalytic domain of protein kinase PknB from Mycobacterium tuberculosis in complex with mitoxantrone	7.641E-04	1.000	100	53	257	263	7	213	263	239	0.779	0.787
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6e6e-assembly6.cif.gz_F	6e6e-assembly6.cif.gz_F DGY-06-116, a novel and selective covalent inhibitor of SRC kinase	1.601E-03	1.000	100	58	263	263	15	193	266	225	0.783	0.673
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8flh-assembly1.cif.gz_A	8flh-assembly1.cif.gz_A Bruton's tyrosine kinase in complex with an orthosteric inhibitor	3.861E-04	1.000	100	53	263	263	9	223	266	251	0.802	0.808
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6hve-assembly1.cif.gz_A	6hve-assembly1.cif.gz_A Kinase domain of cSrc in complex with compound 9	8.088E-04	1.000	100	58	260	263	17	211	267	234	0.772	0.730
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6fer-assembly3.cif.gz_C	6fer-assembly3.cif.gz_C Crystal Structure of human DDR2 kinase in complex with 2-[4,5-difluoro-2-oxo-1'-(1H-pyrazolo[3,4-b]pyridine-5-carbonyl)spiro[indole-3,4'-piperidine]-1-yl]-N-(2,2,2-trifluoroethyl)acetamide	2.314E-04	1.000	100	49	260	263	8	224	272	256	0.806	0.798
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4uwc-assembly2.cif.gz_B	4uwc-assembly2.cif.gz_B Fibroblast growth factor receptor 1 kinase in complex with JK-P3	2.186E-04	1.000	100	55	263	263	22	255	301	269	0.795	0.777
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6f7b-assembly1.cif.gz_A	6f7b-assembly1.cif.gz_A Crystal structure of the human Bub1 kinase domain in complex with BAY 1816032	2.449E-04	1.000	100	55	260	263	57	316	343	293	0.783	0.758
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5wng-assembly1.cif.gz_B	5wng-assembly1.cif.gz_B X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR	8.795E-05	1.000	100	36	259	263	45	294	365	281	0.852	0.685
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5u7r-assembly1.cif.gz_D	5u7r-assembly1.cif.gz_D Identification of A New Class of Potent Cdc7 Inhibitors Designed by Putative Pharmacophore Model: Synthesis and Biological Evaluation of 2,3-Dihydrothieno[3,2-d]pyrimidin-4(1H)-ones	1.695E-03	1.000	100	36	218	263	41	214	382	202	0.696	0.455
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3tv7-assembly1.cif.gz_A	3tv7-assembly1.cif.gz_A Human Rho-associated protein kinase 1 (ROCK 1) in COMPLEX WITH RKI1342	5.131E-04	1.000	100	21	259	263	39	309	394	308	0.909	0.688
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3qgy-assembly1.cif.gz_A	3qgy-assembly1.cif.gz_A Crystal structure of ITK inhibitor complex	1.350E-03	0.999	99	54	260	263	10	201	246	235	0.787	0.780
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2hwo-assembly1.cif.gz_A	2hwo-assembly1.cif.gz_A Crystal structure of Src kinase domain in complex with covalent inhibitor	5.131E-04	0.999	99	60	263	263	19	197	251	227	0.776	0.713
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5ap3-assembly1.cif.gz_A	5ap3-assembly1.cif.gz_A Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance.	2.065E-04	0.999	99	55	261	263	12	234	254	255	0.787	0.878
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5v5y-assembly1.cif.gz_A	5v5y-assembly1.cif.gz_A CRYSTAL STRUCTURE OF HUMAN WEE1 KINASE DOMAIN IN COMPLEX WITH MK1775	1.075E-03	0.999	99	46	258	263	2	216	259	258	0.810	0.830
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5p9h-assembly1.cif.gz_A	5p9h-assembly1.cif.gz_A BTK1 COCRYSTALLIZED WITH RN983	1.075E-03	0.999	99	53	260	263	6	218	264	247	0.791	0.807
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2pzp-assembly1.cif.gz_B	2pzp-assembly1.cif.gz_B Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K526E Mutation Responsible for Crouzon Syndrome	9.063E-04	0.999	99	65	260	263	22	234	282	248	0.745	0.755
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2qon-assembly1.cif.gz_A	2qon-assembly1.cif.gz_A Human EphA3 kinase and juxtamembrane region, Y596F:Y602F:Y742A triple mutant	3.445E-04	0.999	99	47	256	263	14	215	282	243	0.798	0.716
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5lpv-assembly1.cif.gz_A	5lpv-assembly1.cif.gz_A Crystal structure of the BRI1 kinase domain (865-1160) in complex with AMPPNP and Mn from Arabidopsis thaliana	9.063E-04	0.999	99	41	218	263	8	163	285	191	0.677	0.547
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2pvy-assembly1.cif.gz_C	2pvy-assembly1.cif.gz_C Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K659N Mutation Responsible for an Unclassified Craniosynostosis Syndrome.	5.431E-04	0.999	99	65	263	263	28	242	285	250	0.757	0.754
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4d2w-assembly2.cif.gz_C	4d2w-assembly2.cif.gz_C Structure of MELK in complex with inhibitors	2.592E-04	0.999	99	53	260	263	9	203	313	238	0.791	0.623
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4qpm-assembly1.cif.gz_A	4qpm-assembly1.cif.gz_A Structure of Bub1 kinase domain	3.861E-04	0.999	99	55	260	263	51	303	330	288	0.783	0.767
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5u7q-assembly6.cif.gz_D-3	5u7q-assembly6.cif.gz_D-3 Identification of A New Class of Potent Cdc7 Inhibitors Designed by Putative Pharmacophore Model: Synthesis and Biological Evaluation of 2,3-Dihydrothieno[3,2-d]pyrimidin-4(1H)-ones	7.641E-04	0.999	99	26	218	263	23	212	383	218	0.734	0.496
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7s26-assembly1.cif.gz_A	7s26-assembly1.cif.gz_A ROCK1 IN COMPLEX WITH LIGAND G5018	3.861E-04	0.999	99	19	259	263	43	304	388	301	0.916	0.675
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4bi2-assembly1.cif.gz_A	4bi2-assembly1.cif.gz_A Scaffold Focused Virtual Screening: Prospective Application to the Discovery of TTK Inhibitor	2.592E-04	0.999	98	55	263	263	12	239	253	261	0.795	0.901
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5eho-assembly1.cif.gz_A	5eho-assembly1.cif.gz_A Rapid Discovery of Pyrido[3,4-d]pyrimidine Inhibitors of Monopolar Spindle kinase 1 (MPS1) Using a Structure-Based Hydridization Approach	4.579E-04	0.999	98	55	263	263	12	213	258	236	0.795	0.783
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6tn9-assembly1.cif.gz_A	6tn9-assembly1.cif.gz_A X-RAY STRUCTURE OF MPS1 IN COMPLEX WITH COMPOUND 16	4.579E-04	0.999	98	55	263	263	15	245	259	267	0.795	0.892
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3zfx-assembly4.cif.gz_D	3zfx-assembly4.cif.gz_D Crystal structure of EphB1	3.255E-04	0.999	98	58	263	263	14	213	265	240	0.783	0.755
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5nki-assembly1.cif.gz_A	5nki-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 4b	2.905E-04	0.999	98	58	260	263	15	245	268	261	0.772	0.862
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1qpd-assembly1.cif.gz_A	1qpd-assembly1.cif.gz_A STRUCTURAL ANALYSIS OF THE LYMPHOCYTE-SPECIFIC KINASE LCK IN COMPLEX WITH NON-SELECTIVE AND SRC FAMILY SELECTIVE KINASE INHIBITORS	1.075E-03	0.999	98	55	263	263	17	248	271	268	0.795	0.856
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4g2f-assembly1.cif.gz_A	4g2f-assembly1.cif.gz_A Human EphA3 kinase domain in complex with compound 7	1.237E-04	0.999	98	47	260	263	10	216	275	254	0.814	0.753
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3ckx-assembly1.cif.gz_A	3ckx-assembly1.cif.gz_A Crystal structure of sterile 20-like kinase 3 (MST3, STK24) in complex with staurosporine	3.445E-04	0.999	98	55	263	263	7	258	277	284	0.795	0.910
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4zji-assembly3.cif.gz_C	4zji-assembly3.cif.gz_C PAK1 in complex with 2-chloro-5-ethyl-8-fluoro-11-(4-methylpiperazin-1-yl)-dibenzodiazepine	1.016E-03	0.999	98	40	260	263	2	214	281	254	0.840	0.758
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6fek-assembly1.cif.gz_A	6fek-assembly1.cif.gz_A Oncogenic point mutation of RET receptor tyrosine kinase	9.063E-04	0.999	98	40	263	263	4	296	296	327	0.852	0.990
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3tl8-assembly1.cif.gz_A	3tl8-assembly1.cif.gz_A The AvrPtoB-BAK1 complex reveals two structurally similar kinaseinteracting domains in a single type III effector	1.075E-03	0.999	98	53	218	263	20	168	304	184	0.631	0.490
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6sun-assembly1.cif.gz_A	6sun-assembly1.cif.gz_A Amicoumacin kinase hAmiN in complex with AMP-PNP, Ca2+ and Ami	1.645E-04	0.999	98	43	262	263	12	266	334	299	0.837	0.763
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5wnh-assembly1.cif.gz_A	5wnh-assembly1.cif.gz_A X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR	6.442E-04	0.999	98	33	259	263	35	312	394	306	0.863	0.706
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2pzi-assembly2.cif.gz_B	2pzi-assembly2.cif.gz_B Crystal Structure of Protein kinase PknG from Mycobacterium tuberculosis in Complex with Tetrahydrobenzothiophene AX20017	8.562E-04	0.999	98	51	240	263	71	256	644	224	0.722	0.289
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5jt2-assembly1.cif.gz_B	5jt2-assembly1.cif.gz_B BRAFV600E Kinase Domain In Complex with Chemically Linked Vemurafenib Inhibitor VEM-BISAMIDE	3.255E-04	0.999	97	50	263	263	9	206	251	243	0.814	0.789
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6tnb-assembly1.cif.gz_A	6tnb-assembly1.cif.gz_A X-RAY STRUCTURE OF MPS1 IN COMPLEX WITH COMPOUND 41	3.861E-04	0.999	97	55	261	263	11	232	252	253	0.787	0.881
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5n87-assembly1.cif.gz_A	5n87-assembly1.cif.gz_A TTK kinase domain in complex with NTRC 0066-0	1.554E-04	0.999	97	54	261	263	11	236	256	259	0.791	0.883
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7bjr-assembly1.cif.gz_A	7bjr-assembly1.cif.gz_A Crystal structure of CHK1-10pt-mutant complex with compound 18	1.794E-03	0.999	97	54	240	263	6	182	257	216	0.711	0.689
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3hmp-assembly1.cif.gz_A	3hmp-assembly1.cif.gz_A Crystal structure of human Mps1 catalytic domain in complex with a quinazolin ligand Compound 4	6.086E-04	0.999	97	54	263	263	11	244	258	266	0.798	0.907
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7n4q-assembly1.cif.gz_A	7n4q-assembly1.cif.gz_A Bruton's tyrosine kinase in complex with compound 45	6.819E-04	0.999	97	53	260	263	9	214	260	246	0.791	0.792
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3tv6-assembly2.cif.gz_B	3tv6-assembly2.cif.gz_B Human B-Raf Kinase Domain in Complex with a Methoxypyrazolopyridinyl Benzamide Inhibitor	3.445E-04	0.999	97	50	263	263	8	227	276	259	0.814	0.797
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3kc3-assembly5.cif.gz_C	3kc3-assembly5.cif.gz_C MK2 complexed to inhibitor N4-(7-(benzofuran-2-yl)-1H-indazol-5-yl)pyrimidine-2,4-diamine	6.086E-04	0.999	97	53	261	263	21	244	281	261	0.795	0.797
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5nk6-assembly1.cif.gz_A	5nk6-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 2d	4.326E-04	0.999	97	58	260	263	14	220	284	244	0.772	0.729
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5cf4-assembly1.cif.gz_A	5cf4-assembly1.cif.gz_A CRYSTAL STRUCTURE OF JANUS KINASE 2 IN COMPLEX WITH N,N-DICYCLOPROPYL-10-ETHYL-7-[(3-METHOXYPROPYL)AMINO] -3-METHYL-3,5,8,10-TETRAAZATRICYCLO[7.3.0.0,6] DODECA-1(9),2(6),4,7,11-PENTAENE-11-CARBOXAMIDE	1.350E-03	0.999	97	54	260	263	8	234	285	260	0.787	0.796
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5l4q-assembly1.cif.gz_A	5l4q-assembly1.cif.gz_A Crystal Structure of Adaptor Protein 2 Associated Kinase 1 (AAK1) in Complex with LKB1 (AAK1 Dual Inhibitor)	5.431E-04	0.999	97	58	252	263	19	202	293	222	0.741	0.628
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5igh-assembly1.cif.gz_A	5igh-assembly1.cif.gz_A Macrolide 2'-phosphotransferase type I	7.415E-05	0.999	97	34	262	263	3	270	301	300	0.871	0.890
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4lue-assembly1.cif.gz_A	4lue-assembly1.cif.gz_A Crystal Structure of HCK in complex with 7-[trans-4-(4-methylpiperazin-1-yl)cyclohexyl]-5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (resulting from displacement of SKF86002)	8.088E-04	0.999	97	55	263	263	181	393	423	252	0.795	0.504
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7k7z-assembly1.cif.gz_A	7k7z-assembly1.cif.gz_A Structure of a hit for G Protein Coupled Receptor Kinase 2 (GRK2) Inhibitor for the Potential Treatment of Heart Failure	1.350E-03	0.999	97	36	220	263	140	314	625	204	0.703	0.280
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3wzk-assembly1.cif.gz_A	3wzk-assembly1.cif.gz_A CRYSTAL STRUCTURE OF HUMAN MPS1 CATALYTIC DOMAIN IN COMPLEX WITH N-cyclopropyl-4-(8-((thiophen-2-ylmethyl)amino)imidazo[1,2-a]pyrazin-3-yl)benzamide	6.086E-04	0.999	96	55	263	263	12	244	258	265	0.795	0.903
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5vda-assembly1.cif.gz_A	5vda-assembly1.cif.gz_A Crystal structure of human WEE1 kinase domain in complex with RAC-IV-101, a MK1775 analogue	6.442E-04	0.999	96	53	249	263	5	205	259	243	0.749	0.776
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6mzq-assembly2.cif.gz_B	6mzq-assembly2.cif.gz_B TAS-120 in reversible binding mode with FGFR1	9.594E-04	0.999	96	54	260	263	18	214	260	236	0.787	0.758
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5jsm-assembly1.cif.gz_A	5jsm-assembly1.cif.gz_A BRAFV600E Kinase Domain In Complex with Chemically Linked Vemurafenib Inhibitor VEM-3-VEM	1.237E-04	0.999	96	50	263	263	11	218	265	248	0.814	0.785
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6cd6-assembly4.cif.gz_D	6cd6-assembly4.cif.gz_D Crystal Structure of the Human CAMKK1A in complex with GSK650394	5.597E-03	0.999	96	55	218	263	8	155	267	175	0.624	0.554
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3dqw-assembly3.cif.gz_C	3dqw-assembly3.cif.gz_C c-Src kinase domain Thr338Ile mutant in complex with ATPgS	1.350E-03	0.999	96	58	260	263	15	220	276	245	0.772	0.746
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8g8x-assembly1.cif.gz_A	8g8x-assembly1.cif.gz_A X-ray co-crystal structure of compound 27 in with complex JAK2	1.794E-03	0.999	96	54	263	263	9	256	279	281	0.798	0.889
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5nho-assembly1.cif.gz_A	5nho-assembly1.cif.gz_A Human Erk2 with an Erk1/2 inhibitor	1.512E-03	0.999	96	54	259	263	14	231	343	259	0.783	0.636
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3cbl-assembly1.cif.gz_A	3cbl-assembly1.cif.gz_A Crystal structure of human feline sarcoma viral oncogene homologue (v-FES) in complex with staurosporine and a consensus peptide	9.063E-04	0.999	96	54	263	263	97	333	356	273	0.798	0.666
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6p5m-assembly6.cif.gz_B	6p5m-assembly6.cif.gz_B Discovery of a Novel, Highly Potent, and Selective Thieno[3,2-d]pyrimidinone-Based Cdc7 inhibitor with a Quinuclidine Moiety (TAK-931) as an Orally Active Investigational Anti-Tumor Agent	2.993E-03	0.999	96	28	260	263	31	288	388	286	0.886	0.665
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4wot-assembly2.cif.gz_B	4wot-assembly2.cif.gz_B ROCK2 IN COMPLEX WITH 1426382-07-1	6.442E-04	0.999	96	36	260	263	44	287	394	276	0.856	0.619
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7k7l-assembly1.cif.gz_A	7k7l-assembly1.cif.gz_A Structure of a hit for G Protein Coupled Receptor Kinase 2 (GRK2) Inhibitor for the Potential Treatment of Heart Failure	9.594E-04	0.999	96	54	263	263	163	381	616	248	0.798	0.356
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1snu-assembly2.cif.gz_B	1snu-assembly2.cif.gz_B CRYSTAL STRUCTURE OF THE UNPHOSPHORYLATED INTERLEUKIN-2 TYROSINE KINASE CATALYTIC DOMAIN	6.442E-04	0.998	95	54	263	263	7	241	241	272	0.798	0.975
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4bi1-assembly1.cif.gz_A	4bi1-assembly1.cif.gz_A Scaffold Focused Virtual Screening: Prospective Application to the Discovery of TTK Inhibitor	2.905E-04	0.998	95	54	261	263	11	232	252	259	0.791	0.881
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3zfx-assembly7.cif.gz_G	3zfx-assembly7.cif.gz_G Crystal structure of EphB1	1.016E-03	0.998	95	54	260	263	10	200	253	236	0.787	0.755
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3byu-assembly1.cif.gz_A	3byu-assembly1.cif.gz_A co-crystal structure of Lck and aminopyrimidine reverse amide 23	9.063E-04	0.998	95	55	260	263	17	251	256	275	0.783	0.918
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7ax4-assembly2.cif.gz_B	7ax4-assembly2.cif.gz_B Human TYK2 pseudokinase domain (575-869) in complex with 5-(4-Fluoro-phenyl)-2-ureido-thiophene-3-carboxylic acid amide.	1.794E-03	0.998	95	53	262	263	9	223	261	252	0.798	0.824
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3b2w-assembly1.cif.gz_A	3b2w-assembly1.cif.gz_A Crystal structure of pyrimidine amide 11 bound to Lck	1.016E-03	0.998	95	54	260	263	9	216	261	243	0.787	0.797
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7jxh-assembly6.cif.gz_F	7jxh-assembly6.cif.gz_F HER2 in complex with JBJ-08-178-01	7.219E-04	0.998	95	54	263	263	9	231	262	261	0.798	0.851
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3tz8-assembly2.cif.gz_B	3tz8-assembly2.cif.gz_B Kinase domain of cSrc in complex with RL104	1.075E-03	0.998	95	53	260	263	10	207	263	239	0.791	0.753
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4ybk-assembly1.cif.gz_A	4ybk-assembly1.cif.gz_A C-Helix-Out Dasatinib Analog Crystallized with c-Src Kinase	1.275E-03	0.998	95	58	260	263	17	210	266	235	0.772	0.729
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5nud-assembly1.cif.gz_A	5nud-assembly1.cif.gz_A FIBROBLAST GROWTH FACTOR RECEPTOR 4 KINASE DOMAIN (449-753) IN COMPLEX WITH IRREVERSIBLE LIGAND CGA159527	4.326E-04	0.998	95	54	260	263	16	259	267	278	0.787	0.914
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7k0v-assembly1.cif.gz_D	7k0v-assembly1.cif.gz_D Crystal structure of bRaf in complex with inhibitor GNE-0749	3.550E-03	0.998	95	50	212	263	7	146	271	178	0.620	0.517
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6fer-assembly7.cif.gz_G	6fer-assembly7.cif.gz_G Crystal Structure of human DDR2 kinase in complex with 2-[4,5-difluoro-2-oxo-1'-(1H-pyrazolo[3,4-b]pyridine-5-carbonyl)spiro[indole-3,4'-piperidine]-1-yl]-N-(2,2,2-trifluoroethyl)acetamide	5.431E-04	0.998	95	51	260	263	10	225	273	255	0.798	0.791
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6u5l-assembly1.cif.gz_A	6u5l-assembly1.cif.gz_A Structure of human ULK4 in complex with an inhibitor	1.794E-03	0.998	95	55	246	263	8	174	276	205	0.730	0.605
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3ky2-assembly2.cif.gz_B	3ky2-assembly2.cif.gz_B Crystal structure of Fibroblast Growth Factor Receptor 1 kinase domain	1.601E-03	0.998	95	55	260	263	21	232	280	243	0.783	0.757
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2x2m-assembly1.cif.gz_B	2x2m-assembly1.cif.gz_B Crystal Structure of phosphorylated RET tyrosine kinase domain with inhibitor	1.016E-03	0.998	95	40	262	263	4	278	280	310	0.848	0.982
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2gsf-assembly1.cif.gz_A	2gsf-assembly1.cif.gz_A The Human Epha3 Receptor Tyrosine Kinase and Juxtamembrane Region	5.131E-04	0.998	95	47	256	263	16	217	281	243	0.798	0.719
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6z55-assembly2.cif.gz_B	6z55-assembly2.cif.gz_B Crystal structure of CLK3 in complex with macrocycle ODS2004070	3.978E-03	0.998	95	53	242	263	27	240	357	243	0.722	0.599
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2f2u-assembly2.cif.gz_B-3	2f2u-assembly2.cif.gz_B-3 crystal structure of the Rho-kinase kinase domain	1.601E-03	0.998	95	26	260	263	23	282	383	288	0.894	0.679
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1fmk-assembly1.cif.gz_A	1fmk-assembly1.cif.gz_A CRYSTAL STRUCTURE OF HUMAN TYROSINE-PROTEIN KINASE C-SRC	1.205E-03	0.998	95	58	263	263	191	384	438	237	0.783	0.443
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2ofv-assembly1.cif.gz_A	2ofv-assembly1.cif.gz_A crystal structure of aminoquinazoline 1 bound to Lck	5.431E-04	0.998	94	55	263	263	17	224	244	251	0.795	0.852
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4kio-assembly3.cif.gz_C	4kio-assembly3.cif.gz_C Kinase domain mutant of human Itk in complex with a covalently-binding inhibitor	1.138E-03	0.998	94	54	260	263	10	245	251	274	0.787	0.940
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5fbo-assembly1.cif.gz_A	5fbo-assembly1.cif.gz_A BTK-inhibitor co-structure	7.219E-04	0.998	94	53	260	263	9	208	255	244	0.791	0.784
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3hmo-assembly1.cif.gz_A	3hmo-assembly1.cif.gz_A Crystal structure of human Mps1 catalytic domain in complex with the inhibitor staurosporine	7.641E-04	0.998	94	55	259	263	14	211	257	231	0.779	0.770
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4mne-assembly2.cif.gz_F	4mne-assembly2.cif.gz_F Crystal structure of the BRAF:MEK1 complex	1.350E-03	0.998	94	67	263	263	17	211	258	233	0.749	0.756
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3f3t-assembly2.cif.gz_B	3f3t-assembly2.cif.gz_B Kinase domain of cSrc in complex with inhibitor RL38 (Type III)	1.075E-03	0.998	94	58	263	263	12	205	259	232	0.783	0.749
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1yom-assembly2.cif.gz_B	1yom-assembly2.cif.gz_B Crystal structure of Src kinase domain in complex with Purvalanol A	1.429E-03	0.998	94	54	260	263	14	205	261	232	0.787	0.736
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6ccf-assembly2.cif.gz_B	6ccf-assembly2.cif.gz_B Crystal Structure of the Human CAMKK1A in complex with Hesperadin	5.431E-04	0.998	94	55	261	263	8	243	262	270	0.787	0.901
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4ehg-assembly1.cif.gz_A	4ehg-assembly1.cif.gz_A B-Raf Kinase Domain in Complex with an Aminopyridimine-based Inhibitor	1.843E-04	0.998	94	58	263	263	15	237	262	261	0.783	0.851
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3f6x-assembly4.cif.gz_D	3f6x-assembly4.cif.gz_D c-Src kinase domain in complex with small molecule inhibitor	9.063E-04	0.998	94	58	260	263	16	211	267	236	0.772	0.734
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5xp5-assembly2.cif.gz_B	5xp5-assembly2.cif.gz_B C-Src in complex with ATP-Chf	9.063E-04	0.998	94	58	263	263	14	194	267	230	0.783	0.678
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4mne-assembly1.cif.gz_B	4mne-assembly1.cif.gz_B Crystal structure of the BRAF:MEK1 complex	2.128E-03	0.998	94	60	263	263	10	222	270	249	0.776	0.789
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3rhx-assembly1.cif.gz_B	3rhx-assembly1.cif.gz_B Crystal structure of the catalytic domain of FGFR1 kinase in complex with ARQ 069	1.794E-03	0.998	94	54	263	263	19	252	275	268	0.798	0.851
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4j97-assembly6.cif.gz_D-3	4j97-assembly6.cif.gz_D-3 Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic Gain-of-Function K659E Mutation Identified in Endometrial Cancer.	1.075E-03	0.998	94	65	260	263	25	239	285	250	0.745	0.754
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3f7w-assembly1.cif.gz_A	3f7w-assembly1.cif.gz_A Crystal structure of putative fructosamine-3-kinase (YP_290396.1) from THERMOBIFIDA FUSCA YX-ER1 at 1.85 A resolution	2.186E-04	0.998	94	44	263	263	7	273	288	294	0.837	0.927
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4jdk-assembly1.cif.gz_A	4jdk-assembly1.cif.gz_A Crystal structure of Serine/threonine-protein kinase PAK 4 F461V mutant in complex with Paktide S peptide substrate	3.550E-03	0.998	94	49	262	263	19	228	290	243	0.814	0.724
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4xrl-assembly1.cif.gz_A	4xrl-assembly1.cif.gz_A Crystal structure at room temperature of Erk2 in complex with an inhibitor	3.978E-03	0.998	94	54	259	263	14	231	338	251	0.783	0.645
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4g6o-assembly1.cif.gz_A	4g6o-assembly1.cif.gz_A Crystal Structure of the ERK2	3.758E-03	0.998	94	54	218	263	14	161	341	179	0.627	0.434
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4fv7-assembly1.cif.gz_A	4fv7-assembly1.cif.gz_A Crystal Structure of the ERK2 complexed with E94	2.671E-03	0.998	94	54	218	263	14	163	344	183	0.627	0.436
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5ce3-assembly2.cif.gz_D	5ce3-assembly2.cif.gz_D The Yersinia YopO - actin complex with MgADP	8.562E-04	0.998	94	57	253	263	25	235	598	248	0.749	0.353
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5ap4-assembly1.cif.gz_A	5ap4-assembly1.cif.gz_A Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance.	8.088E-04	0.998	93	55	261	263	13	238	258	259	0.787	0.876
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6b4w-assembly1.cif.gz_A	6b4w-assembly1.cif.gz_A TTK in Complex with Inhibitor	1.138E-03	0.998	93	54	261	263	12	240	259	259	0.791	0.884
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5d12-assembly1.cif.gz_A	5d12-assembly1.cif.gz_A Kinase domain of cSrc in complex with RL40	4.087E-04	0.998	93	58	263	263	16	187	260	229	0.783	0.662
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1mqb-assembly1.cif.gz_A	1mqb-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (ephA2) Receptor Protein Kinase	1.275E-03	0.998	93	58	260	263	14	208	263	230	0.772	0.741
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6nzm-assembly1.cif.gz_A	6nzm-assembly1.cif.gz_A Brutons tyrosine kinase in complex with compound 50.	1.016E-03	0.998	93	53	260	263	6	216	263	251	0.791	0.802
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8x5k-assembly1.cif.gz_A	8x5k-assembly1.cif.gz_A The Crystal Structure of SYK from Biortus.	2.671E-03	0.998	93	49	263	263	5	222	264	255	0.817	0.826
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1jpa-assembly2.cif.gz_B	1jpa-assembly2.cif.gz_B Crystal Structure of unphosphorylated EphB2 receptor tyrosine kinase and juxtamembrane region	7.219E-04	0.998	93	44	263	263	13	222	269	249	0.837	0.781
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6fer-assembly1.cif.gz_A	6fer-assembly1.cif.gz_A Crystal Structure of human DDR2 kinase in complex with 2-[4,5-difluoro-2-oxo-1'-(1H-pyrazolo[3,4-b]pyridine-5-carbonyl)spiro[indole-3,4'-piperidine]-1-yl]-N-(2,2,2-trifluoroethyl)acetamide	5.131E-04	0.998	93	51	260	263	10	223	271	252	0.798	0.790
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5i9x-assembly1.cif.gz_A	5i9x-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with bosutinib (SKI-606)	1.138E-03	0.998	93	58	260	263	15	220	284	241	0.772	0.725
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5nkb-assembly1.cif.gz_A	5nkb-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 4a	6.442E-04	0.998	93	58	260	263	14	221	285	248	0.772	0.730
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1v0b-assembly1.cif.gz_A	1v0b-assembly1.cif.gz_A Crystal structure of the t198a mutant of pfpk5	1.794E-03	0.998	93	52	212	263	1	143	286	174	0.612	0.500
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4ump-assembly2.cif.gz_C	4ump-assembly2.cif.gz_C Structure of MELK in complex with inhibitors	2.128E-03	0.998	93	42	260	263	3	201	311	240	0.833	0.640
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3pg1-assembly1.cif.gz_A	3pg1-assembly1.cif.gz_A MAP kinase LmaMPK10 from Leishmania major (1.95 angs resolution)	1.645E-04	0.998	93	43	256	263	9	240	341	266	0.814	0.680
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4ix3-assembly1.cif.gz_A	4ix3-assembly1.cif.gz_A Crystal structure of a Stt7 homolog from Micromonas algae	3.169E-03	0.998	93	53	216	263	19	192	346	204	0.624	0.503
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5wg4-assembly1.cif.gz_A	5wg4-assembly1.cif.gz_A Human GRK2 in complex with Gbetagamma subunits and CCG257284	2.010E-03	0.998	93	36	259	263	139	377	621	269	0.852	0.385
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6u7c-assembly1.cif.gz_A	6u7c-assembly1.cif.gz_A Human GRK2 in complex with Gbetagamma subunits and CCG258747	2.010E-03	0.998	93	36	261	263	140	402	631	290	0.859	0.417
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5bpy-assembly2.cif.gz_B	5bpy-assembly2.cif.gz_B Crystal structure of bruton agammaglobulinemia tyrosine kinase complexed with BMS-824171 AKA 6-[(3R)-3-(4-tert-bu tylbenzamido)piperidin-1-yl]-2-{[4-(morpholine-4-carbonyl) phenyl]amino}pyridine-3-carboxamide	8.562E-04	0.997	92	53	260	263	6	243	247	274	0.791	0.964
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7ah3-assembly2.cif.gz_B	7ah3-assembly2.cif.gz_B Kinase domain of cSrc in complex with a pyrazolopyrimidine	1.016E-03	0.997	92	58	260	263	17	199	255	230	0.772	0.718
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4cv9-assembly1.cif.gz_A	4cv9-assembly1.cif.gz_A MPS1 kinase with 3-aminopyridin-2-one inhibitors	3.445E-04	0.997	92	54	261	263	12	235	255	256	0.791	0.878
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5ei2-assembly1.cif.gz_A	5ei2-assembly1.cif.gz_A Rapid Discovery of Pyrido[3,4-d]pyrimidine Inhibitors of Monopolar Spindle kinase 1 (MPS1) Using a Structure-Based Hydridization Approach	5.431E-04	0.997	92	55	261	263	12	236	256	258	0.787	0.879
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4ez5-assembly1.cif.gz_A	4ez5-assembly1.cif.gz_A CDK6 (monomeric) in complex with inhibitor	3.169E-03	0.997	92	54	241	263	4	170	258	212	0.715	0.647
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6l8l-assembly1.cif.gz_A	6l8l-assembly1.cif.gz_A C-Src in complex with ibrutinib	1.138E-03	0.997	92	58	263	263	12	204	258	234	0.783	0.748
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5n9s-assembly1.cif.gz_A	5n9s-assembly1.cif.gz_A TTK kinase domain in complex with BAY 1161909	6.086E-04	0.997	92	54	261	263	11	240	260	263	0.791	0.885
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5jsm-assembly2.cif.gz_C	5jsm-assembly2.cif.gz_C BRAFV600E Kinase Domain In Complex with Chemically Linked Vemurafenib Inhibitor VEM-3-VEM	4.579E-04	0.997	92	50	263	263	11	214	262	248	0.814	0.779
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5mrb-assembly1.cif.gz_A	5mrb-assembly1.cif.gz_A Crystal structure of human Mps1 (TTK) in complex with Cpd-5	3.647E-04	0.997	92	55	263	263	14	249	264	269	0.795	0.894
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5bq0-assembly1.cif.gz_A	5bq0-assembly1.cif.gz_A Crystal structure of bruton agammaglobulinemia tyrosine kinase complexed with BMS-824171 AKA 6-[(3R)-3-(4-tert-bu tylbenzamido)piperidin-1-yl]-2-{[4-(morpholine-4-carbonyl) phenyl]amino}pyridine-3-carboxamide	1.075E-03	0.997	92	53	260	263	12	218	265	250	0.791	0.781
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5o91-assembly1.cif.gz_A	5o91-assembly1.cif.gz_A Crystal structure of human Mps1 (TTK) C604W mutant in complex with Cpd-5	8.088E-04	0.997	92	55	263	263	14	250	266	267	0.795	0.891
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6xag-assembly1.cif.gz_C	6xag-assembly1.cif.gz_C Apo BRAF dimer bound to 14-3-3	1.275E-03	0.997	92	55	263	263	11	218	276	249	0.795	0.754
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6x8e-assembly2.cif.gz_B	6x8e-assembly2.cif.gz_B Crystal structure of JAK2 with Compound 11	8.562E-04	0.997	92	54	263	263	8	236	281	260	0.798	0.815
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5lpy-assembly1.cif.gz_A	5lpy-assembly1.cif.gz_A Crystal structure of the BRI1 kinase domain (865-1160) in complex with ATP from Arabidopsis thaliana	1.794E-03	0.997	92	41	263	263	8	286	286	315	0.848	0.976
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6cmj-assembly2.cif.gz_B	6cmj-assembly2.cif.gz_B Human CAMKK2 with GSK650393	6.086E-04	0.997	92	55	261	263	7	254	287	270	0.787	0.864
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3qti-assembly1.cif.gz_A	3qti-assembly1.cif.gz_A c-Met Kinase in Complex with NVP-BVU972	1.275E-03	0.997	92	45	260	263	10	271	292	294	0.821	0.897
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6joi-assembly1.cif.gz_A	6joi-assembly1.cif.gz_A Crystal structure of PDGFRA T674I in complex with crenolanib by co-crystallization	7.641E-04	0.997	92	55	262	263	27	256	296	265	0.791	0.777
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5a46-assembly2.cif.gz_B	5a46-assembly2.cif.gz_B FGFR1 in complex with dovitinib	1.138E-03	0.997	92	55	260	263	23	288	297	301	0.783	0.896
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4wsq-assembly2.cif.gz_B	4wsq-assembly2.cif.gz_B Crystal Structure of Adaptor Protein 2 Associated Kinase (AAK1) in complex with small molecule inhibitor	6.819E-04	0.997	92	50	261	263	1	223	310	260	0.806	0.719
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4otg-assembly1.cif.gz_A	4otg-assembly1.cif.gz_A Crystal Structure of PRK1 Catalytic Domain in Complex with Lestaurtinib	1.108E-02	0.997	92	53	218	263	9	160	324	177	0.631	0.469
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7ugb-assembly1.cif.gz_A	7ugb-assembly1.cif.gz_A Crystal structure of rat ERK2 complexed with docking peptide from ISG20	1.075E-03	0.997	92	54	260	263	14	247	333	265	0.787	0.703
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5wng-assembly2.cif.gz_C	5wng-assembly2.cif.gz_C X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR	2.186E-04	0.997	92	36	259	263	46	305	387	291	0.852	0.672
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6ate-assembly1.cif.gz_A	6ate-assembly1.cif.gz_A SRC kinase bound to covalent inhibitor	1.350E-03	0.997	91	58	263	263	16	201	255	237	0.783	0.729
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5ehy-assembly1.cif.gz_A	5ehy-assembly1.cif.gz_A Rapid Discovery of Pyrido[3,4-d]pyrimidine Inhibitors of Monopolar Spindle kinase 1 (MPS1) Using a Structure-Based Hydridization Approach	3.075E-04	0.997	91	55	263	263	13	241	255	261	0.795	0.898
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3el8-assembly2.cif.gz_B	3el8-assembly2.cif.gz_B Crystal structure of c-Src in complex with pyrazolopyrimidine 5	1.075E-03	0.997	91	58	263	263	17	226	259	253	0.783	0.811
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6nzr-assembly1.cif.gz_B	6nzr-assembly1.cif.gz_B CRYSTAL STRUCTURE OF TYROSINE KINASE 2 JH2 (PSEUDO KINASE DOMAIN) COMPLEXED WITH Compound_12 AKA 4-[(2-methanesulfonylphenyl)amino]-N-(H3)methyl-6-[(pyridin-2- yl)amino]pyridazine-3-carboxamide	1.016E-03	0.997	91	53	261	263	8	221	259	247	0.795	0.826
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3qlg-assembly1.cif.gz_A	3qlg-assembly1.cif.gz_A Crystal structure of the L317I mutant of the C-src tyrosine kinase domain complexed with dasatinib	9.594E-04	0.997	91	58	263	263	15	226	259	252	0.783	0.819
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4mxx-assembly1.cif.gz_A	4mxx-assembly1.cif.gz_A Human Src A403T mutant bound to kinase inhibitor bosutinib	1.899E-03	0.997	91	54	263	263	12	233	266	260	0.798	0.835
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6q7f-assembly1.cif.gz_A	6q7f-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with the NVP-BHG712 derivative ATDL18	4.326E-04	0.997	91	58	260	263	14	203	267	231	0.772	0.712
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6nvh-assembly1.cif.gz_A	6nvh-assembly1.cif.gz_A FGFR4 complex with N-(2-((5-((2,6-dichloro-3,5-dimethoxybenzyl)oxy)pyrimidin-2-yl)amino)-3-methylphenyl)acrylamide	7.641E-04	0.997	91	54	260	263	16	266	271	285	0.787	0.926
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2q0b-assembly1.cif.gz_B	2q0b-assembly1.cif.gz_B Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic E565A Mutation Responsible for Pfeiffer Syndrome	1.601E-03	0.997	91	65	260	263	23	234	282	249	0.745	0.752
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1u59-assembly1.cif.gz_A	1u59-assembly1.cif.gz_A Crystal Structure of the ZAP-70 Kinase Domain in Complex with Staurosporine	1.205E-03	0.997	91	53	262	263	8	267	282	293	0.798	0.922
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7mxj-assembly1.cif.gz_A	7mxj-assembly1.cif.gz_A Crystal structure of the S/T protein kinase PknG from Corynebacterium glutamicum (residues 130-433) in complex with AMP-PNP, isoform 1	6.086E-04	0.997	91	51	262	263	32	279	285	285	0.806	0.870
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7xaf-assembly1.cif.gz_A	7xaf-assembly1.cif.gz_A The crystal structure of TrkA kinase in complex with 4^6,14-dimethyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-10-oxo-5-oxa-11,14-diaza-1(3,6)-imidazo[1,2-b]pyridazina-4(1,3)-benzenacyclo- tetradecaphan-2-yne-45-carboxamide	5.131E-04	0.997	91	53	260	263	11	233	286	265	0.791	0.780
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1r0p-assembly1.cif.gz_A	1r0p-assembly1.cif.gz_A Crystal structure of the tyrosine kinase domain of the hepatocyte growth factor receptor c-Met in complex with the microbial alkaloid K-252a	1.075E-03	0.997	91	43	260	263	13	280	301	302	0.829	0.890
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4oh4-assembly1.cif.gz_A	4oh4-assembly1.cif.gz_A Crystal structure of BRI1 in complex with BKI1	9.063E-04	0.997	91	41	263	263	23	303	303	321	0.848	0.927
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8aoh-assembly1.cif.gz_A	8aoh-assembly1.cif.gz_A Specific covalent inhibitor(18) of ERK2	7.438E-03	0.997	91	51	218	263	11	159	334	186	0.639	0.446
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8agy-assembly1.cif.gz_A	8agy-assembly1.cif.gz_A The Corramycin phosphotransferase in complex with Corramycin	4.326E-04	0.997	91	43	262	263	3	260	346	301	0.837	0.746
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7jnt-assembly3.cif.gz_E	7jnt-assembly3.cif.gz_E CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 2 (ROCK2) IN COMPLEX WITH A POTENT AND SELECTIVE DUAL ROCK INHIBITOR	5.131E-04	0.997	91	36	259	263	43	306	384	292	0.852	0.688
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4yvc-assembly1.cif.gz_B	4yvc-assembly1.cif.gz_B ROCK 1 bound to thiazole inhibitor	1.695E-03	0.997	91	19	259	263	43	313	392	307	0.916	0.691
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3vs2-assembly2.cif.gz_B	3vs2-assembly2.cif.gz_B Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor 7-[cis-4-(4-methylpiperazin-1-yl)cyclohexyl]-5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine	1.512E-03	0.997	91	58	263	263	188	403	434	248	0.783	0.498
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3v8w-assembly3.cif.gz_B	3v8w-assembly3.cif.gz_B Crystal Structure of Interleukin-2 Inducible T-cell Kinase Itk Catalytic Domain with Thienopyrazolylindole Inhibitor 469	1.429E-03	0.996	90	55	260	263	11	237	242	272	0.783	0.938
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4feu-assembly6.cif.gz_F	4feu-assembly6.cif.gz_F Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor anthrapyrazolone SP600125	1.386E-04	0.996	90	65	263	263	13	226	245	265	0.757	0.873
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3zew-assembly2.cif.gz_B	3zew-assembly2.cif.gz_B Crystal structure of EphB4 in complex with staurosporine	2.384E-03	0.996	90	55	263	263	9	203	252	236	0.795	0.774
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6mny-assembly2.cif.gz_B	6mny-assembly2.cif.gz_B Crystal structure of mouse BTK kinase domain in complex with compound 9a	1.794E-03	0.996	90	53	263	263	6	253	253	281	0.802	0.980
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3mpm-assembly1.cif.gz_A	3mpm-assembly1.cif.gz_A LCK complexed with a pyrazolopyrimidine	2.993E-03	0.996	90	55	260	263	10	214	257	239	0.783	0.798
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3wzj-assembly1.cif.gz_A	3wzj-assembly1.cif.gz_A CRYSTAL STRUCTURE OF HUMAN MPS1 CATALYTIC DOMAIN IN COMPLEX WITH 4-(6-(cyclohexylamino)-8-(((tetrahydro-2H-pyran-4-yl)methyl)amino)imidazo[1,2-b]pyridazin-3-yl)-N-cyclopropylbenzamide	1.899E-03	0.996	90	55	263	263	10	243	257	264	0.795	0.911
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3nlb-assembly1.cif.gz_A	3nlb-assembly1.cif.gz_A Novel kinase profile highlights the temporal basis of context dependent checkpoint pathways to cell death	5.597E-03	0.996	90	52	218	263	1	144	261	178	0.635	0.552
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3tv4-assembly1.cif.gz_A	3tv4-assembly1.cif.gz_A Human B-Raf Kinase Domain in Complex with an Bromopyridine Benzamide Inhibitor	1.601E-03	0.996	90	50	263	263	8	215	264	253	0.814	0.788
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6brc-assembly1.cif.gz_A	6brc-assembly1.cif.gz_A Crystal Structure of the Human CAMKK2B in complex with AP26113-analog (ALK-IN-1)	1.138E-03	0.996	90	55	261	263	9	246	265	275	0.787	0.898
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6c1c-assembly2.cif.gz_B	6c1c-assembly2.cif.gz_B FGFR1 kinase complex with inhibitor SN37116	3.758E-03	0.996	90	54	260	263	17	219	267	241	0.787	0.760
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6het-assembly1.cif.gz_A	6het-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with the NVP-BHG712 derivative AT055	5.131E-04	0.996	90	58	260	263	14	204	268	231	0.772	0.713
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7lqd-assembly1.cif.gz_A	7lqd-assembly1.cif.gz_A Structure of Human MPS1 (TTK) covalently bound to RMS-07 inhibitor	6.442E-04	0.996	90	54	261	263	12	248	269	270	0.791	0.881
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6m7z-assembly5.cif.gz_E	6m7z-assembly5.cif.gz_E A divergent kinase lacking the glycine-rich loop regulates membrane ultrastructure of the Toxoplasma parasitophorous vacuole	1.138E-03	0.996	90	35	263	263	22	264	269	287	0.871	0.903
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4trl-assembly1.cif.gz_A	4trl-assembly1.cif.gz_A Structure of Ephrin type-A receptor 2	6.086E-04	0.996	90	58	260	263	20	226	269	246	0.772	0.770
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7juz-assembly1.cif.gz_A	7juz-assembly1.cif.gz_A Crystal Structure of KSR1:MEK1 in complex with AMP-PNP, and allosteric MEK inhibitor Selumetinib	5.924E-03	0.996	90	54	214	263	14	152	273	175	0.612	0.509
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1yi6-assembly2.cif.gz_B	1yi6-assembly2.cif.gz_B C-term tail segment of human tyrosine kinase (258-533)	3.550E-03	0.996	90	58	263	263	15	203	276	235	0.783	0.685
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6cpy-assembly1.cif.gz_A	6cpy-assembly1.cif.gz_A Structure of apo GRMZM2G135359 pseudokinase	3.861E-04	0.996	90	45	262	263	19	273	277	297	0.829	0.921
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3gc0-assembly1.cif.gz_A	3gc0-assembly1.cif.gz_A Structure of the CMGC CDK Kinase from Giardia lamblia in complex with AMP	1.899E-03	0.996	90	58	261	263	10	198	278	236	0.776	0.680
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6fer-assembly4.cif.gz_D	6fer-assembly4.cif.gz_D Crystal Structure of human DDR2 kinase in complex with 2-[4,5-difluoro-2-oxo-1'-(1H-pyrazolo[3,4-b]pyridine-5-carbonyl)spiro[indole-3,4'-piperidine]-1-yl]-N-(2,2,2-trifluoroethyl)acetamide	3.075E-04	0.996	90	55	260	263	13	232	280	258	0.783	0.786
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5uyj-assembly1.cif.gz_A	5uyj-assembly1.cif.gz_A Crystal Structure of the Human CAMKK2B	6.442E-04	0.996	90	55	261	263	9	261	281	266	0.787	0.900
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3wbl-assembly1.cif.gz_A	3wbl-assembly1.cif.gz_A Crystal structure of CDK2 in complex with pyrazolopyrimidine inhibitor	4.719E-03	0.996	90	52	259	263	1	201	283	243	0.791	0.710
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7jnt-assembly1.cif.gz_B	7jnt-assembly1.cif.gz_B CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 2 (ROCK2) IN COMPLEX WITH A POTENT AND SELECTIVE DUAL ROCK INHIBITOR	4.087E-04	0.996	90	36	259	263	43	298	376	285	0.852	0.681
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3vry-assembly1.cif.gz_A	3vry-assembly1.cif.gz_A Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor 4-Amino-5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl-cyclopentane	2.252E-03	0.996	90	58	263	263	182	398	429	251	0.783	0.506
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2h8h-assembly1.cif.gz_A	2h8h-assembly1.cif.gz_A Src kinase in complex with a quinazoline inhibitor	1.601E-03	0.996	90	58	260	263	188	393	445	246	0.772	0.463
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3k54-assembly1.cif.gz_A	3k54-assembly1.cif.gz_A Structures of human Bruton's tyrosine kinase in active and inactive conformations suggests a mechanism of activation for TEC family kinases.	1.512E-03	0.996	89	53	260	263	9	197	243	236	0.791	0.778
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4c4h-assembly1.cif.gz_A	4c4h-assembly1.cif.gz_A Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase MPS1	6.086E-04	0.996	89	55	261	263	12	228	248	255	0.787	0.875
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4c4g-assembly1.cif.gz_A	4c4g-assembly1.cif.gz_A Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase MPS1	3.861E-04	0.996	89	55	261	263	13	232	252	254	0.787	0.873
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7s26-assembly2.cif.gz_D	7s26-assembly2.cif.gz_D ROCK1 IN COMPLEX WITH LIGAND G5018	1.016E-03	0.996	89	19	259	263	42	249	256	258	0.916	0.812
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7n4r-assembly1.cif.gz_A	7n4r-assembly1.cif.gz_A Bruton's tyrosine kinase in complex with compound 21	1.601E-03	0.996	89	53	260	263	8	211	257	248	0.791	0.794
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7clh-assembly1.cif.gz_A	7clh-assembly1.cif.gz_A Crystal structure of TTK kinase domain in complex with compound 19	1.205E-03	0.996	89	54	261	263	11	239	260	259	0.791	0.881
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3f3w-assembly2.cif.gz_B	3f3w-assembly2.cif.gz_B Drug resistant cSrc kinase domain in complex with inhibitor RL45 (Type II)	3.758E-03	0.996	89	58	263	263	15	206	260	235	0.783	0.738
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4js8-assembly1.cif.gz_A	4js8-assembly1.cif.gz_A Crystal structure of TTK kinase domain with an inhibitor: 401348	4.326E-04	0.996	89	55	261	263	13	242	261	259	0.787	0.881
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3zon-assembly1.cif.gz_A	3zon-assembly1.cif.gz_A Human TYK2 pseudokinase domain bound to a kinase inhibitor	8.088E-04	0.996	89	53	260	263	11	259	261	284	0.791	0.954
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6fer-assembly8.cif.gz_H	6fer-assembly8.cif.gz_H Crystal Structure of human DDR2 kinase in complex with 2-[4,5-difluoro-2-oxo-1'-(1H-pyrazolo[3,4-b]pyridine-5-carbonyl)spiro[indole-3,4'-piperidine]-1-yl]-N-(2,2,2-trifluoroethyl)acetamide	8.562E-04	0.996	89	55	260	263	13	224	272	249	0.783	0.779
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5f20-assembly1.cif.gz_A	5f20-assembly1.cif.gz_A Structure of TYK2 with inhibitor 4: 3-azanyl-5-(2-methylphenyl)-7-(1-methylpyrazol-3-yl)-1~{H}-pyrazolo[4,3-c]pyridin-4-one	1.205E-03	0.996	89	51	260	263	9	224	274	260	0.798	0.788
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6bql-assembly1.cif.gz_A	6bql-assembly1.cif.gz_A Crystal Structure of the Human CAMKK2B in complex with TAE-226	5.749E-04	0.996	89	55	261	263	9	259	278	268	0.787	0.903
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6bsd-assembly1.cif.gz_A	6bsd-assembly1.cif.gz_A DDR1 bound to Dasatinib	2.905E-04	0.996	89	55	260	263	9	225	278	257	0.783	0.781
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4uwb-assembly2.cif.gz_B	4uwb-assembly2.cif.gz_B Fibroblast growth factor receptor 1 kinase in complex with JK-P5	1.601E-03	0.996	89	55	263	263	22	252	299	266	0.795	0.773
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4l6q-assembly1.cif.gz_A	4l6q-assembly1.cif.gz_A ROCK2 in complex with benzoxaborole	9.063E-04	0.996	89	36	260	263	39	282	388	278	0.856	0.629
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6p5m-assembly1.cif.gz_A	6p5m-assembly1.cif.gz_A Discovery of a Novel, Highly Potent, and Selective Thieno[3,2-d]pyrimidinone-Based Cdc7 inhibitor with a Quinuclidine Moiety (TAK-931) as an Orally Active Investigational Anti-Tumor Agent	1.429E-03	0.996	89	28	263	263	35	318	396	312	0.897	0.717
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3vs5-assembly2.cif.gz_B	3vs5-assembly2.cif.gz_B Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor 7-(1-methylpiperidin-4-yl)-5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine	1.512E-03	0.996	89	58	263	263	182	397	428	252	0.783	0.505
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5d11-assembly1.cif.gz_A	5d11-assembly1.cif.gz_A Kinase domain of cSrc in complex with RL235	1.429E-03	0.995	88	58	263	263	15	200	254	234	0.783	0.732
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4jt3-assembly1.cif.gz_A	4jt3-assembly1.cif.gz_A Crystal Structure of TTK kinase domain with an inhibitor: 400740	1.205E-03	0.995	88	55	261	263	13	234	254	254	0.787	0.874
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6tnd-assembly1.cif.gz_A	6tnd-assembly1.cif.gz_A X-RAY STRUCTURE OF MPS1 IN COMPLEX WITH COMPOUND 79	4.579E-04	0.995	88	55	261	263	12	235	254	255	0.787	0.882
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3nux-assembly1.cif.gz_A	3nux-assembly1.cif.gz_A CDK6 (monomeric) in complex with inhibitor	4.995E-03	0.995	88	54	241	263	5	172	261	209	0.715	0.644
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6cd6-assembly1.cif.gz_A	6cd6-assembly1.cif.gz_A Crystal Structure of the Human CAMKK1A in complex with GSK650394	1.205E-03	0.995	88	55	261	263	6	245	264	267	0.787	0.909
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8bof-assembly1.cif.gz_A	8bof-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 12	7.219E-04	0.995	88	58	260	263	14	202	266	231	0.772	0.711
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4ehe-assembly1.cif.gz_A	4ehe-assembly1.cif.gz_A B-Raf Kinase Domain in Complex with an Aminothienopyrimidine-based Inhibitor	1.016E-03	0.995	88	50	263	263	8	217	266	250	0.814	0.789
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7k0v-assembly1.cif.gz_C	7k0v-assembly1.cif.gz_C Crystal structure of bRaf in complex with inhibitor GNE-0749	1.512E-03	0.995	88	50	263	263	8	219	267	255	0.814	0.794
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6zcp-assembly1.cif.gz_A	6zcp-assembly1.cif.gz_A SYK Kinase domain in complex with azabenzimidazole inhibitor 2b	2.524E-03	0.995	88	49	263	263	5	219	267	259	0.817	0.805
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6hex-assembly1.cif.gz_A	6hex-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with the NVP-BHG712 derivative ATMM006	6.819E-04	0.995	88	58	260	263	14	204	268	231	0.772	0.713
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4fsr-assembly1.cif.gz_A	4fsr-assembly1.cif.gz_A Crystal Structure of the CHK1	4.995E-03	0.995	88	51	218	263	3	143	269	177	0.639	0.524
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5ap1-assembly1.cif.gz_A	5ap1-assembly1.cif.gz_A Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance.	9.594E-04	0.995	88	55	263	263	13	257	272	277	0.795	0.901
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8p7j-assembly1.cif.gz_A	8p7j-assembly1.cif.gz_A Crystal structure of MAP2K6 with a covalent compound GCL96	3.354E-03	0.995	88	53	260	263	7	216	277	247	0.791	0.758
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5uy6-assembly1.cif.gz_A	5uy6-assembly1.cif.gz_A Crystal Structure of the Human CAMKK2B	5.431E-04	0.995	88	55	261	263	9	263	282	268	0.787	0.904
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7wcl-assembly2.cif.gz_B	7wcl-assembly2.cif.gz_B Crystal structure of FGFR1 kinase domain with Pemigatinib	4.211E-03	0.995	88	54	263	263	24	242	287	257	0.798	0.763
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6fxv-assembly1.cif.gz_A	6fxv-assembly1.cif.gz_A Crystal structure of ERK2 in complex with an adenosine derivative	1.046E-02	0.995	88	54	218	263	12	160	337	183	0.627	0.442
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3r63-assembly1.cif.gz_A	3r63-assembly1.cif.gz_A Structure of ERK2 (SPE) mutant (S246E)	8.823E-03	0.995	88	54	218	263	14	163	347	181	0.627	0.432
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5u7r-assembly2.cif.gz_C	5u7r-assembly2.cif.gz_C Identification of A New Class of Potent Cdc7 Inhibitors Designed by Putative Pharmacophore Model: Synthesis and Biological Evaluation of 2,3-Dihydrothieno[3,2-d]pyrimidin-4(1H)-ones	2.524E-03	0.995	88	26	260	263	25	284	387	294	0.894	0.672
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4lue-assembly2.cif.gz_B	4lue-assembly2.cif.gz_B Crystal Structure of HCK in complex with 7-[trans-4-(4-methylpiperazin-1-yl)cyclohexyl]-5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (resulting from displacement of SKF86002)	1.138E-03	0.995	88	58	263	263	184	388	418	251	0.783	0.490
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2pzi-assembly1.cif.gz_A	2pzi-assembly1.cif.gz_A Crystal Structure of Protein kinase PknG from Mycobacterium tuberculosis in Complex with Tetrahydrobenzothiophene AX20017	1.205E-03	0.995	88	51	262	263	73	296	654	261	0.806	0.343
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3qgw-assembly1.cif.gz_A	3qgw-assembly1.cif.gz_A Crystal Structure of ITK kinase bound to an inhibitor	2.384E-03	0.994	87	55	263	263	8	244	244	271	0.795	0.971
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3of0-assembly2.cif.gz_B	3of0-assembly2.cif.gz_B crystal structure of the L317I mutant of the chicken c-Src tyrosine kinase domain	2.384E-03	0.994	87	54	263	263	12	197	251	233	0.798	0.741
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3en4-assembly1.cif.gz_A	3en4-assembly1.cif.gz_A Targeted polypharmacology: crystal structure of the c-Src kinase domain in complex with PP121, a multitargeted kinase inhibitor	1.512E-03	0.994	87	58	263	263	15	203	257	235	0.783	0.735
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3vqu-assembly1.cif.gz_A	3vqu-assembly1.cif.gz_A CRYSTAL STRUCTURE OF HUMAN MPS1 CATALYTIC DOMAIN IN COMPLEX WITH 4-[(4-amino-5-cyano-6-ethoxypyridin-2- yl)amino]benzamide	7.641E-04	0.994	87	52	261	263	12	237	258	264	0.798	0.876
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3tz7-assembly2.cif.gz_B	3tz7-assembly2.cif.gz_B Kinase domain of cSrc in complex with RL103	1.138E-03	0.994	87	58	263	263	16	187	260	225	0.783	0.662
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8fln-assembly1.cif.gz_A	8fln-assembly1.cif.gz_A Crystal structure of BTK C481S kinase domain in complex with pirtobrutinib	1.275E-03	0.994	87	53	262	263	6	261	263	291	0.798	0.973
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7cil-assembly1.cif.gz_A	7cil-assembly1.cif.gz_A Crystal structure of TTK kinase domain in complex with compound 7	1.205E-03	0.994	87	55	263	263	13	250	265	270	0.795	0.898
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6fer-assembly6.cif.gz_F	6fer-assembly6.cif.gz_F Crystal Structure of human DDR2 kinase in complex with 2-[4,5-difluoro-2-oxo-1'-(1H-pyrazolo[3,4-b]pyridine-5-carbonyl)spiro[indole-3,4'-piperidine]-1-yl]-N-(2,2,2-trifluoroethyl)acetamide	8.088E-04	0.994	87	51	260	263	10	227	275	256	0.798	0.793
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5f1z-assembly1.cif.gz_A	5f1z-assembly1.cif.gz_A Structure of TYK2 with inhibitor 16: 3-azanyl-5-[(2~{S})-3-methylbutan-2-yl]-7-[1-methyl-5-(2-oxidanylpropan-2-yl)pyrazol-3-yl]-1~{H}-pyrazolo[4,3-c]pyridin-4-one	1.695E-03	0.994	87	51	263	263	11	236	281	268	0.810	0.804
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4rwj-assembly2.cif.gz_B	4rwj-assembly2.cif.gz_B Crystal Structure of FGFR1 (C488A, C584S) in complex with AZD4547 (N-{3-[2-(3,5-DIMETHOXYPHENYL)ETHYL]-1H-PYRAZOL-5-YL}-4-[(3R,5S)-3,5-DIMETHYLPIPERAZIN-1-YL]BENZAMIDE)	2.252E-03	0.994	87	55	260	263	22	275	282	287	0.783	0.901
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5xd6-assembly1.cif.gz_A	5xd6-assembly1.cif.gz_A CARK1 phosphorylates ABA receptors	7.219E-04	0.994	87	58	263	263	29	282	282	287	0.783	0.901
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4fv4-assembly1.cif.gz_A	4fv4-assembly1.cif.gz_A Crystal Structure of the ERK2 complexed with EK7	5.597E-03	0.994	87	54	259	263	16	214	330	231	0.783	0.603
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4fuy-assembly1.cif.gz_A	4fuy-assembly1.cif.gz_A Crystal Structure of the ERK2 complexed with EK2	4.995E-03	0.994	87	46	259	263	3	222	332	259	0.814	0.663
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4s30-assembly1.cif.gz_A	4s30-assembly1.cif.gz_A ERK2 intrinsically active mutant (I84A)	8.823E-03	0.994	87	54	216	263	13	159	342	180	0.620	0.430
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5wnf-assembly1.cif.gz_B	5wnf-assembly1.cif.gz_B X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR	2.905E-04	0.994	87	33	259	263	36	294	358	293	0.863	0.723
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5wnf-assembly2.cif.gz_C	5wnf-assembly2.cif.gz_C X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR	4.087E-04	0.994	87	33	259	263	37	305	386	300	0.863	0.697
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4wot-assembly1.cif.gz_A	4wot-assembly1.cif.gz_A ROCK2 IN COMPLEX WITH 1426382-07-1	2.010E-03	0.994	87	36	260	263	44	284	389	275	0.856	0.620
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4lud-assembly2.cif.gz_B	4lud-assembly2.cif.gz_B Crystal Structure of HCK in complex with the fluorescent compound SKF86002	1.350E-03	0.994	87	58	263	263	168	381	410	253	0.783	0.522
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3vs7-assembly2.cif.gz_B	3vs7-assembly2.cif.gz_B Crystal structure of HCK complexed with a pyrazolo-pyrimidine inhibitor 1-cyclopentyl-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine	4.211E-03	0.994	87	58	263	263	183	396	427	248	0.783	0.501
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3vs4-assembly2.cif.gz_B	3vs4-assembly2.cif.gz_B Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor 5-(4-phenoxyphenyl)-7-(tetrahydro-2H-pyran-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine	3.978E-03	0.994	87	58	262	263	188	403	435	250	0.779	0.497
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4c4e-assembly1.cif.gz_A	4c4e-assembly1.cif.gz_A Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase MPS1	4.579E-04	0.993	86	55	261	263	12	237	257	259	0.787	0.879
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6h3k-assembly1.cif.gz_A	6h3k-assembly1.cif.gz_A Introduction of a methyl group curbs metabolism of pyrido[3,4-d]pyrimidine MPS1 inhibitors and enables the discovery of the Phase 1 clinical candidate BOS172722.	1.138E-03	0.993	86	55	261	263	12	237	257	258	0.787	0.879
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5eh0-assembly1.cif.gz_A-2	5eh0-assembly1.cif.gz_A-2 Rapid Discovery of Pyrido[3,4-d]pyrimidine Inhibitors of Monopolar Spindle kinase 1 (MPS1) Using a Structure-Based Hydridization Approach	5.431E-04	0.993	86	55	263	263	12	244	258	266	0.795	0.903
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3tz9-assembly2.cif.gz_B	3tz9-assembly2.cif.gz_B Kinase domain of cSrc in complex with RL130	3.550E-03	0.993	86	55	260	263	13	203	259	232	0.783	0.737
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6brc-assembly2.cif.gz_B	6brc-assembly2.cif.gz_B Crystal Structure of the Human CAMKK2B in complex with AP26113-analog (ALK-IN-1)	1.429E-03	0.993	86	55	261	263	7	241	260	270	0.787	0.904
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3f3u-assembly1.cif.gz_A	3f3u-assembly1.cif.gz_A Kinase domain of cSrc in complex with inhibitor RL37 (Type III)	1.695E-03	0.993	86	58	263	263	16	207	261	237	0.783	0.736
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3oez-assembly1.cif.gz_A	3oez-assembly1.cif.gz_A crystal structure of the L317I mutant of the chicken c-Src tyrosine kinase domain complexed with imatinib	1.794E-03	0.993	86	58	260	263	16	205	261	234	0.772	0.728
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5ap6-assembly1.cif.gz_A	5ap6-assembly1.cif.gz_A Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance.	1.138E-03	0.993	86	54	263	263	11	248	262	273	0.798	0.908
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4c4j-assembly1.cif.gz_A	4c4j-assembly1.cif.gz_A Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase MPS1	9.063E-04	0.993	86	54	261	263	11	242	262	267	0.791	0.885
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3g6g-assembly1.cif.gz_A	3g6g-assembly1.cif.gz_A Equally potent inhibition of c-Src and Abl by compounds that recognize inactive kinase conformations	2.671E-03	0.993	86	58	260	263	17	208	264	233	0.772	0.727
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6nzm-assembly2.cif.gz_D	6nzm-assembly2.cif.gz_D Brutons tyrosine kinase in complex with compound 50.	1.695E-03	0.993	86	53	260	263	6	217	264	255	0.791	0.803
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6u2g-assembly1.cif.gz_B	6u2g-assembly1.cif.gz_B BRAF-MEK complex with AMP-PCP bound to BRAF	1.275E-03	0.993	86	54	263	263	8	216	264	249	0.798	0.792
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3vf9-assembly1.cif.gz_A	3vf9-assembly1.cif.gz_A Crystal Structure of Spleen Tyrosine Kinase Syk Catalytic Domain with Thienopyrazolylindole Inhibitor 027	1.138E-03	0.993	86	58	263	263	13	220	265	252	0.783	0.785
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5nwz-assembly2.cif.gz_B	5nwz-assembly2.cif.gz_B FIBROBLAST GROWTH FACTOR RECEPTOR 4 KINASE DOMAIN (449-753) IN COMPLEX WITH IRREVERSIBLE LIGAND CGA159527	1.205E-03	0.993	86	65	260	263	28	220	268	231	0.745	0.720
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2r2p-assembly1.cif.gz_A	2r2p-assembly1.cif.gz_A Kinase domain of human ephrin type-A receptor 5 (EphA5)	7.641E-04	0.993	86	58	260	263	19	230	283	252	0.772	0.749
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6pnx-assembly1.cif.gz_A	6pnx-assembly1.cif.gz_A Crystal Structure of an Asymmetric Dimer of FGF Receptor 3 Kinases Trapped in A-loop Tyrosine Transphosphorylation Reaction	3.758E-03	0.993	86	54	260	263	18	243	291	263	0.787	0.777
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4e7w-assembly1.cif.gz_A	4e7w-assembly1.cif.gz_A Structure of GSK3 from Ustilago maydis	1.350E-03	0.993	86	55	218	263	23	172	360	188	0.624	0.417
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3vs3-assembly2.cif.gz_B	3vs3-assembly2.cif.gz_B Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor 7-[trans-4-(4-methylpiperazin-1-yl)cyclohexyl]-5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine	6.271E-03	0.993	86	58	260	263	183	378	432	237	0.772	0.454
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7uy0-assembly2.cif.gz_B	7uy0-assembly2.cif.gz_B Crystal structure of human Fgr tyrosine kinase in complex with A-419259	3.354E-03	0.993	86	58	260	263	189	394	448	244	0.772	0.460
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4oli-assembly1.cif.gz_A	4oli-assembly1.cif.gz_A The pseudokinase/kinase protein from JAK-family member TYK2	3.978E-03	0.993	86	51	262	263	272	487	539	258	0.806	0.401
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6n6o-assembly1.cif.gz_A	6n6o-assembly1.cif.gz_A Crystal structure of the human TTK in complex with an inhibitor	1.429E-03	0.992	85	54	261	263	12	234	254	252	0.791	0.878
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3cr0-assembly1.cif.gz_A	3cr0-assembly1.cif.gz_A Wee1 kinase complex with inhibitor PD259_809	3.354E-03	0.992	85	47	261	263	2	256	257	293	0.817	0.992
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3jvr-assembly1.cif.gz_A	3jvr-assembly1.cif.gz_A Characterization of the Chk1 allosteric inhibitor binding site	7.027E-03	0.992	85	51	218	263	4	140	258	178	0.639	0.531
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4zeg-assembly1.cif.gz_A	4zeg-assembly1.cif.gz_A Crystal structure of TTK kinase domain in complex with a pyrazolopyrimidine inhibitor	1.016E-03	0.992	85	54	263	263	11	245	260	264	0.798	0.904
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3svv-assembly1.cif.gz_A	3svv-assembly1.cif.gz_A Crystal Structure of T338C c-Src covalently bound to vinylsulfonamide-pyrazolopyrimidine 9	4.211E-03	0.992	85	58	263	263	16	207	261	235	0.783	0.736
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5k9i-assembly2.cif.gz_B	5k9i-assembly2.cif.gz_B Crystal structure of c-SRC in complex with a covalent lysine probe	3.169E-03	0.992	85	58	263	263	14	208	262	239	0.783	0.744
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5teh-assembly2.cif.gz_B	5teh-assembly2.cif.gz_B c-Src V281C kinase domain in complex with Rao-IV-156	3.354E-03	0.992	85	58	263	263	17	208	262	230	0.783	0.733
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8ff0-assembly1.cif.gz_A	8ff0-assembly1.cif.gz_A Structure of BTK kinase domain with the second-generation inhibitor tirabrutinib	1.350E-03	0.992	85	53	263	263	6	221	265	256	0.802	0.815
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7ng7-assembly1.cif.gz_A	7ng7-assembly1.cif.gz_A Src kinase bound to eCF506 trapped in inactive conformation	1.601E-03	0.992	85	58	260	263	16	218	274	249	0.772	0.741
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8c12-assembly1.cif.gz_AAA	8c12-assembly1.cif.gz_AAA Identification of an intermediate activation state of PAK5 reveals a novel mechanism of kinase inhibition.	1.275E-03	0.992	85	43	263	263	9	280	293	310	0.840	0.928
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5n1k-assembly1.cif.gz_A	5n1k-assembly1.cif.gz_A cAMP-dependent Protein Kinase A from Cricetulus griseus in complex with fragment like molecule 2-amino-1-(4-fluorophenyl)ethanol	2.252E-03	0.992	85	22	261	263	4	269	344	302	0.913	0.773
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3vs4-assembly1.cif.gz_A	3vs4-assembly1.cif.gz_A Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor 5-(4-phenoxyphenyl)-7-(tetrahydro-2H-pyran-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine	1.695E-03	0.992	85	58	260	263	182	376	430	238	0.772	0.453
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4pqn-assembly1.cif.gz_A	4pqn-assembly1.cif.gz_A ITK kinase domain with compound GNE-9822	2.993E-03	0.991	84	55	260	263	9	198	240	237	0.783	0.792
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6hve-assembly2.cif.gz_B	6hve-assembly2.cif.gz_B Kinase domain of cSrc in complex with compound 9	1.075E-03	0.991	84	58	263	263	15	192	246	232	0.783	0.724
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6hm6-assembly1.cif.gz_A	6hm6-assembly1.cif.gz_A CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE (SYK) IN COMPLEX WITH A 2-(PYRIDINYLOXYMETHYL)PYRIDINE INHIBITOR	2.010E-03	0.991	84	49	263	263	4	246	261	280	0.817	0.931
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2c3l-assembly1.cif.gz_A	2c3l-assembly1.cif.gz_A Identification of a buried pocket for potent and selective inhibition of Chk1: prediction and verification	1.601E-03	0.991	84	51	263	263	4	239	265	279	0.810	0.891
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3aln-assembly1.cif.gz_A	3aln-assembly1.cif.gz_A Crystal Structure of human non-phosphorylated MKK4 kinase domain complexed with AMP-PNP	1.899E-03	0.991	84	52	262	263	20	252	270	271	0.802	0.863
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5ya5-assembly1.cif.gz_A	5ya5-assembly1.cif.gz_A CRYSTAL STRUCTURE OF c-MET IN COMPLEX WITH NOVEL INHIBITOR	1.695E-03	0.991	84	43	260	263	6	227	273	263	0.829	0.813
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6v9c-assembly1.cif.gz_A	6v9c-assembly1.cif.gz_A Crystal structure of FGFR4 kinase domain in complex with covalent inhibitor	1.899E-03	0.991	84	54	260	263	16	273	279	290	0.787	0.925
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8wsw-assembly4.cif.gz_D	8wsw-assembly4.cif.gz_D The Crystal Structure of LIMK2a from Biortus	2.128E-03	0.991	84	58	259	263	7	251	281	279	0.768	0.872
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5uv4-assembly1.cif.gz_A	5uv4-assembly1.cif.gz_A Crystal Structure of Maize SIRK1 (sucrose-induced receptor kinase 1) kinase domain bound to AMP-PNP	4.847E-04	0.991	84	58	263	263	23	290	290	305	0.783	0.924
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5uxb-assembly2.cif.gz_B	5uxb-assembly2.cif.gz_B Crystal structure of macrolide 2'-phosphotransferase MphH from Brachybacterium faecium, apoenzyme	3.075E-04	0.991	84	43	259	263	7	264	297	286	0.825	0.869
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8gds-assembly2.cif.gz_B	8gds-assembly2.cif.gz_B CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 2 (ROCK2) IN COMPLEX WITH 4-(4-(2-(2,3-DIHYDRO-1H- INDOL-1-YL)-2-OXOETHYL)PHENYL)-1(2H)-PHTHALAZINONE	2.384E-03	0.991	84	36	260	263	42	279	384	271	0.856	0.620
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4w7p-assembly3.cif.gz_A	4w7p-assembly3.cif.gz_A Crystal Structure of ROCK 1 bound to YB-15-QD37	1.016E-03	0.991	84	19	259	263	42	306	388	303	0.916	0.683
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4wot-assembly2.cif.gz_D	4wot-assembly2.cif.gz_D ROCK2 IN COMPLEX WITH 1426382-07-1	1.138E-03	0.991	84	36	263	263	43	310	389	300	0.867	0.689
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4c4i-assembly1.cif.gz_A	4c4i-assembly1.cif.gz_A Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase MPS1	2.128E-03	0.990	83	55	261	263	12	233	253	252	0.787	0.877
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2zmd-assembly1.cif.gz_A	2zmd-assembly1.cif.gz_A Crystal structure of human Mps1 catalytic domain T686A mutant in complex with SP600125 inhibitor	1.512E-03	0.990	83	55	261	263	12	238	259	258	0.787	0.876
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4mxx-assembly2.cif.gz_B	4mxx-assembly2.cif.gz_B Human Src A403T mutant bound to kinase inhibitor bosutinib	3.758E-03	0.990	83	58	263	263	15	187	260	225	0.783	0.665
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7cht-assembly1.cif.gz_A	7cht-assembly1.cif.gz_A Crystal structure of TTK kinase domain in complex with compound 30	1.275E-03	0.990	83	54	263	263	12	247	261	269	0.798	0.904
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5vt1-assembly1.cif.gz_A	5vt1-assembly1.cif.gz_A Crystal Structure of the Human CAMKK2B bound to a thiadiazinone benzamide inhibitor	4.995E-03	0.990	83	55	261	263	8	246	265	269	0.787	0.902
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3zfx-assembly1.cif.gz_A	3zfx-assembly1.cif.gz_A Crystal structure of EphB1	1.512E-03	0.990	83	66	260	263	20	213	267	239	0.741	0.727
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4yhf-assembly2.cif.gz_B	4yhf-assembly2.cif.gz_B Bruton's tyrosine kinase in complex with a t-butyl cyanoacrylamide inhibitor	1.794E-03	0.990	83	53	260	263	11	264	269	296	0.791	0.944
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7juw-assembly1.cif.gz_B	7juw-assembly1.cif.gz_B Crystal Structure of KSR1:MEK1 in complex with AMP-PNP	8.823E-03	0.990	83	54	212	263	14	150	277	173	0.605	0.495
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8ho6-assembly1.cif.gz_A	8ho6-assembly1.cif.gz_A ScRIPK WT	4.719E-03	0.990	83	43	262	263	7	256	281	295	0.837	0.890
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8ov7-assembly1.cif.gz_A	8ov7-assembly1.cif.gz_A Crystal structure of D1228V c-MET bound by compound 10	1.601E-03	0.990	83	43	263	263	12	224	289	268	0.840	0.737
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6tua-assembly1.cif.gz_A	6tua-assembly1.cif.gz_A The RYK Pseudokinase Domain	2.524E-03	0.990	83	42	262	263	8	287	294	318	0.840	0.952
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6x3n-assembly1.cif.gz_A	6x3n-assembly1.cif.gz_A Co-structure of BTK kinase domain with L-005085737 inhibitor	8.088E-04	0.988	82	53	260	263	9	207	254	247	0.791	0.783
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3wyx-assembly1.cif.gz_A	3wyx-assembly1.cif.gz_A CRYSTAL STRUCTURE OF HUMAN MPS1 CATALYTIC DOMAIN IN COMPLEX WITH 6-((3-(cyanomethoxy)-4-(1-methyl-1H-pyrazol-4-yl)phenyl)amino)-2-(cyclohexylamino)nicotinonitrile	1.899E-03	0.988	82	55	261	263	12	237	258	259	0.787	0.876
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7chm-assembly1.cif.gz_A	7chm-assembly1.cif.gz_A Crystal structure of TTK kinase domain in complex with compound 8	7.874E-03	0.988	82	54	261	263	11	240	260	264	0.791	0.885
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5n93-assembly1.cif.gz_A	5n93-assembly1.cif.gz_A TTK kinase domain in complex with TC-Mps1-12	3.169E-03	0.988	82	54	261	263	11	240	260	262	0.791	0.885
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6c1o-assembly2.cif.gz_B	6c1o-assembly2.cif.gz_B FGFR1 kinase domain complexed with FIIN-1	2.671E-03	0.988	82	62	260	263	18	255	262	271	0.757	0.908
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6m7z-assembly3.cif.gz_C	6m7z-assembly3.cif.gz_C A divergent kinase lacking the glycine-rich loop regulates membrane ultrastructure of the Toxoplasma parasitophorous vacuole	4.458E-03	0.988	82	73	263	263	61	257	262	229	0.726	0.752
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6cd6-assembly3.cif.gz_C	6cd6-assembly3.cif.gz_C Crystal Structure of the Human CAMKK1A in complex with GSK650394	2.384E-03	0.988	82	55	261	263	7	246	265	275	0.787	0.906
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2w96-assembly1.cif.gz_B	2w96-assembly1.cif.gz_B Crystal Structure of CDK4 in complex with a D-type cyclin	1.350E-03	0.988	82	59	255	263	9	193	267	230	0.749	0.693
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6aam-assembly1.cif.gz_A	6aam-assembly1.cif.gz_A Crystal structure of TYK2 in complex with peficitinib	4.719E-03	0.988	82	66	260	263	19	217	269	236	0.741	0.740
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3u4w-assembly1.cif.gz_A	3u4w-assembly1.cif.gz_A Src in complex with DNA-templated macrocyclic inhibitor MC4b	3.354E-03	0.988	82	58	263	263	14	202	275	235	0.783	0.687
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2q0b-assembly1.cif.gz_A	2q0b-assembly1.cif.gz_A Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic E565A Mutation Responsible for Pfeiffer Syndrome	3.550E-03	0.988	82	62	260	263	17	233	280	254	0.757	0.775
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5lpb-assembly1.cif.gz_A	5lpb-assembly1.cif.gz_A Crystal structure of the BRI1 kinase domain (865-1160) in complex with ADP from Arabidopsis thaliana	7.874E-03	0.988	82	41	218	263	8	164	284	192	0.677	0.553
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2pmi-assembly2.cif.gz_C	2pmi-assembly2.cif.gz_C Structure of the Pho85-Pho80 CDK-cyclin Complex of the Phosphate-responsive Signal Transduction Pathway with Bound ATP-gamma-S	7.874E-03	0.988	82	67	260	263	9	207	285	236	0.738	0.698
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5u7q-assembly3.cif.gz_C	5u7q-assembly3.cif.gz_C Identification of A New Class of Potent Cdc7 Inhibitors Designed by Putative Pharmacophore Model: Synthesis and Biological Evaluation of 2,3-Dihydrothieno[3,2-d]pyrimidin-4(1H)-ones	8.088E-04	0.988	82	26	218	263	27	216	390	227	0.734	0.487
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3vs7-assembly1.cif.gz_A	3vs7-assembly1.cif.gz_A Crystal structure of HCK complexed with a pyrazolo-pyrimidine inhibitor 1-cyclopentyl-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine	2.828E-03	0.988	82	58	263	263	188	402	433	255	0.783	0.497
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2qlq-assembly2.cif.gz_B	2qlq-assembly2.cif.gz_B Crystal structure of SRC kinase domain with covalent inhibitor RL3	2.524E-03	0.986	81	58	263	263	16	175	248	229	0.783	0.645
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7n9g-assembly1.cif.gz_A	7n9g-assembly1.cif.gz_A Crystal structure of the Abl 1b Kinase domain in complex with Dasatinib and Imatinib	5.924E-03	0.986	81	67	263	263	24	208	250	227	0.749	0.740
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6v2u-assembly2.cif.gz_B	6v2u-assembly2.cif.gz_B Crystal structure of the insect cell-expressed WT-BRAF kinase in complex with Dabrafenib	2.010E-03	0.986	81	54	263	263	10	204	250	238	0.798	0.780
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8s9f-assembly1.cif.gz_A	8s9f-assembly1.cif.gz_A Crystal structure of the kinase domain of Bruton's Tyrosine Kinase bound to dasatinib	1.046E-02	0.986	81	54	262	263	12	250	254	274	0.795	0.941
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6wiw-assembly1.cif.gz_A	6wiw-assembly1.cif.gz_A c-Src Bound to ATP-Competitive Inhibitor I14	2.828E-03	0.986	81	58	263	263	14	201	255	233	0.783	0.737
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4aua-assembly1.cif.gz_A	4aua-assembly1.cif.gz_A Liganded X-ray crystal structure of cyclin dependent kinase 6 (CDK6)	1.558E-02	0.986	81	54	241	263	4	166	256	206	0.715	0.637
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4dgg-assembly2.cif.gz_B	4dgg-assembly2.cif.gz_B c-SRC kinase domain in complex with RM-1-176	2.828E-03	0.986	81	58	263	263	17	186	259	226	0.783	0.656
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8s99-assembly3.cif.gz_C	8s99-assembly3.cif.gz_C Crystal structure of the TYK2 pseudokinase domain in complex with compound 11	3.978E-03	0.986	81	53	260	263	10	223	260	247	0.791	0.823
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3piy-assembly1.cif.gz_A	3piy-assembly1.cif.gz_A Crystal structure of BTK kinase domain complexed with R406	3.169E-03	0.986	81	53	260	263	10	216	262	248	0.791	0.790
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3h9f-assembly1.cif.gz_A	3h9f-assembly1.cif.gz_A Crystal Structure of Human Dual Specificity Protein Kinase (TTK) in complex with a pyrimido-diazepin ligand	9.886E-03	0.986	81	54	263	263	12	222	263	244	0.798	0.802
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6bqq-assembly1.cif.gz_A	6bqq-assembly1.cif.gz_A Crystal Structure of the Human CAMKK2B in complex with BI2526	2.671E-03	0.986	81	55	261	263	9	252	271	271	0.787	0.900
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6gvj-assembly1.cif.gz_A	6gvj-assembly1.cif.gz_A Human Mps1 kinase domain with ordered activation loop	2.252E-03	0.986	81	54	261	263	12	251	272	269	0.791	0.882
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6hew-assembly1.cif.gz_A	6hew-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with the NVP-BHG712 derivative AT069	1.138E-03	0.986	81	58	260	263	14	208	272	233	0.772	0.717
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7jv1-assembly1.cif.gz_D	7jv1-assembly1.cif.gz_D Crystal Structure of KSR1:MEK1 in complex with AMP-PNP, and allosteric MEK inhibitor APS-9-95-1	6.638E-03	0.986	81	54	212	263	15	151	275	172	0.605	0.498
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4rwi-assembly2.cif.gz_B	4rwi-assembly2.cif.gz_B Crystal structure of V561M FGFR1 gatekeeper mutation (C488A, C584S, V561M), apo	3.169E-03	0.986	81	54	260	263	19	273	280	288	0.787	0.911
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4neu-assembly1.cif.gz_A	4neu-assembly1.cif.gz_A X-ray structure of Receptor Interacting Protein 1 (RIP1)kinase domain with a 1-aminoisoquinoline inhibitor	1.016E-03	0.986	81	53	260	263	10	235	286	266	0.791	0.790
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4q5j-assembly1.cif.gz_A	4q5j-assembly1.cif.gz_A Crystal structure of SeMet derivative BRI1 in complex with BKI1	1.350E-03	0.986	81	58	263	263	37	277	298	279	0.783	0.809
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6nyb-assembly1.cif.gz_A	6nyb-assembly1.cif.gz_A Structure of a MAPK pathway complex	3.550E-03	0.986	81	58	263	263	74	286	350	249	0.783	0.609
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3vs2-assembly1.cif.gz_A	3vs2-assembly1.cif.gz_A Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor 7-[cis-4-(4-methylpiperazin-1-yl)cyclohexyl]-5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine	6.638E-03	0.986	81	58	263	263	185	400	431	252	0.783	0.501
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3d7u-assembly2.cif.gz_D	3d7u-assembly2.cif.gz_D Structural basis for the recognition of c-Src by its inactivator Csk	1.241E-02	0.984	80	49	263	263	8	204	248	241	0.817	0.794
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4o6l-assembly2.cif.gz_B	4o6l-assembly2.cif.gz_B Crystal Structure of TTK kinase domain with an inhibitor: 401498 (N-[(1R)-1-(2-chlorophenyl)propyl]-3-{4-[(1-methylpiperidin-4-yl)oxy]phenyl}-1H-indazole-5-carboxamide)	1.695E-03	0.984	80	54	261	263	12	237	256	258	0.791	0.883
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3qlf-assembly2.cif.gz_B	3qlf-assembly2.cif.gz_B Crystal structure of the L317I mutant of the C-src tyrosine kinase domain complexed with pyrazolopyrimidine 5	2.252E-03	0.984	80	58	260	263	15	202	258	233	0.772	0.729
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2zmc-assembly1.cif.gz_A	2zmc-assembly1.cif.gz_A Crystal structure of human mitotic checkpoint kinase Mps1 catalytic domain apo form	2.384E-03	0.984	80	52	261	263	5	240	260	264	0.798	0.908
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3en5-assembly2.cif.gz_B	3en5-assembly2.cif.gz_B Targeted polypharmacology: crystal structure of the c-Src kinase domain in complex with PP494, a multitargeted kinase inhibitor	4.719E-03	0.984	80	58	263	263	17	207	261	235	0.783	0.732
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8s9a-assembly3.cif.gz_C	8s9a-assembly3.cif.gz_C Crystal structure of the TYK2 pseudokinase domain in complex with TAK-279	3.978E-03	0.984	80	53	261	263	10	224	261	250	0.795	0.824
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5ei6-assembly1.cif.gz_A	5ei6-assembly1.cif.gz_A Rapid Discovery of Pyrido[3,4-d]pyrimidine Inhibitors of Monopolar Spindle kinase 1 (MPS1) Using a Structure-Based Hydridization Approach	1.695E-03	0.984	80	52	263	263	12	250	264	275	0.806	0.905
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4gh2-assembly1.cif.gz_A	4gh2-assembly1.cif.gz_A Crystal Structure of the CHK1	3.758E-03	0.984	80	51	256	263	3	249	268	289	0.783	0.922
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4oh4-assembly2.cif.gz_B	4oh4-assembly2.cif.gz_B Crystal structure of BRI1 in complex with BKI1	1.899E-03	0.984	80	40	263	263	17	293	293	314	0.852	0.945
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7ybp-assembly1.cif.gz_A	7ybp-assembly1.cif.gz_A Crystal structure of FGFR4(V550L) kinase domain with 10z	2.671E-03	0.984	80	55	263	263	17	235	300	262	0.795	0.730
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7ybx-assembly1.cif.gz_A	7ybx-assembly1.cif.gz_A Crystal structure of FGFR4(V550M) kinase domain with 10z	1.512E-03	0.984	80	55	263	263	17	235	300	256	0.795	0.730
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4y85-assembly2.cif.gz_B	4y85-assembly2.cif.gz_B Crystal structure of COT kinase domain in complex with 5-(5-(1H-indol-3-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl)-1,3,4-oxadiazol-2-amine	1.899E-03	0.984	80	58	263	263	60	270	306	253	0.783	0.690
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4l68-assembly2.cif.gz_B	4l68-assembly2.cif.gz_B Structure of the psedudokinase domain of BIR2, an immune regulator of the RLK/Pelle family	2.524E-03	0.984	80	32	260	263	33	251	325	267	0.871	0.674
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3oz6-assembly1.cif.gz_B	3oz6-assembly1.cif.gz_B Crystal structure of MapK from Cryptosporidium Parvum, cgd2_1960	1.899E-03	0.984	80	61	261	263	16	246	341	265	0.764	0.677
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3byv-assembly1.cif.gz_A	3byv-assembly1.cif.gz_A Crystal structure of Toxoplasma gondii specific rhoptry antigen kinase domain	2.993E-03	0.984	80	54	259	263	61	312	345	282	0.783	0.730
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1snx-assembly2.cif.gz_B	1snx-assembly2.cif.gz_B CRYSTAL STRUCTURE OF APO INTERLEUKIN-2 TYROSINE KINASE CATALYTIC DOMAIN	2.828E-03	0.981	79	54	263	263	8	244	245	279	0.798	0.967
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5ap2-assembly1.cif.gz_A	5ap2-assembly1.cif.gz_A Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance.	1.205E-03	0.981	79	54	263	263	11	242	256	263	0.798	0.906
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3cek-assembly1.cif.gz_A	3cek-assembly1.cif.gz_A Crystal structure of human dual specificity protein kinase (TTK)	1.350E-03	0.981	79	54	263	263	12	242	256	264	0.798	0.902
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5nad-assembly1.cif.gz_A	5nad-assembly1.cif.gz_A TTK kinase domain in complex with BAY 1217389	2.993E-03	0.981	79	54	261	263	11	237	257	256	0.791	0.883
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6bqp-assembly1.cif.gz_A	6bqp-assembly1.cif.gz_A Crystal Structure of the Human CAMKK2B in complex with Crenolanib	1.275E-03	0.981	79	55	261	263	8	244	263	271	0.787	0.901
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7cja-assembly1.cif.gz_A	7cja-assembly1.cif.gz_A Crystal structure of TTK kinase domain in complex with compound 28	2.524E-03	0.981	79	54	263	263	12	248	265	270	0.798	0.894
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7dt2-assembly1.cif.gz_A	7dt2-assembly1.cif.gz_A Strategic design of catalytic lysine-targeting reversible covalent BCR-ABL Inhibitors	2.524E-03	0.981	79	67	263	263	24	221	265	246	0.749	0.747
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4o2p-assembly1.cif.gz_A	4o2p-assembly1.cif.gz_A Kinase domain of cSrc in complex with a substituted pyrazolopyrimidine	5.924E-03	0.981	79	58	263	263	16	211	265	234	0.783	0.740
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7chn-assembly1.cif.gz_A	7chn-assembly1.cif.gz_A Crystal structure of TTK kinase domain in complex with compound 9	1.899E-03	0.981	79	54	263	263	12	250	266	276	0.798	0.898
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4rwk-assembly2.cif.gz_B	4rwk-assembly2.cif.gz_B Crystal structure of V561M FGFR1 gatekeeper mutation (C488A, C584S, V561M) in complex with N-{3-[2-(3,5-DIMETHOXYPHENYL)ETHYL]-1H-PYRAZOL-5-YL}-4-[(3R,5S)-3,5-DIMETHYLPIPERAZIN-1-YL]BENZAMIDE (AZD4547)	4.458E-03	0.981	79	54	260	263	21	275	282	286	0.787	0.904
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5nk7-assembly1.cif.gz_A	5nk7-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 2a	2.828E-03	0.981	79	58	260	263	15	220	284	244	0.772	0.725
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6jpe-assembly1.cif.gz_A	6jpe-assembly1.cif.gz_A Crystal structure of FGFR4 kinase domain with irreversible inhibitor 1	1.601E-03	0.981	79	55	263	263	18	234	298	260	0.795	0.728
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5h3q-assembly1.cif.gz_A	5h3q-assembly1.cif.gz_A Crystal Structure of TrkA kinase with ligand	1.695E-03	0.981	79	53	260	263	25	249	302	270	0.791	0.745
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6w8i-assembly1.cif.gz_A	6w8i-assembly1.cif.gz_A Ternary complex structure - BTK cIAP compound 15	4.995E-03	0.978	78	53	262	263	8	252	254	282	0.798	0.965
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5n7v-assembly1.cif.gz_A	5n7v-assembly1.cif.gz_A TTK kinase domain in complex with MPI-0479605	1.794E-03	0.978	78	55	261	263	12	241	261	262	0.787	0.881
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5teh-assembly1.cif.gz_A	5teh-assembly1.cif.gz_A c-Src V281C kinase domain in complex with Rao-IV-156	2.524E-03	0.978	78	58	263	263	17	207	261	231	0.783	0.732
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7wf5-assembly1.cif.gz_A	7wf5-assembly1.cif.gz_A c-Src in complex with ponatinib	3.169E-03	0.978	78	58	260	263	16	205	261	236	0.772	0.728
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2oiq-assembly1.cif.gz_A	2oiq-assembly1.cif.gz_A Crystal Structure of chicken c-Src kinase domain in complex with the cancer drug imatinib.	2.252E-03	0.978	78	58	260	263	17	209	265	239	0.772	0.728
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6bku-assembly1.cif.gz_A	6bku-assembly1.cif.gz_A Crystal Structure of the Human CAMKK2B bound to GSK650394	2.384E-03	0.978	78	55	261	263	9	248	267	271	0.787	0.899
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6fer-assembly11.cif.gz_K	6fer-assembly11.cif.gz_K Crystal Structure of human DDR2 kinase in complex with 2-[4,5-difluoro-2-oxo-1'-(1H-pyrazolo[3,4-b]pyridine-5-carbonyl)spiro[indole-3,4'-piperidine]-1-yl]-N-(2,2,2-trifluoroethyl)acetamide	4.211E-03	0.978	78	55	260	263	11	220	268	247	0.783	0.784
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5zj6-assembly1.cif.gz_A	5zj6-assembly1.cif.gz_A Crystal structure of HCK kinase complexed with a pyrrolo-pyrimidine inhibitor 7-[trans-4-(4-methylpiperazin-1-yl)cyclohexyl]-5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine	1.391E-02	0.978	78	58	263	263	20	227	271	248	0.783	0.768
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4qqt-assembly1.cif.gz_A	4qqt-assembly1.cif.gz_A Crystal Structure of FGF Receptor (FGFR) 4 Tyrosine Kinase Domain	8.335E-03	0.978	78	55	263	263	16	239	283	258	0.795	0.792
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6xi8-assembly1.cif.gz_A	6xi8-assembly1.cif.gz_A Yeast TFIIK (Kin28/Ccl1/Tfb3) Complex	4.211E-03	0.978	78	54	261	263	3	203	290	247	0.791	0.693
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4q5j-assembly2.cif.gz_B	4q5j-assembly2.cif.gz_B Crystal structure of SeMet derivative BRI1 in complex with BKI1	3.354E-03	0.978	78	40	263	263	18	294	294	317	0.852	0.942
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7f3m-assembly1.cif.gz_A	7f3m-assembly1.cif.gz_A Crystal structure of FGFR4 kinase domain with PRN1371	3.354E-03	0.978	78	55	263	263	17	251	298	266	0.795	0.789
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4bwk-assembly1.cif.gz_B	4bwk-assembly1.cif.gz_B Structure of Neurospora crassa PAN3 pseudokinase	2.010E-03	0.978	78	36	262	263	1	269	387	309	0.863	0.695
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4bhz-assembly1.cif.gz_A	4bhz-assembly1.cif.gz_A Scaffold Focused Virtual Screening: Prospective Application to the Discovery of TTK Inhibitor	2.524E-03	0.975	77	55	261	263	2	231	251	264	0.787	0.916
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8s98-assembly1.cif.gz_A	8s98-assembly1.cif.gz_A Crystal structure of the TYK2 pseudokinase domain in complex with compound 8	6.271E-03	0.975	77	53	261	263	10	223	256	249	0.795	0.836
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6gcx-assembly1.cif.gz_A	6gcx-assembly1.cif.gz_A Focal Adhesion Kinase catalytic domain in complex with irreversible inhibitor	6.271E-03	0.975	77	54	263	263	11	212	258	243	0.798	0.783
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6tnc-assembly1.cif.gz_A	6tnc-assembly1.cif.gz_A X-RAY STRUCTURE OF MPS1 IN COMPLEX WITH COMPOUND 46	3.169E-03	0.975	77	55	263	263	12	245	259	268	0.795	0.903
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6ccf-assembly1.cif.gz_A	6ccf-assembly1.cif.gz_A Crystal Structure of the Human CAMKK1A in complex with Hesperadin	1.794E-03	0.975	77	55	261	263	8	241	260	270	0.787	0.900
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1yom-assembly1.cif.gz_A	1yom-assembly1.cif.gz_A Crystal structure of Src kinase domain in complex with Purvalanol A	1.391E-02	0.975	77	58	263	263	18	206	260	232	0.783	0.727
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2qkr-assembly1.cif.gz_A	2qkr-assembly1.cif.gz_A Cryptosporidium parvum cyclin-dependent kinase cgd5_2510 with indirubin 3'-monoxime bound	1.046E-02	0.975	77	58	256	263	9	193	273	233	0.757	0.678
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5w84-assembly1.cif.gz_A	5w84-assembly1.cif.gz_A CRYSTAL STRUCTURE OF IRAK-4 WITH A 4,6-DIAMINONICOTINAMIDE INHIBITOR (COMPOUND NUMBER 4)	3.354E-03	0.975	77	34	263	263	3	282	282	324	0.875	0.993
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5nkc-assembly1.cif.gz_A	5nkc-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 2h	2.010E-03	0.975	77	58	260	263	18	222	286	240	0.772	0.717
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7v29-assembly2.cif.gz_A	7v29-assembly2.cif.gz_A Crystal structure of FGFR4 with a dual-warhead covalent inhhibitor	4.211E-03	0.975	77	55	263	263	16	230	293	258	0.795	0.734
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8ao9-assembly1.cif.gz_A	8ao9-assembly1.cif.gz_A Specific covalent inhibitor(10) of ERK2	6.271E-03	0.975	77	57	259	263	19	229	338	249	0.772	0.624
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8gds-assembly4.cif.gz_D	8gds-assembly4.cif.gz_D CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 2 (ROCK2) IN COMPLEX WITH 4-(4-(2-(2,3-DIHYDRO-1H- INDOL-1-YL)-2-OXOETHYL)PHENYL)-1(2H)-PHTHALAZINONE	7.027E-03	0.975	77	36	260	263	42	275	379	267	0.856	0.617
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5d10-assembly2.cif.gz_B	5d10-assembly2.cif.gz_B Kinase domain of cSrc in complex with RL236	4.458E-03	0.971	76	58	263	263	16	193	247	232	0.783	0.721
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8haq-assembly1.cif.gz_A	8haq-assembly1.cif.gz_A The complex of Src with GW8510	4.458E-03	0.971	76	58	260	263	16	191	247	229	0.772	0.713
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7bjx-assembly2.cif.gz_B	7bjx-assembly2.cif.gz_B Crystal structure of CHK1-10pt-mutant complex with compound 26	1.391E-02	0.971	76	54	240	263	3	177	252	216	0.711	0.694
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4ybj-assembly1.cif.gz_B	4ybj-assembly1.cif.gz_B Type II Dasatinib Analog Crystallized with c-Src Kinase	5.597E-03	0.971	76	58	260	263	14	197	253	231	0.772	0.727
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3u51-assembly2.cif.gz_B	3u51-assembly2.cif.gz_B Src in complex with DNA-templated macrocyclic inhibitor MC1	2.671E-03	0.971	76	58	263	263	12	201	255	235	0.783	0.745
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2zv2-assembly1.cif.gz_A	2zv2-assembly1.cif.gz_A Crystal structure of human calcium/calmodulin-dependent protein kinase kinase 2, beta, CaMKK2 kinase domain in complex with STO-609	2.010E-03	0.971	76	55	261	263	8	237	256	268	0.787	0.898
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6m7z-assembly2.cif.gz_B	6m7z-assembly2.cif.gz_B A divergent kinase lacking the glycine-rich loop regulates membrane ultrastructure of the Toxoplasma parasitophorous vacuole	4.995E-03	0.971	76	35	263	263	21	254	258	275	0.871	0.907
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3g6h-assembly2.cif.gz_B	3g6h-assembly2.cif.gz_B Src Thr338Ile inhibited in the DFG-Asp-Out conformation	3.550E-03	0.971	76	58	263	263	15	205	259	239	0.783	0.737
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7ote-assembly2.cif.gz_B	7ote-assembly2.cif.gz_B Src Kinase Domain in complex with ponatinib	4.211E-03	0.971	76	58	260	263	15	244	259	263	0.772	0.888
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6nvk-assembly1.cif.gz_A	6nvk-assembly1.cif.gz_A FGFR4 complex with BLU-554, N-((3S,4S)-3-((6-(2,6-dichloro-3,5-dimethoxyphenyl)quinazolin-2-yl)amino)tetrahydro-2H-pyran-4-yl)acrylamide	4.719E-03	0.971	76	54	260	263	16	263	268	282	0.787	0.925
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5fdx-assembly2.cif.gz_B	5fdx-assembly2.cif.gz_B Structure of DDR1 receptor tyrosine kinase in complex with D2164 inhibitor at 2.65 Angstroms resolution.	1.138E-03	0.971	76	55	260	263	8	226	274	259	0.783	0.799
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4qqj-assembly1.cif.gz_A	4qqj-assembly1.cif.gz_A Crystal Structure of FGF Receptor (FGFR) 4 Kinase Domain Harboring the V550L Gate-Keeper Mutation	6.271E-03	0.971	76	55	263	263	16	217	282	246	0.795	0.716
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3vs1-assembly1.cif.gz_A	3vs1-assembly1.cif.gz_A Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor 1-[4-(4-amino-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)phenyl]-3-phenylurea	4.211E-03	0.971	76	58	263	263	179	394	425	256	0.783	0.508
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3vrz-assembly1.cif.gz_A	3vrz-assembly1.cif.gz_A Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor 1-[4-(4-amino-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)phenyl]-3-benzylurea	8.823E-03	0.971	76	58	263	263	184	399	430	257	0.783	0.502
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5h09-assembly1.cif.gz_A	5h09-assembly1.cif.gz_A Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor (S)-ethyl2-(((1r,4S)-4-(4-amino-5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)cyclohexyl)amino)-4-methylpentanoate	9.339E-03	0.971	76	58	263	263	188	416	447	266	0.783	0.512
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4k11-assembly1.cif.gz_A	4k11-assembly1.cif.gz_A The structure of 1NA in complex with Src T338G	1.108E-02	0.971	76	58	263	263	189	396	448	245	0.783	0.464
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3u51-assembly1.cif.gz_A	3u51-assembly1.cif.gz_A Src in complex with DNA-templated macrocyclic inhibitor MC1	2.671E-03	0.967	75	58	263	263	12	202	256	237	0.783	0.746
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8an8-assembly1.cif.gz_A	8an8-assembly1.cif.gz_A Crystal structure of wild-type c-MET bound by compound 7.	6.638E-03	0.961	74	67	260	263	20	197	244	223	0.738	0.730
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6w8i-assembly2.cif.gz_B	6w8i-assembly2.cif.gz_B Ternary complex structure - BTK cIAP compound 15	2.010E-03	0.961	74	53	262	263	6	249	251	287	0.798	0.972
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6nzq-assembly3.cif.gz_B	6nzq-assembly3.cif.gz_B CRYSTAL STRUCTURE OF TYROSINE KINASE 2 JH2 (PSEUDO KINASE DOMAIN) COMPLEXED WITH Compound_29 AKA 6-[(5-FLUORO-4-METH YLPYRIDIN-2-YL)AMINO]-4-({2-METHOXY-3-[(PYRIDIN-2-YLMETHYL )CARBAMOYL]PHENYL}AMINO)-N-METHYLPYRIDINE-3-CARBOXAMIDE	1.108E-02	0.961	74	53	261	263	8	220	258	246	0.795	0.826
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6o8i-assembly1.cif.gz_A	6o8i-assembly1.cif.gz_A BTK In Complex With Inhibitor	3.354E-03	0.961	74	53	260	263	10	214	260	254	0.791	0.788
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4wun-assembly1.cif.gz_A	4wun-assembly1.cif.gz_A Structure of FGFR1 in complex with AZD4547 (N-{3-[2-(3,5-DIMETHOXYPHENYL)ETHYL]-1H-PYRAZOL-5-YL}-4-[(3R,5S)-3,5-DIMETHYLPIPERAZIN-1-YL]BENZAMIDE) at 1.65 angstrom	4.458E-03	0.961	74	54	260	263	15	232	282	260	0.787	0.773
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5xd6-assembly2.cif.gz_B	5xd6-assembly2.cif.gz_B CARK1 phosphorylates ABA receptors	5.597E-03	0.961	74	58	263	263	25	282	282	292	0.783	0.915
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3vn9-assembly1.cif.gz_A	3vn9-assembly1.cif.gz_A Rifined Crystal structure of non-phosphorylated MAP2K6 in a putative auto-inhibition state	5.597E-03	0.961	74	54	260	263	11	229	291	255	0.787	0.753
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4y85-assembly3.cif.gz_C	4y85-assembly3.cif.gz_C Crystal structure of COT kinase domain in complex with 5-(5-(1H-indol-3-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl)-1,3,4-oxadiazol-2-amine	1.695E-03	0.961	74	55	263	263	54	267	303	257	0.795	0.706
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6f3f-assembly1.cif.gz_A	6f3f-assembly1.cif.gz_A Autoinhibited Src kinase bound to ADP	9.339E-03	0.961	74	58	260	263	192	397	449	250	0.772	0.459
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3v8w-assembly3.cif.gz_A	3v8w-assembly3.cif.gz_A Crystal Structure of Interleukin-2 Inducible T-cell Kinase Itk Catalytic Domain with Thienopyrazolylindole Inhibitor 469	9.886E-03	0.956	73	55	260	263	11	197	243	234	0.783	0.770
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7kxw-assembly1.cif.gz_A	7kxw-assembly1.cif.gz_A Crystal structure of DCLK1-KD in complex with DCLK1-IN-1	3.084E-02	0.956	73	53	258	263	7	199	247	235	0.783	0.781
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3dk7-assembly1.cif.gz_A	3dk7-assembly1.cif.gz_A Crystal structure of mutant ABL kinase domain in complex with small molecule fragment	3.978E-03	0.956	73	67	263	263	24	220	266	247	0.749	0.741
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6pme-assembly1.cif.gz_A	6pme-assembly1.cif.gz_A TRK-A IN COMPLEX WITH LIGAND	7.438E-03	0.956	73	53	263	263	9	267	268	298	0.802	0.966
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5ime-assembly1.cif.gz_A	5ime-assembly1.cif.gz_A Crystal structure of P21-activated kinase 1 (PAK1) in complex with compound 9	1.746E-02	0.956	73	43	258	263	4	210	280	257	0.821	0.739
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6iup-assembly1.cif.gz_A	6iup-assembly1.cif.gz_A Crystal structure of FGFR4 kinase domain in complex with compound 5	4.995E-03	0.956	73	59	263	263	22	225	288	249	0.779	0.708
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4lud-assembly1.cif.gz_A	4lud-assembly1.cif.gz_A Crystal Structure of HCK in complex with the fluorescent compound SKF86002	8.823E-03	0.956	73	58	263	263	183	391	422	252	0.783	0.495
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3vrz-assembly2.cif.gz_B	3vrz-assembly2.cif.gz_B Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor 1-[4-(4-amino-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)phenyl]-3-benzylurea	1.472E-02	0.956	73	58	263	263	184	400	431	257	0.783	0.503
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7bjx-assembly1.cif.gz_A	7bjx-assembly1.cif.gz_A Crystal structure of CHK1-10pt-mutant complex with compound 26	2.457E-02	0.949	72	54	256	263	1	246	255	283	0.772	0.965
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3srv-assembly1.cif.gz_A	3srv-assembly1.cif.gz_A Crystal structure of spleen tyrosine kinase (SYK) in complex with a diaminopyrimidine carboxamide inhibitor	1.108E-02	0.949	72	58	263	263	9	219	263	254	0.783	0.802
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3omv-assembly1.cif.gz_B	3omv-assembly1.cif.gz_B Crystal structure of c-raf (raf-1)	6.271E-03	0.949	72	54	262	263	11	259	264	284	0.795	0.943
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3q4z-assembly1.cif.gz_A	3q4z-assembly1.cif.gz_A Structure of unphosphorylated PAK1 kinase domain	8.823E-03	0.949	72	43	263	263	4	261	282	305	0.840	0.915
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5iqc-assembly3.cif.gz_C	5iqc-assembly3.cif.gz_C Aminoglycoside Phosphotransferase (2'')-Ia (CTD of AAC(6')-Ie/APH(2'')-Ia) in complex with GMPPNP, Magnesium, and Gentamicin C1	1.350E-03	0.949	72	43	261	263	7	264	297	292	0.833	0.869
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4xv3-assembly1.cif.gz_B	4xv3-assembly1.cif.gz_B B-Raf Kinase V600E oncogenic mutant in complex with PLX7922	7.874E-03	0.941	71	60	263	263	11	194	238	228	0.776	0.773
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3nup-assembly1.cif.gz_A	3nup-assembly1.cif.gz_A CDK6 (monomeric) in complex with inhibitor	3.084E-02	0.941	71	61	241	263	3	165	252	208	0.688	0.647
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1v0b-assembly2.cif.gz_B	1v0b-assembly2.cif.gz_B Crystal structure of the t198a mutant of pfpk5	1.650E-02	0.941	71	55	262	263	2	207	261	257	0.791	0.789
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3g6g-assembly2.cif.gz_B	3g6g-assembly2.cif.gz_B Equally potent inhibition of c-Src and Abl by compounds that recognize inactive kinase conformations	1.046E-02	0.941	71	58	260	263	17	207	263	241	0.772	0.726
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7wf5-assembly2.cif.gz_B	7wf5-assembly2.cif.gz_B c-Src in complex with ponatinib	1.108E-02	0.941	71	58	263	263	19	211	265	238	0.783	0.728
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4dei-assembly1.cif.gz_A	4dei-assembly1.cif.gz_A Crystal structure of c-Met in complex with triazolopyridinone inhibitor 24	3.978E-03	0.941	71	44	260	263	8	240	287	270	0.825	0.812
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5kkr-assembly1.cif.gz_C	5kkr-assembly1.cif.gz_C KSR2:MEK1 Complex Bound to the Small Molecule APS-2-79	3.550E-03	0.941	71	36	256	263	4	243	309	276	0.840	0.777
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8h7f-assembly2.cif.gz_B	8h7f-assembly2.cif.gz_B The crystal structure of human abl1 kinase domain in complex with abl1-B-EBA	1.314E-02	0.933	70	66	263	263	23	213	257	240	0.753	0.743
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5iqg-assembly1.cif.gz_A	5iqg-assembly1.cif.gz_A Aminoglycoside Phosphotransferase (2'')-Ia (CTD of AAC(6')-Ie/APH(2'')-Ia) in complex with GDP, Magnesium, and Gentamicin C1	1.899E-03	0.933	70	43	261	263	7	259	292	295	0.833	0.866
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4tth-assembly1.cif.gz_B	4tth-assembly1.cif.gz_B Crystal structure of a CDK6/Vcyclin complex with inhibitor bound	6.462E-02	0.923	69	62	260	263	6	203	256	238	0.757	0.773
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7fd0-assembly1.cif.gz_A	7fd0-assembly1.cif.gz_A Crystal Structure of human RIPK1 kinase domain in complex with a novel inhibitor	5.287E-03	0.923	69	53	263	263	7	241	266	270	0.802	0.883
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5i8a-assembly1.cif.gz_A	5i8a-assembly1.cif.gz_A TrkA with (6~{R})-3-methylsulfanyl-6-phenyl-1-(1~{H}-pyrazol-3-yl)-6,7-dihydro-5~{H}-thieno[3,4-c]pyridin-4-one	5.287E-03	0.923	69	53	260	263	8	221	270	262	0.791	0.793
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6c18-assembly1.cif.gz_A	6c18-assembly1.cif.gz_A FGFR1 kinase complex with inhibitor SN37115	9.339E-03	0.923	69	54	260	263	15	226	276	254	0.787	0.768
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7s26-assembly1.cif.gz_B	7s26-assembly1.cif.gz_B ROCK1 IN COMPLEX WITH LIGAND G5018	1.314E-02	0.923	69	19	259	263	42	293	372	291	0.916	0.677
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6eqi-assembly1.cif.gz_C	6eqi-assembly1.cif.gz_C Structure of PINK1 bound to ubiquitin	1.108E-02	0.923	69	54	261	263	14	310	395	323	0.791	0.752
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3vs0-assembly1.cif.gz_A	3vs0-assembly1.cif.gz_A Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor N-[4-(4-amino-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)phenyl]benzamide	1.558E-02	0.923	69	58	263	263	183	398	429	253	0.783	0.503
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7s7a-assembly1.cif.gz_A	7s7a-assembly1.cif.gz_A Crystal structure of CDK2 liganded with compound EF3019	2.914E-02	0.912	68	54	259	263	4	196	278	246	0.783	0.694
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4fzf-assembly1.cif.gz_B	4fzf-assembly1.cif.gz_B Crystal structure of MST4-MO25 complex with DKI	9.886E-03	0.912	68	53	261	263	6	259	279	290	0.795	0.910
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4l68-assembly1.cif.gz_A	4l68-assembly1.cif.gz_A Structure of the psedudokinase domain of BIR2, an immune regulator of the RLK/Pelle family	4.719E-03	0.912	68	32	263	263	27	272	313	295	0.882	0.786
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3biz-assembly1.cif.gz_A	3biz-assembly1.cif.gz_A Wee1 kinase complex with inhibitor PD331618	1.046E-02	0.900	67	53	258	263	5	207	250	253	0.783	0.812
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3c5i-assembly4.cif.gz_D	3c5i-assembly4.cif.gz_D Crystal structure of Plasmodium knowlesi choline kinase, PKH_134520	6.638E-03	0.900	67	43	262	263	7	297	355	330	0.837	0.820
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5clr-assembly1.cif.gz_A	5clr-assembly1.cif.gz_A Crystal structure of LegK4_APO Kinase	8.335E-03	0.900	67	65	263	263	75	288	376	245	0.757	0.569
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8gds-assembly1.cif.gz_A	8gds-assembly1.cif.gz_A CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 2 (ROCK2) IN COMPLEX WITH 4-(4-(2-(2,3-DIHYDRO-1H- INDOL-1-YL)-2-OXOETHYL)PHENYL)-1(2H)-PHTHALAZINONE	9.339E-03	0.900	67	36	260	263	42	279	384	273	0.856	0.620
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6p8e-assembly1.cif.gz_B	6p8e-assembly1.cif.gz_B Crystal structure of CDK4 in complex with CyclinD1 and P27	6.462E-02	0.887	66	67	212	263	3	134	260	162	0.555	0.508
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7ah3-assembly1.cif.gz_A	7ah3-assembly1.cif.gz_A Kinase domain of cSrc in complex with a pyrazolopyrimidine	2.457E-02	0.887	66	58	260	263	16	209	265	238	0.772	0.732
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3oct-assembly1.cif.gz_A	3oct-assembly1.cif.gz_A Crystal structure of bruton's tyrosine kinase mutant V555R in complex with dasatinib	9.339E-03	0.872	65	53	263	263	7	244	244	282	0.802	0.975
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8a8m-assembly1.cif.gz_B	8a8m-assembly1.cif.gz_B Structure of the MAPK p38alpha in complex with its activating MAP2K MKK6	2.192E-02	0.872	65	54	263	263	31	239	298	250	0.798	0.701
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1oiq-assembly1.cif.gz_A	1oiq-assembly1.cif.gz_A Imidazopyridines: a potent and selective class of Cyclin-dependent Kinase inhibitors identified through Structure-based hybridisation	5.147E-02	0.855	64	52	259	263	1	181	264	234	0.791	0.686
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6m0u-assembly1.cif.gz_A	6m0u-assembly1.cif.gz_A Structure of AhSYMRK kinase domain mutant - K625E	1.957E-02	0.855	64	48	262	263	11	265	273	299	0.817	0.934
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3nyx-assembly1.cif.gz_A	3nyx-assembly1.cif.gz_A Non-phosphorylated TYK2 JH1 domain with Quinoline-Thiadiazole-Thiophene Inhibitor	7.438E-03	0.855	64	65	263	263	23	241	287	253	0.757	0.763
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4i93-assembly1.cif.gz_A	4i93-assembly1.cif.gz_A Structure of the BSK8 kinase domain (SeMet labeled)	1.391E-02	0.855	64	42	263	263	9	276	289	308	0.844	0.927
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4mkc-assembly1.cif.gz_A	4mkc-assembly1.cif.gz_A Crystal Structure of Anaplastic Lymphoma Kinase Complexed with LDK378	5.147E-02	0.855	64	55	260	263	26	246	303	260	0.783	0.729
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8gds-assembly3.cif.gz_C	8gds-assembly3.cif.gz_C CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 2 (ROCK2) IN COMPLEX WITH 4-(4-(2-(2,3-DIHYDRO-1H- INDOL-1-YL)-2-OXOETHYL)PHENYL)-1(2H)-PHTHALAZINONE	8.823E-03	0.855	64	26	259	263	26	305	385	316	0.890	0.727
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7s25-assembly2.cif.gz_D	7s25-assembly2.cif.gz_D ROCK1 IN COMPLEX WITH LIGAND G4998	7.027E-03	0.837	63	19	262	263	39	246	257	260	0.928	0.809
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6p8f-assembly1.cif.gz_B	6p8f-assembly1.cif.gz_B Crystal structure of CDK4 in complex with CyclinD1 and P27	1.848E-02	0.837	63	67	253	263	3	200	262	231	0.711	0.756
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4i93-assembly2.cif.gz_B	4i93-assembly2.cif.gz_B Structure of the BSK8 kinase domain (SeMet labeled)	8.335E-03	0.837	63	42	263	263	9	270	283	302	0.844	0.926
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5dfz-assembly1.cif.gz_C	5dfz-assembly1.cif.gz_C Structure of Vps34 complex II from S. cerevisiae.	4.211E-03	0.837	63	14	262	263	440	742	783	335	0.947	0.387
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4v04-assembly1.cif.gz_A	4v04-assembly1.cif.gz_A FGFR1 in complex with ponatinib.	1.391E-02	0.817	62	54	263	263	17	265	292	284	0.798	0.853
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6c18-assembly2.cif.gz_B	6c18-assembly2.cif.gz_B FGFR1 kinase complex with inhibitor SN37115	3.873E-02	0.795	61	62	263	263	16	231	255	250	0.768	0.847
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7rsp-assembly2.cif.gz_B	7rsp-assembly2.cif.gz_B Structure of the VPS34 kinase domain with compound 14	2.252E-03	0.795	61	52	262	263	264	509	534	273	0.802	0.461
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3eps-assembly1.cif.gz_A	3eps-assembly1.cif.gz_A The crystal structure of isocitrate dehydrogenase kinase/phosphatase from E. coli	4.099E-02	0.795	61	38	261	263	293	543	566	288	0.852	0.443
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6p8g-assembly1.cif.gz_B	6p8g-assembly1.cif.gz_B Crystal structure of CDK4 in complex with CyclinD1 and P27	8.114E-02	0.772	60	67	212	263	3	132	259	165	0.555	0.502
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4pdy-assembly1.cif.gz_A	4pdy-assembly1.cif.gz_A Crystal structure of aminoglycoside phosphotransferase from Alicyclobacillus acidocaldarius subsp. acidocaldarius DSM 446	6.638E-03	0.772	60	51	262	263	22	284	332	303	0.806	0.792
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3ihy-assembly5.cif.gz_E	3ihy-assembly5.cif.gz_E Human PIK3C3 crystal structure	4.719E-03	0.772	60	52	262	263	265	510	535	279	0.802	0.460
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4uwl-assembly1.cif.gz_A	4uwl-assembly1.cif.gz_A Discovery of (2S)-8-((3R)-3-Methylmorpholin-4-yl)-1-(3-methyl-2-oxo- butyl)-2-(trifluoromethyl)-3,4-dihydro-2H-pyrimido(1,2-a)pyrimidin-6- one: a Novel Potent and Selective Inhibitor of Vps34 for the Treatment of Solid Tumors	1.794E-03	0.772	60	55	262	263	275	520	543	273	0.791	0.453
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6i3u-assembly1.cif.gz_A	6i3u-assembly1.cif.gz_A Optimization of potent and selective ATM inhibitors suitable for a proof-of-concept study in Huntington's disease models	1.794E-03	0.747	59	55	262	263	286	532	557	274	0.791	0.443
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4fzd-assembly1.cif.gz_B	4fzd-assembly1.cif.gz_B Crystal structure of MST4-MO25 complex with WSF motif	2.600E-02	0.720	58	59	261	263	16	255	275	280	0.772	0.873
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4uwg-assembly1.cif.gz_A	4uwg-assembly1.cif.gz_A Discovery of (2S)-8-((3R)-3-Methylmorpholin-4-yl)-1-(3-methyl-2-oxo- butyl)-2-(trifluoromethyl)-3,4-dihydro-2H-pyrimido(1,2-a)pyrimidin-6- one: a Novel Potent and Selective Inhibitor of Vps34 for the Treatment of Solid Tumors	2.384E-03	0.692	57	55	262	263	276	521	544	271	0.791	0.452
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4uwf-assembly1.cif.gz_A	4uwf-assembly1.cif.gz_A Discovery of (2S)-8-((3R)-3-Methylmorpholin-4-yl)-1-(3-methyl-2-oxo- butyl)-2-(trifluoromethyl)-3,4-dihydro-2H-pyrimido(1,2-a)pyrimidin-6- one: a Novel Potent and Selective Inhibitor of Vps34 for the Treatment of Solid Tumors	7.874E-03	0.692	57	52	262	263	278	523	550	276	0.802	0.447
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4ith-assembly1.cif.gz_A	4ith-assembly1.cif.gz_A Crystal structure of RIP1 kinase in complex with necrostatin-1 analog	3.265E-02	0.663	56	69	240	263	14	168	247	198	0.654	0.628
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3ls8-assembly1.cif.gz_A	3ls8-assembly1.cif.gz_A Crystal structure of human PIK3C3 in complex with 3-[4-(4-Morpholinyl)thieno[3,2-d]pyrimidin-2-yl]-phenol	5.597E-03	0.663	56	55	262	263	277	522	547	277	0.791	0.450
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3ls8-assembly2.cif.gz_B	3ls8-assembly2.cif.gz_B Crystal structure of human PIK3C3 in complex with 3-[4-(4-Morpholinyl)thieno[3,2-d]pyrimidin-2-yl]-phenol	4.719E-03	0.632	55	57	262	263	261	497	522	268	0.783	0.454
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2bva-assembly1.cif.gz_A	2bva-assembly1.cif.gz_A Crystal structure of the human P21-activated kinase 4	6.841E-02	0.601	54	44	263	263	3	215	273	264	0.837	0.780
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4uwk-assembly1.cif.gz_A	4uwk-assembly1.cif.gz_A Discovery of (2S)-8-((3R)-3-Methylmorpholin-4-yl)-1-(3-methyl-2-oxo- butyl)-2-(trifluoromethyl)-3,4-dihydro-2H-pyrimido(1,2-a)pyrimidin-6- one: a Novel Potent and Selective Inhibitor of Vps34 for the Treatment of Solid Tumors	5.287E-03	0.601	54	55	262	263	276	521	544	275	0.791	0.452
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6hwl-assembly1.cif.gz_A	6hwl-assembly1.cif.gz_A Glucosamine kinase in complex with glucosamine, ADP and inorganic phosphate	7.665E-02	0.537	52	55	262	263	29	367	420	363	0.791	0.807
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4uwh-assembly1.cif.gz_A	4uwh-assembly1.cif.gz_A Discovery of (2S)-8-((3R)-3-Methylmorpholin-4-yl)-1-(3-methyl-2-oxo- butyl)-2-(trifluoromethyl)-3,4-dihydro-2H-pyrimido(1,2-a)pyrimidin-6- one: a Novel Potent and Selective Inhibitor of Vps34 for the Treatment of Solid Tumors	7.438E-03	0.537	52	55	262	263	282	527	554	273	0.791	0.444
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6pyr-assembly1.cif.gz_A	6pyr-assembly1.cif.gz_A Human PI3Kdelta in complex with Compound 2-10 ((3S)-3-benzyl-3-methyl-5-[5-(2-methylpyrimidin-5-yl)pyrazolo[1,5-a]pyrimidin-3-yl]-1,3-dihydro-2H-indol-2-one)	1.848E-02	0.537	52	57	261	263	674	919	933	278	0.779	0.264
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7ni6-assembly1.cif.gz_A	7ni6-assembly1.cif.gz_A Human ATM kinase with bound ATPyS	7.027E-03	0.505	51	55	262	263	1085	1385	1424	324	0.791	0.211
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6hwj-assembly1.cif.gz_A	6hwj-assembly1.cif.gz_A Glucosamine kinase (crystal form A)	1.141E-01	0.473	50	55	262	263	35	372	428	346	0.791	0.790
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4ph4-assembly1.cif.gz_B	4ph4-assembly1.cif.gz_B The crystal structure of Human VPS34 in complex with PIK-III	1.241E-02	0.473	50	55	262	263	259	504	529	272	0.791	0.465
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6ykg-assembly1.cif.gz_AAA	6ykg-assembly1.cif.gz_AAA Structure-based exploration of selectivity for ATM inhibitors in Huntingtons disease	9.339E-03	0.473	50	55	262	263	288	534	559	273	0.791	0.442
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2yzl-assembly1.cif.gz_A	2yzl-assembly1.cif.gz_A Crystal structure of phosphoribosylaminoimidazole-succinocarboxamide synthase with ADP from Methanocaldococcus jannaschii	6.841E-02	0.442	49	58	262	263	10	235	238	272	0.779	0.950
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7ni6-assembly1.cif.gz_B	7ni6-assembly1.cif.gz_B Human ATM kinase with bound ATPyS	1.391E-02	0.442	49	51	261	263	1076	1345	1423	305	0.802	0.190
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2z02-assembly1.cif.gz_B	2z02-assembly1.cif.gz_B Crystal structure of phosphoribosylaminoimidazolesuccinocarboxamide synthase wit ATP from Methanocaldococcus jannaschii	6.841E-02	0.411	48	45	262	263	2	239	242	282	0.829	0.983
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5wby-assembly2.cif.gz_A	5wby-assembly2.cif.gz_A Crystal structure of mTOR(deltaN)-mLST8-PRAS40(beta-strand) complex	3.758E-03	0.411	48	57	262	263	719	1011	1052	313	0.783	0.279
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8oxo-assembly1.cif.gz_B	8oxo-assembly1.cif.gz_B ATM(Q2971A) dimeric C-terminal region activated by oxidative stress in complex with Mg AMP-PNP and p53 peptide	4.458E-03	0.411	48	55	262	263	1147	1437	1476	311	0.791	0.197
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8oxq-assembly1.cif.gz_B	8oxq-assembly1.cif.gz_B ATM(Q2971A) dimeric C-terminal region in complex with Mg AMP-PNP	4.995E-03	0.411	48	55	262	263	1210	1511	1550	321	0.791	0.195
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7uxh-assembly1.cif.gz_C	7uxh-assembly1.cif.gz_C cryo-EM structure of the mTORC1-TFEB-Rag-Ragulator complex	4.995E-03	0.411	48	57	262	263	1855	2147	2188	313	0.783	0.134
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2ywv-assembly1.cif.gz_A	2ywv-assembly1.cif.gz_A Crystal structure of SAICAR synthetase from Geobacillus kaustophilus	1.354E-01	0.382	47	58	149	263	7	83	237	99	0.350	0.325
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6hwk-assembly1.cif.gz_D	6hwk-assembly1.cif.gz_D Glucosamine kinase (crystal form B)	3.265E-02	0.382	47	55	262	263	28	362	416	352	0.791	0.805
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6zwo-assembly1.cif.gz_B	6zwo-assembly1.cif.gz_B cryo-EM structure of human mTOR complex 2, focused on one half	3.550E-03	0.382	47	55	262	263	1254	1551	1592	319	0.791	0.187
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6sb2-assembly1.cif.gz_B	6sb2-assembly1.cif.gz_B cryo-EM structure of mTORC1 bound to active RagA/C GTPases	6.271E-03	0.382	47	52	261	263	1835	2104	2178	303	0.798	0.124
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6zwm-assembly1.cif.gz_A	6zwm-assembly1.cif.gz_A cryo-EM structure of human mTOR complex 2, overall refinement	3.978E-03	0.382	47	55	262	263	1846	2143	2184	320	0.791	0.136
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4fob-assembly1.cif.gz_A	4fob-assembly1.cif.gz_A Crystal structure of human anaplastic lymphoma kinase in complex with acyliminobenzimidazole inhibitor 1	3.178E-01	0.353	46	55	263	263	26	282	295	295	0.795	0.871
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6zwm-assembly1.cif.gz_B	6zwm-assembly1.cif.gz_B cryo-EM structure of human mTOR complex 2, overall refinement	6.271E-03	0.353	46	52	262	263	1847	2144	2185	320	0.802	0.136
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6bcu-assembly1.cif.gz_B	6bcu-assembly1.cif.gz_B Cryo-EM structure of the activated RHEB-mTORC1 refined to 3.4 angstrom	1.173E-02	0.353	46	52	261	263	1863	2130	2204	307	0.798	0.122
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6sl1-assembly1.cif.gz_A	6sl1-assembly1.cif.gz_A Structure of the open conformation of CtTel1	1.650E-02	0.353	46	52	263	263	2318	2588	2652	301	0.806	0.102
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7rsj-assembly1.cif.gz_A	7rsj-assembly1.cif.gz_A Structure of the VPS34 kinase domain with compound 14	1.046E-02	0.326	45	55	262	263	274	519	545	274	0.791	0.451
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7ni4-assembly1.cif.gz_B	7ni4-assembly1.cif.gz_B Human ATM kinase domain with bound M4076 inhibitor	8.335E-03	0.326	45	55	262	263	1093	1393	1432	321	0.791	0.210
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7pec-assembly1.cif.gz_A	7pec-assembly1.cif.gz_A cryo-EM structure of DEPTOR bound to human mTOR complex 1, DEPt-bound subset local refinement	1.108E-02	0.326	45	57	262	263	1859	2151	2192	318	0.783	0.134
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7pe9-assembly1.cif.gz_A	7pe9-assembly1.cif.gz_A cryo-EM structure of DEPTOR bound to human mTOR complex 2, DEPt-bound subset local refinement	5.924E-03	0.326	45	52	261	263	1856	2123	2194	299	0.798	0.122
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7pqh-assembly1.cif.gz_F	7pqh-assembly1.cif.gz_F Cryo-EM structure of Saccharomyces cerevisiae TOROID (TORC1 Organized in Inhibited Domains).	7.027E-03	0.326	45	55	262	263	1903	2197	2238	320	0.791	0.132
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7ni5-assembly1.cif.gz_A	7ni5-assembly1.cif.gz_A Human ATM kinase with bound inhibitor KU-55933	1.046E-02	0.326	45	55	262	263	2452	2752	2791	322	0.791	0.108
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4kuj-assembly2.cif.gz_B	4kuj-assembly2.cif.gz_B Structural and functional characterization of a novel Alpha Kinase from Entamoeba histolytica	8.114E-02	0.277	43	58	231	263	48	235	268	228	0.662	0.701
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6bcx-assembly1.cif.gz_B	6bcx-assembly1.cif.gz_B mTORC1 structure refined to 3.0 angstroms	5.287E-03	0.277	43	52	261	263	1835	2104	2178	305	0.798	0.124
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8oxp-assembly1.cif.gz_B	8oxp-assembly1.cif.gz_B ATM(Q2971A) in complex with Mg AMP-PNP	1.108E-02	0.277	43	55	262	263	2432	2730	2772	320	0.791	0.108
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6sky-assembly1.cif.gz_B	6sky-assembly1.cif.gz_B FAT and kinase domain of CtTel1	4.099E-02	0.233	41	52	263	263	1078	1348	1412	302	0.806	0.192
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7ale-assembly1.cif.gz_A	7ale-assembly1.cif.gz_A Crystal structure of human PAICS in complex with inhibitor 69	7.898E-01	0.214	40	54	152	263	2	86	419	110	0.376	0.203
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6syt-assembly1.cif.gz_A	6syt-assembly1.cif.gz_A Structure of the SMG1-SMG8-SMG9 complex	6.462E-02	0.214	40	50	262	263	1562	1851	1896	318	0.810	0.153
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6sl0-assembly1.cif.gz_B	6sl0-assembly1.cif.gz_B Complete CtTel1 dimer with C2 symmetry	5.147E-02	0.214	40	52	263	263	2304	2574	2638	302	0.806	0.103
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8oxm-assembly1.cif.gz_B	8oxm-assembly1.cif.gz_B ATM(Q2971A) activated by oxidative stress in complex with Mg AMP-PNP and p53 peptide	1.173E-02	0.214	40	55	262	263	2419	2709	2748	315	0.791	0.106
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7pqh-assembly1.cif.gz_K	7pqh-assembly1.cif.gz_K Cryo-EM structure of Saccharomyces cerevisiae TOROID (TORC1 Organized in Inhibited Domains).	2.914E-02	0.196	39	55	262	263	824	1116	1157	313	0.791	0.253
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4jsp-assembly1.cif.gz_B	4jsp-assembly1.cif.gz_B structure of mTORDeltaN-mLST8-ATPgammaS-Mg complex	5.147E-02	0.179	38	57	262	263	725	1017	1058	314	0.783	0.277
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7sic-assembly1.cif.gz_A	7sic-assembly1.cif.gz_A Human ATM Dimer	1.746E-02	0.179	38	55	262	263	2433	2734	2773	326	0.791	0.109
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7ni5-assembly1.cif.gz_B	7ni5-assembly1.cif.gz_B Human ATM kinase with bound inhibitor KU-55933	6.105E-02	0.179	38	55	262	263	2451	2751	2790	328	0.791	0.108
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5j0a-assembly1.cif.gz_B	5j0a-assembly1.cif.gz_B Crystal structure of PDZ-binding kinase	1.111E+00	0.164	37	119	213	263	65	169	303	116	0.361	0.347
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7k10-assembly1.cif.gz_A	7k10-assembly1.cif.gz_A CryoEM structure of activated-form FATKIN domain of DNA-PK	1.433E-01	0.164	37	52	263	263	850	1141	1259	328	0.806	0.232
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8era-assembly1.cif.gz_A	8era-assembly1.cif.gz_A RMC-5552 in complex with mTORC1 and FKBP12	3.658E-02	0.164	37	57	262	263	1844	2136	2177	313	0.783	0.135
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8ezb-assembly1.cif.gz_L	8ezb-assembly1.cif.gz_L NHEJ Long-range complex with ATP	1.799E-01	0.150	36	55	263	263	3315	3648	3724	356	0.795	0.090
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5ojs-assembly1.cif.gz_T	5ojs-assembly1.cif.gz_T Cryo-EM structure of the SAGA and NuA4 coactivator subunit Tra1	8.589E-02	0.138	35	52	263	263	3114	3433	3473	340	0.806	0.092
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7pw9-assembly1.cif.gz_A	7pw9-assembly1.cif.gz_A Human SMG1-9 kinase complex bound to AMPPNP	8.589E-02	0.126	34	51	262	263	1603	1911	1952	331	0.806	0.158
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7pw8-assembly1.cif.gz_A	7pw8-assembly1.cif.gz_A Human SMG1-8-9 kinase complex bound to AMPPNP	4.593E-02	0.116	33	55	262	263	1595	1902	1943	332	0.791	0.159
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3gxn-assembly1.cif.gz_A	3gxn-assembly1.cif.gz_A Crystal structure of apo alpha-galactosidase A at pH 4.5	4.877E+00	0.090	30	57	83	263	298	324	390	27	0.103	0.069
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5h64-assembly1.cif.gz_a	5h64-assembly1.cif.gz_a Cryo-EM structure of mTORC1	3.003E-01	0.090	30	52	263	263	1760	2085	2101	349	0.806	0.155
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8bhv-assembly1.cif.gz_A	8bhv-assembly1.cif.gz_A DNA-PK XLF mediated dimer bound to PAXX	2.259E-01	0.090	30	54	262	263	3173	3430	3549	298	0.795	0.073
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7pw4-assembly1.cif.gz_A	7pw4-assembly1.cif.gz_A Human SMG1-8-9 kinase complex bound to a SMG1 inhibitor	1.700E-01	0.082	29	57	262	263	1603	1903	1944	325	0.783	0.155
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3cxj-assembly1.cif.gz_A	3cxj-assembly1.cif.gz_A Crystal structure of an uncharacterized protein from Methanothermobacter thermautotrophicus	7.461E-01	0.076	28	40	155	263	4	119	144	138	0.441	0.806
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3a5v-assembly1.cif.gz_A	3a5v-assembly1.cif.gz_A Crystal structure of alpha-galactosidase I from Mortierella vinacea	6.124E+00	0.076	28	57	83	263	303	329	397	27	0.103	0.068
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4n6v-assembly7.cif.gz_4	4n6v-assembly7.cif.gz_4 Partial rotational order disorder structure of human stefin B	2.761E+00	0.069	27	36	91	263	6	71	91	67	0.213	0.725
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3h3h-assembly1.cif.gz_A	3h3h-assembly1.cif.gz_A Crystal structure of a snoal-like protein of unknown function (bth_ii0226) from burkholderia thailandensis e264 at 1.60 A resolution	6.862E+00	0.069	27	44	88	263	63	106	118	46	0.171	0.373
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3h3h-assembly1.cif.gz_B	3h3h-assembly1.cif.gz_B Crystal structure of a snoal-like protein of unknown function (bth_ii0226) from burkholderia thailandensis e264 at 1.60 A resolution	9.120E+00	0.069	27	54	88	263	76	108	120	35	0.133	0.275
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5yh0-assembly1.cif.gz_I	5yh0-assembly1.cif.gz_I The structure of DrFam20C1	1.477E+00	0.069	27	36	262	263	45	362	383	352	0.863	0.830
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3tv8-assembly1.cif.gz_A	3tv8-assembly1.cif.gz_A Pharmacological Chaperoning in Human alpha-Galactosidase	9.120E+00	0.063	26	57	83	263	298	324	390	27	0.103	0.069
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6z2w-assembly1.cif.gz_E	6z2w-assembly1.cif.gz_E Mec1-Ddc2 (F2244L mutant) in complex with Mg AMP-PNP	4.224E-01	0.063	26	58	263	263	2012	2286	2325	307	0.783	0.118
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2gu3-assembly1.cif.gz_A	2gu3-assembly1.cif.gz_A YpmB protein from Bacillus subtilis	2.078E+00	0.057	25	35	146	263	1	97	128	122	0.426	0.758
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1sng-assembly1.cif.gz_A	1sng-assembly1.cif.gz_A Structure of a Thermophilic Serpin in the Native State	6.482E+00	0.057	25	58	84	263	202	228	349	27	0.103	0.077
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4kqb-assembly1.cif.gz_A	4kqb-assembly1.cif.gz_A crystal structure of the Golgi casein kinase with Mn/ADP bound	1.111E+00	0.057	25	36	262	263	80	397	419	351	0.863	0.759
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7pw6-assembly1.cif.gz_A	7pw6-assembly1.cif.gz_A Human SMG1-8-9 kinase complex bound to a SMG1 inhibitor - SMG1 body	4.224E-01	0.057	25	57	262	263	1075	1375	1416	326	0.783	0.213
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3u97-assembly1.cif.gz_A	3u97-assembly1.cif.gz_A 1.1 Angstrom-resolution crystal structure of the Brucella abortus ribonuclease toxin, BrnT	9.120E+00	0.051	24	51	86	263	29	63	77	36	0.137	0.455
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4ogz-assembly2.cif.gz_B	4ogz-assembly2.cif.gz_B Crystal structure of a putative alpha-galactosidase/melibiase (BF4189) from Bacteroides fragilis NCTC 9343 at 2.00 A resolution	8.139E+00	0.051	24	56	83	263	383	412	466	30	0.106	0.064
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7k11-assembly1.cif.gz_A	7k11-assembly1.cif.gz_A CryoEM structure of inactivated-form FATKIN domain of DNA-PK	7.898E-01	0.051	24	58	263	263	854	1149	1254	327	0.783	0.236
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	1uas-assembly1.cif.gz_A	1uas-assembly1.cif.gz_A Crystal structure of rice alpha-galactosidase	7.689E+00	0.045	23	56	83	263	274	305	362	32	0.106	0.088
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3n4x-assembly2.cif.gz_C	3n4x-assembly2.cif.gz_C Structure of Csm1 full-length	6.862E+00	0.040	22	5	84	263	26	101	153	84	0.304	0.497
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2ve7-assembly2.cif.gz_B	2ve7-assembly2.cif.gz_B Crystal structure of a bonsai version of the human Ndc80 complex	5.785E+00	0.040	22	2	82	263	174	257	303	89	0.308	0.277
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2h31-assembly1.cif.gz_A	2h31-assembly1.cif.gz_A Crystal structure of human PAICS, a bifunctional carboxylase and synthetase in purine biosynthesis	7.263E+00	0.040	22	59	149	263	7	68	386	94	0.346	0.161
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5jk2-assembly1.cif.gz_A	5jk2-assembly1.cif.gz_A Crystal structure of Treponema pallidum Tp0751 (Pallilysin)	6.482E+00	0.034	21	55	83	263	62	93	128	33	0.110	0.250
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	5zcs-assembly1.cif.gz_B	5zcs-assembly1.cif.gz_B 4.9 Angstrom Cryo-EM structure of human mTOR complex 2	2.328E+00	0.034	21	57	262	263	1845	2133	2178	314	0.783	0.133
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3u54-assembly1.cif.gz_A	3u54-assembly1.cif.gz_A Crystal structure (Type-1) of SAICAR synthetase from Pyrococcus horikoshii OT3	4.353E+00	0.029	20	58	262	263	4	218	225	264	0.779	0.956
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8amz-assembly1.cif.gz_I	8amz-assembly1.cif.gz_I Spinach 19S proteasome	8.139E+00	0.029	20	1	84	263	11	109	384	103	0.319	0.258
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4kqa-assembly2.cif.gz_B	4kqa-assembly2.cif.gz_B Crystal structure of the golgi casein kinase	3.094E+00	0.020	18	36	262	263	88	405	426	347	0.863	0.746
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	6ik7-assembly2.cif.gz_A	6ik7-assembly2.cif.gz_A Crystal structure of tomato beta-galactosidase (TBG) 4 in complex with beta-1,3-galactobiose	8.615E+00	0.020	18	33	81	263	299	353	705	55	0.186	0.078
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4kqa-assembly3.cif.gz_C	4kqa-assembly3.cif.gz_C Crystal structure of the golgi casein kinase	5.163E+00	0.016	17	36	262	263	79	396	419	346	0.863	0.759
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3epu-assembly1.cif.gz_B	3epu-assembly1.cif.gz_B Crystal Structure of STM2138, a novel virulence chaperone in Salmonella	9.653E+00	0.011	15	40	148	263	9	92	133	115	0.414	0.632
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4wd6-assembly2.cif.gz_B	4wd6-assembly2.cif.gz_B Crystal Structure of DIM-1 metallo-beta-lactamase	7.263E+00	0.009	13	52	237	263	2	212	214	243	0.707	0.986
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	7aqk-assembly1.cif.gz_d	7aqk-assembly1.cif.gz_d Model of the actin filament Arp2/3 complex branch junction in cells	6.482E+00	0.009	13	34	203	263	6	145	281	178	0.646	0.498
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	4lim-assembly1.cif.gz_A	4lim-assembly1.cif.gz_A Crystal structure of the catalytic subunit of yeast primase	9.653E+00	0.008	12	93	260	263	102	252	381	189	0.639	0.396
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8d0k-assembly1.cif.gz_D	8d0k-assembly1.cif.gz_D Human CST-DNA polymerase alpha/primase preinitiation complex bound to 4xTEL-foldback template - PRIM2C advanced PIC	9.120E+00	0.008	12	30	262	263	14	298	419	318	0.886	0.680
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	8ox5-assembly1.cif.gz_A	8ox5-assembly1.cif.gz_A Cryo-EM structure of ATP8B1-CDC50A in E1P-ADP conformation	7.263E+00	0.008	12	55	245	263	321	482	869	222	0.726	0.186
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3fcz-assembly2.cif.gz_B	3fcz-assembly2.cif.gz_B Adaptive protein evolution grants organismal fitness by improving catalysis and flexibility	9.120E+00	0.007	11	48	235	263	7	218	219	251	0.715	0.968
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	3tcs-assembly1.cif.gz_A	3tcs-assembly1.cif.gz_A Crystal structure of a putative racemase from Roseobacter denitrificans	6.862E+00	0.007	11	54	187	263	8	141	366	168	0.510	0.366
LOKIASV2_0096_ESMFold_serine-threonine-protein_kinase_Rio1	2xep-assembly2.cif.gz_B	2xep-assembly2.cif.gz_B Structural and mechanistic studies on a cephalosporin esterase from the clavulanic acid biosynthesis pathway	9.653E+00	0.007	11	28	263	263	42	293	423	311	0.897	0.596
